Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes,Toxicity
Steroid Metabolic Process (GO:0008202),10/106,1.897549871766485e-8,2.3226010430421776e-5,0,0,13.179754273504274,234.3375760603823,UGT2B10;UGT1A1;AKR1C1;AKR1C3;UGT1A3;AKR1C4;CYP2C19;CYP3A5;UGT2B7;UGT1A7,High
Retinoid Metabolic Process (GO:0001523),8/64,5.6699425682814915e-8,3.470004851788273e-5,0,0,17.88245931283906,298.37780625372324,RBP4;UGT1A1;AKR1C1;AKR1C3;UGT1A3;AKR1C4;CYP3A5;UGT1A7,High
Estrogen Metabolic Process (GO:0008210),6/31,1.8512507730793777e-7,7.553103154163861e-5,0,0,29.7135,460.62563431975184,UGT2B10;UGT1A1;UGT1A3;CYP3A5;UGT1A7;UGT2B7,High
Aminoglycoside Antibiotic Metabolic Process (GO:0030647),3/8,3.0497934604365866e-5,0.006871916120738374,0,0,72.99018404907976,758.9411016000184,AKR1C1;AKR1C3;AKR1C4,High
Daunorubicin Metabolic Process (GO:0044597),3/8,3.0497934604365866e-5,0.006871916120738374,0,0,72.99018404907976,758.9411016000184,AKR1C1;AKR1C3;AKR1C4,High
Xenobiotic Catabolic Process (GO:0042178),4/23,3.583089065766689e-5,0.006871916120738374,0,0,25.750487329434698,263.60001799914767,PRKCE;CYP2C19;CYP3A5;UGT1A7,High
Polyketide Metabolic Process (GO:0030638),3/9,4.54679243942918e-5,0.006871916120738374,0,0,60.82208588957055,608.129834932478,AKR1C1;AKR1C3;AKR1C4,High
Doxorubicin Metabolic Process (GO:0044598),3/9,4.54679243942918e-5,0.006871916120738374,0,0,60.82208588957055,608.129834932478,AKR1C1;AKR1C3;AKR1C4,High
Retinoic Acid Metabolic Process (GO:0042573),4/25,5.052879500542922e-5,0.006871916120738374,0,0,23.295708406819518,230.46367884461378,UGT1A1;UGT1A3;CYP3A5;UGT1A7,High
Negative Regulation of Fatty Acid Metabolic Process (GO:0045922),4/26,5.933080619525875e-5,0.007262090678299671,0,0,22.235690235690235,216.4062289495212,UGT1A1;APOC1;UGT1A3;UGT1A7,High
Prostaglandin Metabolic Process (GO:0006693),4/30,1.0598340959353105e-4,0.011793063031134728,0,0,18.811016144349477,172.16270846481115,AKR1C1;AKR1C3;AKR1C4;S100A9,High
Tertiary Alcohol Metabolic Process (GO:1902644),3/13,1.510683847110121e-4,0.014613876372195203,0,0,36.485889570552146,320.9947545597437,AKR1C1;AKR1C3;AKR1C4,High
Negative Regulation of Lipid Metabolic Process (GO:0045833),4/33,1.5521273924717127e-4,0.014613876372195203,0,0,16.862494678586632,147.89611597386534,UGT1A1;APOC1;UGT1A3;UGT1A7,High
Positive Regulation of Release of Sequestered Calcium Ion Into Cytosol (GO:0051281),4/36,2.1914600433410456e-4,0.019159622093210284,0,0,15.279320987654321,128.74008051582524,CXCL10;CXCL9;CXCL11;CALM2,High
Glycoside Metabolic Process (GO:0016137),3/15,2.3741879753489317e-4,0.019373373878847282,0,0,30.401840490797547,253.72418105754255,AKR1C1;AKR1C3;AKR1C4,High
Defense Response to Virus (GO:0051607),8/198,2.5441190858780895e-4,0.019462511006967383,0,0,5.2349100599600265,43.32702583228623,CXCL10;STAT2;DDX60L;RNASE1;IFI44L;IFIT3;IFIT2;BCL2L1,High
Regulation of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904705),4/38,2.7109561562575497e-4,0.01951888432505436,0,0,14.379084967320262,118.09598524886276,CNN1;IGFBP5;MMP2;SOD2,High
C21-steroid Hormone Metabolic Process (GO:0008207),3/16,2.904298199196884e-4,0.01974922775453881,0,0,28.061821613968853,228.53964505964552,AKR1C1;AKR1C3;AKR1C4,High
Lipid Metabolic Process (GO:0006629),9/259,3.226404928228201e-4,0.020784840169217462,0,0,4.49059872611465,36.09979688328802,UGT2B10;UGT1A1;APOC1;AKR1C3;AKR1C4;CYP2C19;CYP3A5;UGT2B7;UGT1A7,High
Neutrophil Chemotaxis (GO:0030593),4/43,4.3886538389310907e-4,0.026858561494258276,0,0,12.532446976891421,96.89233082269298,CXCL10;CXCL9;S100A9;S100A8,High
Regulation of Fatty Acid Metabolic Process (GO:0019217),3/20,5.769863133914015e-4,0.03304158892668399,0,0,21.454709491158425,160.00261559263004,UGT1A1;UGT1A3;UGT1A7,High
Chemokine-Mediated Signaling Pathway (GO:0070098),4/47,6.181665343394704e-4,0.03304158892668399,0,0,11.364341085271318,83.9683054657519,CXCL10;CXCL9;CXCL11;CCL15,High
Cellular Response to Chemokine (GO:1990869),4/48,6.700381131167424e-4,0.03304158892668399,0,0,11.105499438832773,81.16094404430798,CXCL10;CXCL9;CXCL11;CCL15,High
Primary Alcohol Metabolic Process (GO:0034308),4/48,6.700381131167424e-4,0.03304158892668399,0,0,11.105499438832773,81.16094404430798,RBP4;AKR1C1;AKR1C3;AKR1C4,High
Monocarboxylic Acid Metabolic Process (GO:0032787),6/127,6.748690548750815e-4,0.03304158892668399,0,0,6.109400826446281,44.604685817536705,LDHA;UGT1A1;AKR1C1;UGT1A3;CYP3A5;UGT1A7,High
Regulation of Interleukin-2 Production (GO:0032663),4/50,7.829035357803533e-4,0.03549162695537602,0,0,10.621578099838969,75.97084870082031,GLMN;RPS3;GBP1;RUNX1,High
Neutrophil Migration (GO:1990266),4/50,7.829035357803533e-4,0.03549162695537602,0,0,10.621578099838969,75.97084870082031,CXCL10;CXCL9;S100A9;S100A8,High
Regulation of Lipid Metabolic Process (GO:0019216),4/51,8.440887816142691e-4,0.03689873816770948,0,0,10.395061728395062,73.568480528184807,RNF213;MID1IP1;APOC1;CERS2,High
Prostanoid Metabolic Process (GO:0006692),3/23,8.801265209300206e-4,0.03714740902132225,0,0,18.233742331288344,128.28248925631055,AKR1C1;AKR1C3;AKR1C4,High
Regulation of Protein Localization to Plasma Membrane (GO:1903076),5/90,9.231522977418176e-4,0.03766461374786616,0,0,7.215564486664231,50.420317823232594,DLG1;PRKCE;STX3;GBP1;BCL2L1,High
Regulation of Release of Sequestered Calcium Ion Into Cytosol (GO:0051279),4/53,9.764437877146e-4,0.03843723168988146,0,0,9.969765684051398,69.10636175958095,CXCL10;CXCL9;CXCL11;CALM2,High
Negative Regulation of Lipase Activity (GO:0060192),2/6,0.0010048949461406917,0.03843723168988146,0,0,60.457317073170735,417.3291377931697,APOC1;PLIN5,High
Protein Homooligomerization (GO:0051260),6/143,0.0012508236541829843,0.04436986646785385,0,0,5.391514598540146,36.036630290382874,STEAP4;TDO2;AKR1C1;SSBP1;SOD2;S100A9,High
Diterpenoid Metabolic Process (GO:0016101),3/26,0.0012687461816788274,0.04436986646785385,0,0,15.853027473993064,105.7353514987663,AKR1C1;AKR1C3;AKR1C4,High
Positive Regulation of Interleukin-2 Production (GO:0032743),3/26,0.0012687461816788274,0.04436986646785385,0,0,15.853027473993064,105.7353514987663,GLMN;RPS3;RUNX1,High
Positive Regulation of Supramolecular Fiber Organization (GO:1902905),5/98,0.0013527290412339507,0.045992787401954324,0,0,6.59219929205904,43.545637419209214,PRKCE;PLEK;LMOD1;RPS3;RNASE1,High
Leukocyte Aggregation (GO:0070486),2/7,0.0013991842644018836,0.0462865280980515,0,0,48.363414634146345,317.8378744968035,S100A9;S100A8,High
Cytoplasmic Translation (GO:0002181),5/101,0.0015467121823665659,0.04757053131970262,0,0,6.3852225672877845,41.32275816612837,RPL7A;RPS3;RPL38;RPL27;RPS20,High
Inflammatory Response (GO:0006954),8/261,0.0015491729131122797,0.04757053131970262,0,0,3.918747185670686,25.354427900630522,CXCL10;GSDMB;CXCL9;FPR1;RNASE1;S100A9;S100A8;CCL15,High
Negative Regulation of Intrinsic Apoptotic Signaling Pathway (GO:2001243),4/60,0.0015545925267876671,0.04757053131970262,0,0,8.720458553791888,56.39120982599672,TXNDC12;ENO1;SOD2;BCL2L1,High
Regulation of Reactive Oxygen Species Metabolic Process (GO:2000377),4/61,0.0016530508488864515,0.0493496155862687,0,0,8.567034871128438,54.87299518687706,AKR1C1;AKR1C3;RNASE1;PLIN5,High
Negative Regulation of Ferroptosis (GO:0110076),2/8,0.001855415818156856,0.054072118129142664,0,0,40.300813008130085,253.47786536035218,FTH1;SC5D,High
Regulation of Muscle Contraction (GO:0006937),3/30,0.0019336358929995464,0.054921729256612824,0,0,13.501704158145875,84.36341592244764,CNN1;ENO1;PPP1R12B,High
Granulocyte Chemotaxis (GO:0071621),4/64,0.0019743105288324873,0.054921729256612824,0,0,8.137448559670782,50.67625418634994,CXCL10;CXCL9;S100A9;S100A8,High
Apoptotic Mitochondrial Changes (GO:0008637),3/32,0.0023337809211780225,0.06178717379260566,0,0,12.569282843240956,76.173192602866,SOD2;IFIT2;BCL2L1,High
Regulation of Respiratory Burst (GO:0060263),2/9,0.002372546706088616,0.06178717379260566,0,0,34.541811846689896,208.7635033494158,RNASE1;S100A9,High
Progesterone Metabolic Process (GO:0042448),2/9,0.002372546706088616,0.06178717379260566,0,0,34.541811846689896,208.7635033494158,AKR1C3;AKR1C4,High
Cortical Cytoskeleton Organization (GO:0030865),3/33,0.002551638693063508,0.06506678667311945,0,0,12.149693251533742,72.54605534185774,DLG1;PLEK;RNASE1,High
Negative Regulation of Small Molecule Metabolic Process (GO:0062014),3/34,0.002781658680672939,0.06928466146050812,0,0,11.757173956065703,69.18753424317946,UGT1A1;UGT1A3;UGT1A7,High
Antimicrobial Humoral Immune Response Mediated by Antimicrobial Peptide (GO:0061844),5/116,0.0028360124019259016,0.06928466146050812,0,0,5.518157909462257,32.36596224369015,CXCL10;CXCL11;CXCL9;S100A9;CCL15,High
Positive Regulation of Protein Polymerization (GO:0032273),4/71,0.002886860894187838,0.06928466146050812,0,0,7.284687672747374,42.59783446596653,PRKCE;LMOD1;RPS3;RNASE1,High
Copper Ion Transport (GO:0006825),2/10,0.0029495468813782112,0.06942779582321021,0,0,30.222560975609756,176.07977492674317,STEAP4;CUTC,High
Negative Regulation of Smooth Muscle Cell Proliferation (GO:0048662),3/36,0.0032790529897592773,0.07572756338613879,0,0,11.043502509760179,63.17104991333868,CNN1;IGFBP5;SOD2,High
Spliceosomal snRNP Assembly (GO:0000387),3/37,0.0035468414741331956,0.0797914253016277,0,0,10.718152291591483,60.46857617279529,GEMIN4;PRPF19;PRPF8,High
Regulation of Ferroptosis (GO:0110075),2/11,0.003585399012736539,0.0797914253016277,0,0,26.863143631436316,151.2632862407391,FTH1;SC5D,High
Positive Regulation of Intrinsic Apoptotic Signaling Pathway (GO:2001244),3/39,0.004121578956010731,0.09008594003852027,0,0,10.121676891615541,55.583380428642826,RPS3;S100A9;S100A8,High
DNA Strand Elongation Involved in DNA Replication (GO:0006271),2/12,0.004279098349809464,0.09030373069253075,0,0,24.17560975609756,131.8540888655576,POLD2;POLE3,High
T Cell Chemotaxis (GO:0010818),2/12,0.004279098349809464,0.09030373069253075,0,0,24.17560975609756,131.8540888655576,CXCL10;CXCL11,High
Proteolysis Involved in Protein Catabolic Process (GO:0051603),4/80,0.004436538059475615,0.09203936584403649,0,0,6.419103313840156,34.777937386879785,PSMB1;UBC;GLMN;PRPF19,High
Positive Regulation of Apoptotic Process (GO:0043065),8/313,0.004707299960937787,0.09530640522497284,0,0,3.2420004150238637,17.372715671723,HSPA9;UBD;GLMN;ECSCR;RPS3;AKR1C3;IFIT2;BCL2L1,High
Positive Regulation of DNA Biosynthetic Process (GO:2000573),3/41,0.004749747319218418,0.09530640522497284,0,0,9.587988375847594,51.29251488811611,SMOC2;CCT8;HNRNPA1,High
Macromolecule Biosynthetic Process (GO:0009059),6/189,0.005016550369573998,0.09671645090438984,0,0,4.026844262295082,21.32219174683004,RPL7A;ABCC6;RPS3;RPL38;RPL27;RPS20,High
Regulation of Pattern Recognition Receptor Signaling Pathway (GO:0062207),2/13,0.005029652586137185,0.09671645090438984,0,0,21.97671840354767,116.30968042089769,S100A9;S100A8,High
Protein Tetramerization (GO:0051262),4/83,0.005057069328334109,0.09671645090438984,0,0,6.174402250351617,32.64386802806872,TDO2;SSBP1;SOD2;CUTC,High
Spliceosomal tri-snRNP Complex Assembly (GO:0000244),2/14,0.005836081726626109,0.10823278838470239,0,0,20.14430894308943,103.6161941728909,PRPF19;PRPF8,High
Protein Homotrimerization (GO:0070207),2/14,0.005836081726626109,0.10823278838470239,0,0,20.14430894308943,103.6161941728909,STEAP4;S100A9,High
Positive Regulation of Calcium Ion Transmembrane Transport (GO:1904427),3/45,0.006171702422164881,0.11077891320440339,0,0,8.673093777388257,44.12679791400487,CXCL10;CXCL9;CXCL11,High
Endothelial Cell Migration (GO:0043542),3/45,0.006171702422164881,0.11077891320440339,0,0,8.673093777388257,44.12679791400487,GLMN;S100A9;S100A8,High
Regulation of Intrinsic Apoptotic Signaling Pathway (GO:2001242),3/46,0.006562575377164179,0.11077891320440339,0,0,8.47096590098445,42.57822721610337,S100A9;S100A8;BCL2L1,High
Regulation of Calcium-Mediated Signaling (GO:0050848),3/46,0.006562575377164179,0.11077891320440339,0,0,8.47096590098445,42.57822721610337,PLEK;GBP1;CALM2,High
Regulation of Intrinsic Apoptotic Signaling Pathway in Response to DNA Damage (GO:1902229),2/15,0.006697417955168179,0.11077891320440339,0,0,18.593808630393998,93.08122344256823,RPS3;BCL2L1,High
Retinal Metabolic Process (GO:0042574),2/15,0.006697417955168179,0.11077891320440339,0,0,18.593808630393998,93.08122344256823,AKR1C1;AKR1C3,High
Copper Ion Homeostasis (GO:0055070),2/15,0.006697417955168179,0.11077891320440339,0,0,18.593808630393998,93.08122344256823,MT2A;CUTC,High
Protein Trimerization (GO:0070206),2/15,0.006697417955168179,0.11077891320440339,0,0,18.593808630393998,93.08122344256823,STEAP4;S100A9,High
Regulation of Plasminogen Activation (GO:0010755),2/16,0.007612705496478405,0.12237358803042737,0,0,17.264808362369337,84.21664149536396,ENO1;RUNX1,High
Ruffle Organization (GO:0031529),2/16,0.007612705496478405,0.12237358803042737,0,0,17.264808362369337,84.21664149536396,PLEK;RNASE1,High
Antimicrobial Humoral Response (GO:0019730),5/147,0.007698338462698454,0.12237358803042737,0,0,4.306709824162366,20.95968329895587,CXCL10;CXCL11;CXCL9;S100A9;CCL15,High
Negative Regulation of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904706),2/17,0.008581000495283724,0.131289307577841,0,0,16.1130081300813,76.66899205398923,CNN1;SOD2,High
Release of Cytochrome C From Mitochondria (GO:0001836),2/17,0.008581000495283724,0.131289307577841,0,0,16.1130081300813,76.66899205398923,SOD2;BCL2L1,High
Cortical Actin Cytoskeleton Organization (GO:0030866),2/17,0.008581000495283724,0.131289307577841,0,0,16.1130081300813,76.66899205398923,DLG1;PLEK,High
Organic Hydroxy Compound Transport (GO:0015850),3/51,0.008735810014014328,0.13200779576732763,0,0,7.586656441717792,35.963214220811075,RBP4;AKR1C1;AKR1C4,High
Regulation of Substrate Adhesion-Dependent Cell Spreading (GO:1900024),3/52,0.009215030171132827,0.13589393890923593,0,0,7.431451108050582,34.83061247052997,NEDD9;RNASE1;GBP1,High
Positive Regulation of Reactive Oxygen Species Metabolic Process (GO:2000379),3/52,0.009215030171132827,0.13589393890923593,0,0,7.431451108050582,34.83061247052997,PRKCE;AKR1C1;AKR1C3,High
Positive Regulation of Lymphocyte Migration (GO:2000403),2/18,0.009601370877517652,0.13990568992954291,0,0,15.105182926829269,70.1764049009769,CXCL10;NEDD9,High
Hemopoiesis (GO:0030097),4/101,0.01002071079701563,0.14429823547702506,0,0,5.024054982817869,23.1262337615073,MFAP5;ZBTB16;PLEK;RUNX1,High
Defense Response to Bacterium (GO:0042742),6/221,0.010465725757779936,0.1461133274614829,0,0,3.4219186046511627,15.602749709775381,GSDMB;RNF213;RNASE1;S100A9;GBP1;S100A8,High
Negative Regulation of Lipid Catabolic Process (GO:0050995),2/19,0.01067289622724377,0.1461133274614829,0,0,14.215925394548064,64.54098101179628,APOC1;PLIN5,High
Cell Projection Organization (GO:0030030),2/19,0.01067289622724377,0.1461133274614829,0,0,14.215925394548064,64.54098101179628,PLEK;RNASE1,High
DNA-templated DNA Replication (GO:0006261),3/55,0.010743627019226683,0.1461133274614829,0,0,7.001651722510618,31.74158573846616,POLD2;POLE3;SSBP1,High
Positive Regulation of Protein Localization to Plasma Membrane (GO:1903078),3/55,0.010743627019226683,0.1461133274614829,0,0,7.001651722510618,31.74158573846616,DLG1;PRKCE;STX3,High
Regulation of Fibroblast Migration (GO:0010762),2/20,0.011794667655805476,0.15095122278322584,0,0,13.425474254742548,59.61055219489654,PRKCE;RNASE1,High
T Cell Migration (GO:0072678),2/20,0.011794667655805476,0.15095122278322584,0,0,13.425474254742548,59.61055219489654,CXCL10;CXCL11,High
Regulation of Sodium Ion Transmembrane Transport (GO:1902305),2/20,0.011794667655805476,0.15095122278322584,0,0,13.425474254742548,59.61055219489654,DLG1;PRKCE,High
Cellular Response to Fatty Acid (GO:0071398),2/20,0.011794667655805476,0.15095122278322584,0,0,13.425474254742548,59.61055219489654,AKR1C3;AKR1C4,High
Positive Regulation of Protein Localization to Cell Periphery (GO:1904377),3/57,0.011839311590841242,0.15095122278322584,0,0,6.741649625085208,29.90818109167935,DLG1;PRKCE;STX3,High
Myeloid Cell Differentiation (GO:0030099),3/57,0.011839311590841242,0.15095122278322584,0,0,6.741649625085208,29.90818109167935,HSPA9;ZBTB16;RUNX1,High
Positive Regulation of Cell Growth (GO:0030307),4/107,0.012193026452762885,0.15385839565135848,0,0,4.729953254225099,20.844388865888895,GOLGA4;S100A9;TEAD1;S100A8,High
Positive Regulation of Vascular Associated Smooth Muscle Cell Proliferation (GO:1904707),2/21,0.012965787679204827,0.15514701632394065,0,0,12.718228498074454,55.26631293087005,IGFBP5;MMP2,High
Lymphocyte Chemotaxis (GO:0048247),2/21,0.012965787679204827,0.15514701632394065,0,0,12.718228498074454,55.26631293087005,CXCL10;CXCL11,High
Regulation of Cardiac Muscle Cell Proliferation (GO:0060043),2/21,0.012965787679204827,0.15514701632394065,0,0,12.718228498074454,55.26631293087005,RBP4;RUNX1,High
Protein Homotetramerization (GO:0051289),3/59,0.012996976154489567,0.15514701632394065,0,0,6.500219106047327,28.23070217451619,TDO2;SSBP1;SOD2,High
Apoptotic Process (GO:0006915),6/232,0.013055672125298928,0.15514701632394065,0,0,3.2535398230088495,14.115588568091018,PRKCE;ZBTB16;GLMN;PAEP;IFIT2;BCL2L1,High
Translation (GO:0006412),6/232,0.013055672125298928,0.15514701632394065,0,0,3.2535398230088495,14.115588568091018,RPL7A;RPS3;RPL38;RPL27;RPS20;MRPL45,High
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),9/455,0.013912534376532526,0.16227002799159754,0,0,2.491959669818057,10.6530405978326,HERC5;PSMB4;RNF213;ANKIB1;UBXN2B;UBD;UBR5;PSMB1;PSMB9,High
Negative Regulation of Myeloid Cell Differentiation (GO:0045638),2/22,0.014185370094036713,0.16227002799159754,0,0,12.081707317073171,51.4142385392671,HSPA9;ZBTB16,High
Positive Regulation of Telomere Maintenance via Telomerase (GO:0032212),2/22,0.014185370094036713,0.16227002799159754,0,0,12.081707317073171,51.4142385392671,CCT8;HNRNPA1,High
Regulation of Biosynthetic Process (GO:0009889),2/22,0.014185370094036713,0.16227002799159754,0,0,12.081707317073171,51.4142385392671,MID1IP1;RNASE1,High
ATP Metabolic Process (GO:0046034),3/62,0.01485074429194618,0.16676432122332224,0,0,6.168763647707185,25.96867698715954,LDHA;ENO1;ALDOB,High
Antiviral Innate Immune Response (GO:0140374),3/62,0.01485074429194618,0.16676432122332224,0,0,6.168763647707185,25.96867698715954,CXCL10;IFIT3;IFIT2,High
Regulatory ncRNA-mediated Post-Transcriptional Gene Silencing (GO:0035194),2/23,0.01545253984792937,0.1688741854809424,0,0,11.505807200929151,47.97900774627138,HELZ2;TNRC6A,High
Positive Regulation of Phosphate Metabolic Process (GO:0045937),2/23,0.01545253984792937,0.1688741854809424,0,0,11.505807200929151,47.97900774627138,GLMN;S100A9,High
Maturation of LSU-rRNA (GO:0000470),2/23,0.01545253984792937,0.1688741854809424,0,0,11.505807200929151,47.97900774627138,RPL7A;RPL7L1,High
Regulation of Extracellular Matrix Organization (GO:1903053),2/24,0.01676643292366346,0.1777585558991417,0,0,10.982261640798226,44.89961965764408,GLMN;RUNX1,High
Negative Regulation of Protein Localization to Cell Periphery (GO:1904376),2/24,0.01676643292366346,0.1777585558991417,0,0,10.982261640798226,44.89961965764408,GBP1;BCL2L1,High
Negative Regulation of Receptor-Mediated Endocytosis (GO:0048261),2/24,0.01676643292366346,0.1777585558991417,0,0,10.982261640798226,44.89961965764408,APOC1;RNASE1,High
Regulation of Phosphorylation (GO:0042325),3/65,0.01684639908848075,0.1777585558991417,0,0,5.869384524045122,23.968326339547914,STAT2;GLMN;S100A9,High
Negative Regulation of Intrinsic Apoptotic Signaling Pathway in Response to DNA Damage (GO:1902230),2/25,0.018126196217959568,0.18488720142318757,0,0,10.50424178154825,42.12618059130718,S100A9;BCL2L1,High
Bile Acid and Bile Salt Transport (GO:0015721),2/25,0.018126196217959568,0.18488720142318757,0,0,10.50424178154825,42.12618059130718,AKR1C1;AKR1C4,High
Regulation of Toll-Like Receptor Signaling Pathway (GO:0034121),2/25,0.018126196217959568,0.18488720142318757,0,0,10.50424178154825,42.12618059130718,S100A9;S100A8,High
Positive Regulation of Telomere Maintenance via Telomere Lengthening (GO:1904358),2/25,0.018126196217959568,0.18488720142318757,0,0,10.50424178154825,42.12618059130718,CCT8;HNRNPA1,High
Reg of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Sgnlng Pway (GO:1902235),2/26,0.019530987419333175,0.18823565827766778,0,0,10.066056910569106,39.617513445035065,TXNDC12;BCL2L1,High
Regulation of Fatty Acid Biosynthetic Process (GO:0042304),2/26,0.019530987419333175,0.18823565827766778,0,0,10.066056910569106,39.617513445035065,MID1IP1;APOC1,High
Negative Regulation of Lipid Biosynthetic Process (GO:0051055),2/26,0.019530987419333175,0.18823565827766778,0,0,10.066056910569106,39.617513445035065,APOC1;AKR1C3,High
NADH Metabolic Process (GO:0006734),2/26,0.019530987419333175,0.18823565827766778,0,0,10.066056910569106,39.617513445035065,GPD1;ENO1,High
Fatty Acid Derivative Biosynthetic Process (GO:1901570),2/26,0.019530987419333175,0.18823565827766778,0,0,10.066056910569106,39.617513445035065,GGT7;ACACA,High
Regulation of Actin Filament Bundle Assembly (GO:0032231),2/26,0.019530987419333175,0.18823565827766778,0,0,10.066056910569106,39.617513445035065,PLEK;RNASE1,High
Regulation of Cell Size (GO:0008361),2/26,0.019530987419333175,0.18823565827766778,0,0,10.066056910569106,39.617513445035065,PLEK;RNASE1,High
Positive Regulation of Apoptotic Signaling Pathway (GO:2001235),3/70,0.02049025526966963,0.19454158531920007,0,0,5.42999725299881,21.11077513213399,RPS3;S100A9;S100A8,High
Negative Regulation of Protein Localization to Plasma Membrane (GO:1903077),2/27,0.02097997488736471,0.19454158531920007,0,0,9.662926829268292,37.3393550083645,GBP1;BCL2L1,High
Regulation of Myeloid Cell Differentiation (GO:0045637),2/27,0.02097997488736471,0.19454158531920007,0,0,9.662926829268292,37.3393550083645,HSPA9;ZBTB16,High
Striated Muscle Cell Development (GO:0055002),2/27,0.02097997488736471,0.19454158531920007,0,0,9.662926829268292,37.3393550083645,LMOD1;MYH11,High
Gluconeogenesis (GO:0006094),2/27,0.02097997488736471,0.19454158531920007,0,0,9.662926829268292,37.3393550083645,RBP4;ENO1,High
Monocarboxylic Acid Transport (GO:0015718),3/72,0.022059473856344488,0.20077475286697846,0,0,5.272072552680715,20.107753864506382,AKR1C1;UGT1A3;AKR1C4,High
ADP Catabolic Process (GO:0046032),2/28,0.02247233753494775,0.20077475286697846,0,0,9.29080675422139,35.262979882036056,LDHA;ENO1,High
Positive Regulation of Microtubule Polymerization or Depolymerization (GO:0031112),2/28,0.02247233753494775,0.20077475286697846,0,0,9.29080675422139,35.262979882036056,RPS3;RNASE1,High
Glycolytic Process (GO:0006096),2/28,0.02247233753494775,0.20077475286697846,0,0,9.29080675422139,35.262979882036056,LDHA;ENO1,High
Membrane Fusion (GO:0061025),2/28,0.02247233753494775,0.20077475286697846,0,0,9.29080675422139,35.262979882036056,UBXN2B;STX3,High
DNA Replication (GO:0006260),3/73,0.022868047977986455,0.2028296429351842,0,0,5.196494303242769,19.632431489591283,POLD2;POLE3;SSBP1,High
Positive Regulation of Cytoskeleton Organization (GO:0051495),3/74,0.023692598578629136,0.20863122777152565,0,0,5.123045018577724,19.173470252407807,PRKCE;PLEK;LMOD1,High
Negative Regulation of Protein Localization to Membrane (GO:1905476),2/29,0.024007264727038603,0.20989208589925176,0,0,8.94625112917796,33.36413820309008,GBP1;BCL2L1,High
Positive Regulation of Protein Localization to Membrane (GO:1905477),3/76,0.02538960714812374,0.21596387808105919,0,0,4.9821833767543495,18.301628923006675,DLG1;PRKCE;STX3,High
Negative Regulation of Response to Endoplasmic Reticulum Stress (GO:1903573),2/30,0.025583956145223512,0.21596387808105919,0,0,8.626306620209059,31.622227139558046,TXNDC12;BCL2L1,High
Positive Regulation of Catalytic Activity (GO:0043085),2/30,0.025583956145223512,0.21596387808105919,0,0,8.626306620209059,31.622227139558046,MID1IP1;SSBP1,High
Positive Regulation of Microtubule Polymerization (GO:0031116),2/30,0.025583956145223512,0.21596387808105919,0,0,8.626306620209059,31.622227139558046,RPS3;RNASE1,High
Hexose Biosynthetic Process (GO:0019319),2/30,0.025583956145223512,0.21596387808105919,0,0,8.626306620209059,31.622227139558046,RBP4;ENO1,High
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),5/202,0.026840037278584868,0.22345493247527687,0,0,3.095658479679667,11.199660776462702,CXCL10;CXCL11;CXCL9;FPR1;OXER1,High
Regulation of Cell Population Proliferation (GO:0042127),12/769,0.026922787564984133,0.22345493247527687,0,0,1.9636981248606082,7.098341086053361,CXCL10;CXCL11;CXCL9;FTH1;STAT2;GLMN;AKR1C3;STX3;SOD2;S100A9;IFIT3;RUNX1,High
Positive Regulation of ATP-dependent Activity (GO:0032781),2/31,0.027201621682039424,0.22345493247527687,0,0,8.328427249789739,30.019638516383253,ALDOB;SSBP1,High
Transition Metal Ion Transport (GO:0000041),2/31,0.027201621682039424,0.22345493247527687,0,0,8.328427249789739,30.019638516383253,FTH1;CUTC,High
Positive Regulation of Growth (GO:0045927),3/79,0.02805471369761198,0.22446381308118368,0,0,4.784791733936067,17.098925112839883,TEAD1;S100A9;S100A8,High
protein-RNA Complex Assembly (GO:0022618),4/138,0.028105482795669788,0.22446381308118368,0,0,3.6299981573613413,12.965593312422481,GEMIN4;RPS27L;RPL38;PRPF19,High
Regulation of Cytoskeleton Organization (GO:0051493),4/139,0.02875722579879784,0.22446381308118368,0,0,3.6029263831732967,12.786303702631804,NEDD9;RNASE1;S100A9;S100A8,High
Membraneless Organelle Assembly (GO:0140694),4/139,0.02875722579879784,0.22446381308118368,0,0,3.6029263831732967,12.786303702631804,RNF213;LMOD1;RPS3;TNRC6A,High
Bile Acid Metabolic Process (GO:0008206),2/32,0.02885948133509038,0.22446381308118368,0,0,8.050406504065041,28.541240600967136,AKR1C1;AKR1C4,High
Lipid Droplet Organization (GO:0034389),2/32,0.02885948133509038,0.22446381308118368,0,0,8.050406504065041,28.541240600967136,RNF213;PLIN5,High
Pyridine Nucleotide Catabolic Process (GO:0019364),2/32,0.02885948133509038,0.22446381308118368,0,0,8.050406504065041,28.541240600967136,LDHA;ENO1,High
Mitochondrial Membrane Organization (GO:0007006),2/32,0.02885948133509038,0.22446381308118368,0,0,8.050406504065041,28.541240600967136,HSPA9;BCL2L1,High
Response to Tumor Necrosis Factor (GO:0034612),3/80,0.028974903976165867,0.22446381308118368,0,0,4.722412556768385,16.723598609956646,UBD;RPS3;GBP1,High
Regulation of Cytokinesis (GO:0032465),3/81,0.02991096620699741,0.22894517987349866,0,0,4.661632845681925,16.360140801290566,PRKCE;CALM2;BCL2L1,High
Modification-Dependent Protein Catabolic Process (GO:0019941),5/208,0.029927474493267797,0.22894517987349866,0,0,3.0032432763210233,10.538315609734365,HERC5;RNF213;ANKIB1;UBD;UBC,High
Negative Regulation of Endocytosis (GO:0045806),2/34,0.03229271278042159,0.2455048474735157,0,0,7.546493902439025,25.906462189344023,APOC1;RNASE1,High
Platelet Aggregation (GO:0070527),2/35,0.034066574059665906,0.2510774186025793,0,0,7.317442719881744,24.728848441514916,PLEK;CLIC1,High
Positive Regulation of Substrate Adhesion-Dependent Cell Spreading (GO:1900026),2/35,0.034066574059665906,0.2510774186025793,0,0,7.317442719881744,24.728848441514916,NEDD9;RNASE1,High
'De Novo' Post-Translational Protein Folding (GO:0051084),2/36,0.03587760819925143,0.2510774186025793,0,0,7.1018651362984215,23.63246403210629,HSPA9;CCT8,High
Superoxide Metabolic Process (GO:0006801),2/37,0.03772508404145059,0.2510774186025793,0,0,6.898606271777004,22.609699474728522,SOD2;RNASE1,High
Intrinsic Apoptotic Signaling Pathway by P53 Class Mediator (GO:0072332),2/37,0.03772508404145059,0.2510774186025793,0,0,6.898606271777004,22.609699474728522,RPS27L;FHIT,High
Muscle Cell Differentiation (GO:0042692),2/37,0.03772508404145059,0.2510774186025793,0,0,6.898606271777004,22.609699474728522,GLMN;MRTFA,High
Cellular Response to Hormone Stimulus (GO:0032870),3/89,0.03796687955996592,0.2510774186025793,0,0,4.2262804965044944,13.824337161250691,AKR1C1;AKR1C3;AKR1C4,High
Inner Mitochondrial Membrane Organization (GO:0007007),2/38,0.03960827986169273,0.2510774186025793,0,0,6.706639566395664,21.65384181910448,HSPA9;TIMM10,High
Gene Expression (GO:0010467),7/381,0.04008468796813619,0.2510774186025793,0,0,2.290720747990448,7.368700851967508,RPL7A;ABCC6;RPS3;RPL38;RPL27;RPS20;THOC2,High
DNA Metabolic Process (GO:0006259),6/302,0.04050209678690154,0.2510774186025793,0,0,2.4752533783783783,7.936656228712961,EID3;MGMT;POLD2;POLE3;RPS3;SSBP1,High
Negative Regulation of Programmed Cell Death (GO:0043069),7/382,0.04055961431092024,0.2510774186025793,0,0,2.284494758909853,7.321765561092336,HSPA9;MGMT;FTH1;SC5D;S100A9;IFIT3;BCL2L1,High
Negative Regulation of Erythrocyte Differentiation (GO:0045647),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,HSPA9,High
Negative Regulation of Fibroblast Migration (GO:0010764),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,RNASE1,High
Negative Regulation of Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0043569),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,IGFBP5,High
L-phenylalanine Catabolic Process (GO:0006559),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,FAH,High
L-phenylalanine Metabolic Process (GO:0006558),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,FAH,High
Regulation of Inositol Phosphate Biosynthetic Process (GO:0010919),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,PLEK,High
Negative Regulation of Peroxisome Proliferator Activated Receptor Signaling Pathway (GO:0035359),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,PLIN5,High
Astrocyte Differentiation (GO:0048708),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,S100A9,High
Autocrine Signaling (GO:0035425),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,S100A9,High
Nucleic Acid Biosynthetic Process (GO:0141187),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,POLD2,High
Regulation of Respiratory Burst Involved in Inflammatory Response (GO:0060264),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,S100A9,High
Regulation of Sperm Capacitation (GO:1902490),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,PAEP,High
Peripheral Nervous System Neuron Development (GO:0048935),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,RUNX1,High
Phenylpropanoid Metabolic Process (GO:0009698),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,UGT1A7,High
Chronic Inflammatory Response (GO:0002544),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,S100A9,High
Cilium Disassembly (GO:0061523),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,NEDD9,High
Coumarin Metabolic Process (GO:0009804),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,UGT1A7,High
Ruffle Assembly (GO:0097178),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,RNASE1,High
Positive Regulation of Granulocyte Differentiation (GO:0030854),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,RUNX1,High
Thrombin-Activated Receptor Signaling Pathway (GO:0070493),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,PLEK,High
Glutathione Catabolic Process (GO:0006751),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,GGT7,High
Intracellular Oxygen Homeostasis (GO:0032364),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,SOD2,High
Positive Regulation of Vascular Associated Smooth Muscle Cell Differentiation (GO:1905065),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,SOD2,High
Monoterpenoid Metabolic Process (GO:0016098),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,CYP2C19,High
Negative Regulation of Calcium-Mediated Signaling (GO:0050849),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,PLEK,High
Negative Regulation of Cardiac Muscle Tissue Growth (GO:0055022),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,RBP4,High
Negative Regulation of Cellular Response to Hypoxia (GO:1900038),1/5,0.04082059338391608,0.2510774186025793,0,0,30.045454545454547,96.1024470343946,ENO1,High
Positive Regulation of Response to Stimulus (GO:0048584),3/92,0.041245122582799824,0.2524201502067349,0,0,4.083201213207417,13.01815362722486,CXCL10;AKR1C1;RPS3,High
Actin Filament Organization (GO:0007015),4/158,0.04285372214054184,0.2597714065511491,0,0,3.155363155363155,9.939276475596806,CNN1;DLG1;LMOD1;RNASE1,High
Carbohydrate Catabolic Process (GO:0016052),2/40,0.043478991211383655,0.2597714065511491,0,0,6.353016688061618,19.919740362918372,LDHA;ENO1,High
Positive Regulation of Lipid Biosynthetic Process (GO:0046889),2/40,0.043478991211383655,0.2597714065511491,0,0,6.353016688061618,19.919740362918372,MID1IP1;PLIN5,High
Regulation of T Cell Receptor Signaling Pathway (GO:0050856),2/40,0.043478991211383655,0.2597714065511491,0,0,6.353016688061618,19.919740362918372,RPS3;GBP1,High
Positive Regulation of Phosphorylation (GO:0042327),3/94,0.04350746596649147,0.2597714065511491,0,0,3.9930560237308703,12.517522762198771,GLMN;RNASE1;S100A9,High
Positive Regulation of Actin Filament Polymerization (GO:0030838),2/41,0.04546510959358319,0.26304543320668783,0,0,6.1898061288305195,19.131515110021255,PRKCE;LMOD1,High
Negative Regulation of DNA Metabolic Process (GO:0051053),2/41,0.04546510959358319,0.26304543320668783,0,0,6.1898061288305195,19.131515110021255,H1-5;RPS3,High
Regulation of Receptor-Mediated Endocytosis (GO:0048259),2/42,0.04748415348842961,0.26304543320668783,0,0,6.034756097560976,18.390069721084554,APOC1;RNASE1,High
Defense Response to Fungus (GO:0050832),2/42,0.04748415348842961,0.26304543320668783,0,0,6.034756097560976,18.390069721084554,S100A9;S100A8,High
Regulation of Endodeoxyribonuclease Activity (GO:0032071),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,RPS3,High
Negative Regulation of Granulocyte Differentiation (GO:0030853),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,RUNX1,High
Negative Regulation of Steroid Metabolic Process (GO:0045939),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,UGT1A1,High
Neurotransmitter Receptor Transport to Postsynaptic Membrane (GO:0098969),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,STX3,High
Regulation of Potassium Ion Export Across Plasma Membrane (GO:1903764),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,DLG1,High
Regulation of Triglyceride Storage (GO:0010889),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,PLIN5,High
Regulation of Vascular Associated Smooth Muscle Cell Apoptotic Process (GO:1905459),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,SOD2,High
Copper Ion Import (GO:0015677),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,STEAP4,High
Definitive Hemopoiesis (GO:0060216),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,MFAP5,High
Positive Regulation of Fibroblast Growth Factor Receptor Signaling Pathway (GO:0045743),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,SMOC2,High
Glycerol-3-Phosphate Metabolic Process (GO:0006072),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,GPD1,High
Heart Trabecula Formation (GO:0060347),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,RBP4,High
Hepatocyte Growth Factor Receptor Signaling Pathway (GO:0048012),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,RNASE1,High
Positive Regulation of Pyroptotic Inflammatory Response (GO:0140639),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,GBP1,High
Inclusion Body Assembly (GO:0070841),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,UBD,High
Leukotriene Transport (GO:0071716),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,ABCC6,High
Lipid Hydroxylation (GO:0002933),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,CYP3A5,High
Lymphocyte Migration Into Lymphoid Organs (GO:0097021),1/6,0.048783752727057296,0.26304543320668783,0,0,24.035151515151515,72.5947611380124,NEDD9,High
Positive Regulation of Myeloid Leukocyte Differentiation (GO:0002763),2/43,0.04953544685119325,0.264765881859653,0,0,5.887269482450922,17.691637874086517,NEDD9;RUNX1,High
Mitochondrial Transport (GO:0006839),2/43,0.04953544685119325,0.264765881859653,0,0,5.887269482450922,17.691637874086517,TIMM10;BCL2L1,High
Regulation of Telomere Maintenance via Telomerase (GO:0032210),2/44,0.051618322485528084,0.26786790251144804,0,0,5.746806039488966,17.032835338764485,CCT8;HNRNPA1,High
Embryonic Organ Morphogenesis (GO:0048562),2/44,0.051618322485528084,0.26786790251144804,0,0,5.746806039488966,17.032835338764485,MFAP5;RBP4,High
Substantia Nigra Development (GO:0021762),2/44,0.051618322485528084,0.26786790251144804,0,0,5.746806039488966,17.032835338764485,LDHA;CALM2,High
Positive Regulation of Wound Healing (GO:0090303),2/44,0.051618322485528084,0.26786790251144804,0,0,5.746806039488966,17.032835338764485,SMOC2;PRKCE,High
Chromatin Organization (GO:0006325),6/323,0.05296056930202069,0.26786790251144804,0,0,2.308793375394322,6.783714283395833,H1-5;KDM4B;EID3;KDM5D;POLE3;CABIN1,High
Negative Regulation of Translation (GO:0017148),3/102,0.05316057944244062,0.26786790251144804,0,0,3.668897564603086,10.766152964497447,IGFBP5;RPS3;TNRC6A,High
Regulation of Fibroblast Proliferation (GO:0048145),2/46,0.05587619533061399,0.26786790251144804,0,0,5.485033259423504,15.82221927153863,FTH1;S100A9,High
Positive Regulation of Chemotaxis (GO:0050921),2/46,0.05587619533061399,0.26786790251144804,0,0,5.485033259423504,15.82221927153863,SMOC2;STX3,High
Homotypic Cell-Cell Adhesion (GO:0034109),2/46,0.05587619533061399,0.26786790251144804,0,0,5.485033259423504,15.82221927153863,PLEK;CLIC1,High
Negative Regulation of Fatty Acid Oxidation (GO:0046322),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,PLIN5,High
L-tryptophan Catabolic Process (GO:0006569),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,TDO2,High
Negative Regulation of Macrophage Migration (GO:1905522),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,S100A9,High
Negative Regulation of p38MAPK Cascade (GO:1903753),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,DLG1,High
Negative Regulation of Sodium Ion Transport (GO:0010766),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,PRKCE,High
Cellular Response to Erythropoietin (GO:0036018),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,MT2A,High
"Positive Regulation of CD8-positive, Alpha-Beta T Cell Activation (GO:2001187)",1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,RUNX1,High
Chaperone Mediated Protein Folding Independent of Cofactor (GO:0051086),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,CCT8,High
Positive Regulation of Bicellular Tight Junction Assembly (GO:1903348),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,RNASE1,High
Positive Regulation of cAMP/PKA Signal Transduction (GO:0141163),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,S100A9,High
Skeletal Myofibril Assembly (GO:0014866),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,MYH11,High
Elastic Fiber Assembly (GO:0048251),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,MYH11,High
Positive Regulation of Fibroblast Migration (GO:0010763),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,PRKCE,High
Establishment of Centrosome Localization (GO:0051660),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,DLG1,High
Fructose Metabolic Process (GO:0006000),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,ALDOB,High
Glycerol Transmembrane Transport (GO:0015793),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,AQP7,High
Positive Regulation of Phosphatase Activity (GO:0010922),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,PLEK,High
Positive Regulation of Plasminogen Activation (GO:0010756),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,ENO1,High
Positive Regulation of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060316),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,CALM2,High
Leukotriene D4 Biosynthetic Process (GO:1901750),1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,GGT7,High
"Regulation of CD8-positive, Alpha-Beta T Cell Differentiation (GO:0043376)",1/7,0.05668119832554333,0.26786790251144804,0,0,20.02828282828283,57.487435010574046,RUNX1,High
Positive Regulation of NF-kappaB Transcription Factor Activity (GO:0051092),3/105,0.057024394393510404,0.2684533028371413,0,0,3.5604474918801876,10.198104766263324,RPS3;S100A9;S100A8,High
Positive Regulation of miRNA Transcription (GO:1902895),2/47,0.058049901426630884,0.2722340204835103,0,0,5.362872628726287,15.265160961949023,MRTFA;TEAD1,High
Protein Catabolic Process (GO:0030163),3/107,0.0596724685565704,0.27877519661542816,0,0,3.491623407267579,9.842483200902858,GLMN;PSMB1;PRPF19,High
Pyruvate Metabolic Process (GO:0006090),2/48,0.06025260736103883,0.2799748871287214,0,0,5.246023329798516,14.737178217753359,LDHA;ENO1,High
Positive Regulation of Smooth Muscle Cell Proliferation (GO:0048661),2/49,0.06248368864095802,0.2799748871287214,0,0,5.134146341463414,14.236216338017247,IGFBP5;MMP2,High
Supramolecular Fiber Organization (GO:0097435),6/339,0.0638641414129721,0.2799748871287214,0,0,2.1960585585585584,6.041351038651389,CNN1;DLG1;LUM;LMOD1;MYH11;RNASE1,High
Regulation of Interleukin-23 Production (GO:0032667),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,RNASE1,High
Acid Secretion (GO:0046717),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,UGT1A3,High
Negative Regulation of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060315),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,CALM2,High
Regulation of Mitotic Centrosome Separation (GO:0046602),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,UBXN2B,High
Negative Regulation of Sodium Ion Transmembrane Transport (GO:1902306),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,PRKCE,High
Regulation of Morphogenesis of an Epithelium (GO:1905330),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,CXCL10,High
Regulation of Skeletal Muscle Cell Differentiation (GO:2001014),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,UQCC2,High
Sphingosine-1-Phosphate Receptor Signaling Pathway (GO:0003376),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,RNASE1,High
Positive Regulation of Fatty Acid Beta-Oxidation (GO:0032000),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,PLIN5,High
Terpenoid Metabolic Process (GO:0006721),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,CYP2C19,High
Establishment of Protein Localization to Chromatin (GO:0071169),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,H1-5,High
Positive Regulation of Telomerase RNA Localization to Cajal Body (GO:1904874),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,CCT8,High
Positive Regulation of Vascular Associated Smooth Muscle Cell Migration (GO:1904754),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,IGFBP5,High
Kynurenine Metabolic Process (GO:0070189),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,TDO2,High
Negative Regulation of Alpha-Beta T Cell Differentiation (GO:0046639),1/8,0.06451346874924052,0.2799748871287214,0,0,17.166233766233766,47.050608420266336,RUNX1,High
Negative Regulation of ERK1 and ERK2 Cascade (GO:0070373),2/50,0.06474252903659296,0.2799748871287214,0,0,5.0269308943089435,13.760403766207606,DLG1;GBP1,High
External Encapsulating Structure Organization (GO:0045229),3/111,0.06513879270916369,0.2799748871287214,0,0,3.361622358554874,9.181380686478157,SMOC2;COL4A1;MMP2,High
Extracellular Structure Organization (GO:0043062),3/111,0.06513879270916369,0.2799748871287214,0,0,3.361622358554874,9.181380686478157,SMOC2;COL4A1;MMP2,High
Extracellular Matrix Organization (GO:0030198),4/182,0.06532668786073542,0.2799748871287214,0,0,2.7265917602996255,7.439109253361989,SMOC2;COL4A1;LUM;MMP2,High
Nicotinamide Nucleotide Metabolic Process (GO:0046496),2/51,0.06702852046500261,0.2799748871287214,0,0,4.924091587854654,13.30803246921321,LDHA;ENO1,High
Blood Vessel Morphogenesis (GO:0048514),2/51,0.06702852046500261,0.2799748871287214,0,0,4.924091587854654,13.30803246921321,COL4A1;GLMN,High
Positive Regulation of Actin Filament Bundle Assembly (GO:0032233),2/51,0.06702852046500261,0.2799748871287214,0,0,4.924091587854654,13.30803246921321,PLEK;RNASE1,High
Negative Regulation of Cell Migration (GO:0030336),4/184,0.06743107848560409,0.2799748871287214,0,0,2.6960219478738,7.270225596642642,IGFBP5;NEDD9;RNASE1;S100A9,High
Positive Regulation of Cell Migration (GO:0030335),6/344,0.06752405922936251,0.2799748871287214,0,0,2.16301775147929,5.829919692007376,SMOC2;PRKCE;NEDD9;SOD2;RNASE1;CCL15,High
Chromatin Remodeling (GO:0006338),5/262,0.0676967033841978,0.2799748871287214,0,0,2.3656862508156706,6.3701254643010685,KDM4B;KDM5D;UBR5;GLMN;POLE3,High
Regulation of Primary Metabolic Process (GO:0080090),3/113,0.06795560022549446,0.2799748871287214,0,0,3.3001673173452315,8.873822291977328,RNF213;HNRNPA1;CERS2,High
Signal Transduction by P53 Class Mediator (GO:0072331),2/52,0.06934106291795228,0.2799748871287214,0,0,4.825365853658536,12.877540757384395,RPS27L;FHIT,High
Intrinsic Apoptotic Signaling Pathway in Response to DNA Damage (GO:0008630),2/52,0.06934106291795228,0.2799748871287214,0,0,4.825365853658536,12.877540757384395,RPS27L;BCL2L1,High
Proton Motive Force-Driven Mitochondrial ATP Synthesis (GO:0042776),2/52,0.06934106291795228,0.2799748871287214,0,0,4.825365853658536,12.877540757384395,ATP5PD;NDUFA1,High
Positive Regulation of Cell Projection Organization (GO:0031346),3/115,0.07082717318176658,0.2799748871287214,0,0,3.240907099035933,8.580342217800606,SS18L1;NEDD9;S100A9,High
Positive Regulation of Inflammatory Response (GO:0050729),3/115,0.07082717318176658,0.2799748871287214,0,0,3.240907099035933,8.580342217800606,S100A9;GBP1;S100A8,High
Regulation of Microtubule Polymerization (GO:0031113),2/53,0.0716795644008476,0.2799748871287214,0,0,4.730511716881875,12.46749820329263,RPS3;RNASE1,High
Positive Regulation of miRNA Metabolic Process (GO:2000630),2/53,0.0716795644008476,0.2799748871287214,0,0,4.730511716881875,12.46749820329263,MRTFA;TEAD1,High
Regulation of Dendritic Spine Maintenance (GO:1902950),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,NEDD9,High
Regulation of Ketone Biosynthetic Process (GO:0010566),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,AKR1C3,High
Negative Regulation of Release of Sequestered Calcium Ion Into Cytosol (GO:0051280),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,CALM2,High
Negative Regulation of Triglyceride Metabolic Process (GO:0090209),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,PLIN5,High
Regulation of Nitric Oxide Metabolic Process (GO:0080164),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,RNASE1,High
Astral Microtubule Organization (GO:0030953),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,DLG1,High
Regulation of Protein Localization to Cajal Body (GO:1904869),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,CCT8,High
Organic Acid Metabolic Process (GO:0006082),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,CYP2C19,High
Oxidative Demethylation (GO:0070989),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,CYP3A5,High
Regulation of Vascular Wound Healing (GO:0061043),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,SMOC2,High
Embryonic Eye Morphogenesis (GO:0048048),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,MFAP5,High
Error-Prone Translesion Synthesis (GO:0042276),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,POLD2,High
Positive Regulation of Lipase Activity (GO:0060193),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,PLIN5,High
Positive Regulation of Protein Localization to Cajal Body (GO:1904871),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,CCT8,High
Intestinal Cholesterol Absorption (GO:0030299),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,AKR1C1,High
Leukotriene D4 Metabolic Process (GO:1901748),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,GGT7,High
Modification-Dependent Macromolecule Catabolic Process (GO:0043632),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,UBC,High
Myeloid Dendritic Cell Differentiation (GO:0043011),1/9,0.07228109831100976,0.2799748871287214,0,0,15.01969696969697,39.45963700558561,UBD,High
Cytoskeleton Organization (GO:0007010),3/117,0.0737527376449422,0.28477397753125944,0,0,3.183726186632225,8.300092488046465,CAPZB;NEDD9;RNASE1,High
Golgi to Plasma Membrane Transport (GO:0006893),2/55,0.07643211570364376,0.2854261553791219,0,0,4.551541647491947,11.703617122622163,GOLGA4;VPS35L,High
Regulation of Proteasomal Protein Catabolic Process (GO:0061136),2/56,0.07884502059081663,0.2854261553791219,0,0,4.467028003613369,11.347462220737667,GLMN;ECSCR,High
Nucleosome Assembly (GO:0006334),2/56,0.07884502059081663,0.2854261553791219,0,0,4.467028003613369,11.347462220737667,POLE3;CABIN1,High
Response to Peptide Hormone (GO:0043434),2/56,0.07884502059081663,0.2854261553791219,0,0,4.467028003613369,11.347462220737667,IGFBP5;STAT2,High
Positive Regulation of Leukocyte Chemotaxis (GO:0002690),2/56,0.07884502059081663,0.2854261553791219,0,0,4.467028003613369,11.347462220737667,CXCL10;NEDD9,High
Negative Regulation of Cholesterol Transport (GO:0032375),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,APOC1,High
Regulation of Granulocyte Differentiation (GO:0030852),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,RUNX1,High
Regulation of Muscle System Process (GO:0090257),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,PPP1R12B,High
Negative Regulation of Systemic Arterial Blood Pressure (GO:0003085),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,SOD2,High
Regulation of Neutrophil Migration (GO:1902622),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,RNASE1,High
Basement Membrane Organization (GO:0071711),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,COL4A1,High
Cellular Response to UV-A (GO:0071492),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,MMP2,High
Regulation of Triglyceride Catabolic Process (GO:0010896),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,PLIN5,High
Cellular Response to Prostaglandin Stimulus (GO:0071379),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,AKR1C3,High
Response to Corticosteroid (GO:0031960),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,AKR1C3,High
Positive Regulation of Actin Filament Depolymerization (GO:0030836),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,PLEK,High
Positive Regulation of Cell Morphogenesis (GO:0010770),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,SS18L1,High
Smooth Muscle Cell Differentiation (GO:0051145),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,MRTFA,High
Positive Regulation of Chondrocyte Differentiation (GO:0032332),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,ZBTB16,High
Positive Regulation of Integrin Activation (GO:0033625),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,PLEK,High
Erythrose 4-Phosphate/Phosphoenolpyruvate Family Amino Acid Catabolic Process (GO:1902222),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,FAH,High
Positive Regulation of Lipid Localization (GO:1905954),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,PLIN5,High
Very-Low-Density Lipoprotein Particle Assembly (GO:0034379),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,APOC1,High
Heterochromatin Organization (GO:0070828),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,UBR5,High
Mesonephros Development (GO:0001823),1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,ZBTB16,High
"Negative Regulation of CD4-positive, Alpha-Beta T Cell Activation (GO:2000515)",1/10,0.07998461707111014,0.2854261553791219,0,0,13.35016835016835,33.721469913824805,RUNX1,High
Negative Regulation of Response to Stimulus (GO:0048585),2/57,0.08128159444930544,0.28600653382214036,0,0,4.385587583148559,11.007104187793972,GGT7;RPS3,High
Cartilage Development (GO:0051216),2/57,0.08128159444930544,0.28600653382214036,0,0,4.385587583148559,11.007104187793972,ZBTB16;RUNX1,High
Glucose Metabolic Process (GO:0006006),2/57,0.08128159444930544,0.28600653382214036,0,0,4.385587583148559,11.007104187793972,RBP4;ENO1,High
Protein K63-linked Ubiquitination (GO:0070534),2/58,0.08374128384621701,0.28600653382214036,0,0,4.30705574912892,10.681598126277828,RNF213;PRPF19,High
Muscle Organ Development (GO:0007517),2/58,0.08374128384621701,0.28600653382214036,0,0,4.30705574912892,10.681598126277828,CXCL10;COL6A3,High
Cellular Response to Lipopolysaccharide (GO:0071222),3/125,0.08597880555024598,0.28600653382214036,0,0,2.9737503771497535,7.296555876390738,CXCL10;CXCL9;PRKCE,High
Protein Polymerization (GO:0051258),2/59,0.08622354278874728,0.28600653382214036,0,0,4.231279418057339,10.370070459461067,MID1IP1;RNASE1,High
Proton Motive Force-Driven ATP Synthesis (GO:0015986),2/59,0.08622354278874728,0.28600653382214036,0,0,4.231279418057339,10.370070459461067,ATP5PD;NDUFA1,High
Protein Ubiquitination (GO:0016567),6/369,0.0876217965285927,0.28600653382214036,0,0,2.0114669421487603,4.897369842719315,HERC5;RNF213;UBD;UBR5;UBC;PRPF19,High
Negative Regulation of Extracellular Matrix Organization (GO:1903054),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,GLMN,High
Negative Regulation of Leukocyte Chemotaxis (GO:0002689),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,S100A9,High
- Reg of Mt Outer Membrane Permeabilization Inv in Apoptotic Sgnlng Pway (GO:1901029),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,BCL2L1,High
Regulation of Protein Localization to Centrosome (GO:1904779),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,UBXN2B,High
Omega-Hydroxylase P450 Pathway (GO:0097267),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,CYP2C19,High
Regulation of Telomerase RNA Localization to Cajal Body (GO:1904872),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,CCT8,High
Regulation of Ventricular Cardiac Muscle Cell Action Potential (GO:0098911),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,DLG1,High
Positive Regulation of DNA-templated DNA Replication (GO:2000105),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,SSBP1,High
Chromatin Looping (GO:0140588),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,EID3,High
Complement Receptor Mediated Signaling Pathway (GO:0002430),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,FPR1,High
Positive Regulation of Execution Phase of Apoptosis (GO:1900119),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,GLMN,High
Positive Regulation of Fatty Acid Oxidation (GO:0046321),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,PLIN5,High
Positive Regulation of Platelet Activation (GO:0010572),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,PLEK,High
Positive Regulation of Protein Depolymerization (GO:1901881),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,PLEK,High
Hematopoietic Stem Cell Proliferation (GO:0071425),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,RUNX1,High
Positive Regulation of Smooth Muscle Cell Apoptotic Process (GO:0034393),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,SOD2,High
Intestinal Lipid Absorption (GO:0098856),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,AKR1C1,High
Positive Regulation of Triglyceride Biosynthetic Process (GO:0010867),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,PLIN5,High
Positive Regulation of Vascular Endothelial Growth Factor Signaling Pathway (GO:1900748),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,SMOC2,High
Primary Alcohol Catabolic Process (GO:0034310),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,AKR1C3,High
Progesterone Receptor Signaling Pathway (GO:0050847),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,UBR5,High
Protein K29-linked Ubiquitination (GO:0035519),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,UBR5,High
Regulation of Cell Communication by Electrical Coupling Involved in Cardiac Conduction (GO:1901844),1/11,0.087624550803351825,0.28600653382214036,0,0,12.014545454545454,29.25174245169941,CALM2,High
Oxidative Phosphorylation (GO:0006119),2/60,0.0887278326738941,0.28807126576351827,0,0,4.15811606391926,10.071712447363208,ATP5PD;NDUFA1,High
Response to Type II Interferon (GO:0034341),2/60,0.0887278326738941,0.28807126576351827,0,0,4.15811606391926,10.071712447363208,UBD;GBP1,High
Proteasomal Protein Catabolic Process (GO:0010498),6/372,0.09023313431486964,0.28843202824226216,0,0,1.994672131147541,4.797901718221515,PSMB4;UBXN2B;UBR5;PSMB1;PRPF19;PSMB9,High
protein-DNA Complex Assembly (GO:0065004),2/62,0.09380038715602552,0.28843202824226216,0,0,4.019105691056911,9.511560448683708,POLE3;CABIN1,High
Fatty Acid Metabolic Process (GO:0006631),3/130,0.09402866626422539,0.28843202824226216,0,0,2.8559489879715954,6.751907744520151,CYP2C19;ACACA;UGT1A7,High
DNA Strand Elongation (GO:0022616),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,POLD2,High
- Reg of Intrinsic Apoptotic Sgnlng Pway in Resp to DNA Damage by P53 Cls Mediator (GO:1902166),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,S100A9,High
NADH Oxidation (GO:0006116),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,GPD1,High
Negative Regulation of Mitochondrial Membrane Permeability (GO:0035795),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,BCL2L1,High
Regulation of Lamellipodium Organization (GO:1902743),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,RNASE1,High
Negative Regulation of Substrate Adhesion-Dependent Cell Spreading (GO:1900025),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,GBP1,High
Calcium Import Into the Mitochondrion (GO:0036444),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,HSPA9,High
Phospholipid Efflux (GO:0033700),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,APOC1,High
Porphyrin-Containing Compound Catabolic Process (GO:0006787),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,UGT1A1,High
Respiratory Chain Complex III Assembly (GO:0017062),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,UQCC2,High
Detection of Calcium Ion (GO:0005513),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,CALM2,High
Positive Regulation of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032725),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,PAEP,High
Tyrosine Metabolic Process (GO:0006570),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,FAH,High
Vitamin D Metabolic Process (GO:0042359),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,UGT1A3,High
Positive Regulation of Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0060213),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,TNRC6A,High
Positive Regulation of Protein Localization to Cell Surface (GO:2000010),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,STX3,High
Intracellular Copper Ion Homeostasis (GO:0006878),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,MT2A,High
Protein Insertion Into Mitochondrial Inner Membrane (GO:0045039),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,TIMM10,High
Mitochondrial Genome Maintenance (GO:0000002),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,SSBP1,High
Mitochondrial Respiratory Chain Complex III Assembly (GO:0034551),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,UQCC2,High
Regulation of ATP Biosynthetic Process (GO:2001169),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,ENO1,High
"Regulation of CD4-positive, Alpha-Beta T Cell Differentiation (GO:0043370)",1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,RUNX1,High
Regulation of T Cell Chemotaxis (GO:0010819),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,CXCL10,High
Regulation of Actin Filament Depolymerization (GO:0030834),1/12,0.09520142108649829,0.28843202824226216,0,0,10.92176308539945,25.685370030735868,PLEK,High
Negative Regulation of Metabolic Process (GO:0009892),2/63,0.09636761065942155,0.290355824816918,0,0,3.953018792483007,9.24842395717149,APOC1;PLIN5,High
Negative Regulation of Cell Population Proliferation (GO:0008285),6/379,0.0964901054738745,0.290355824816918,0,0,1.9565348525469168,4.574994421685715,RBP4;IGFBP5;FTH1;GLMN;SOD2;IFIT3,High
Monocarboxylic Acid Biosynthetic Process (GO:0072330),2/64,0.09895478270214632,0.290355824816918,0,0,3.889063729346971,8.995763263764347,AKR1C4;ACACA,High
"mRNA Splicing, via Spliceosome (GO:0000398)",4/211,0.09916481878730467,0.290355824816918,0,0,2.3411462992783445,5.410323491492336,GEMIN4;PRPF19;HNRNPA1;PRPF8,High
Regulation of Angiogenesis (GO:0045765),4/211,0.09916481878730467,0.290355824816918,0,0,2.3411462992783445,5.410323491492336,CXCL10;SMOC2;ECSCR;RUNX1,High
Mitochondrion Organization (GO:0007005),3/135,0.10237648222735096,0.290355824816918,0,0,2.7470719464584494,6.260846889154449,SSBP1;IFIT2;BCL2L1,High
Regulation of Fatty Acid Beta-Oxidation (GO:0031998),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,PLIN5,High
P-body Assembly (GO:0033962),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,TNRC6A,High
Reg of Intrinsic Apoptotic Sgnlng Pway in Resp to DNA Damage by P53 Cls Mediator (GO:1902165),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,S100A9,High
Regulation of Peroxisome Proliferator Activated Receptor Signaling Pathway (GO:0035358),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,PLIN5,High
Neuronal Action Potential (GO:0019228),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,SCN9A,High
Nucleotide Metabolic Process (GO:0009117),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,FHIT,High
Cardiac Cell Development (GO:0055006),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,MYH11,High
Cell Projection Assembly (GO:0030031),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,RNASE1,High
Cellular Response to Arsenic-Containing Substance (GO:0071243),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,HNRNPA1,High
Regulation of Vascular Associated Smooth Muscle Cell Migration (GO:1904752),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,IGFBP5,High
Removal of Superoxide Radicals (GO:0019430),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,SOD2,High
Response to UV-A (GO:0070141),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,MMP2,High
Positive Regulation of Alpha-Beta T Cell Differentiation (GO:0046638),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,RUNX1,High
Positive Regulation of Fatty Acid Biosynthetic Process (GO:0045723),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,MID1IP1,High
Positive Regulation of Protein Tyrosine Kinase Activity (GO:0061098),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,NEDD9,High
Lipid Droplet Formation (GO:0140042),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,RNF213,High
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,RPS27L,High
Motor Neuron Axon Guidance (GO:0008045),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,RNASE1,High
Myeloid Dendritic Cell Activation (GO:0001773),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,UBD,High
Regulation of Actomyosin Structure Organization (GO:0110020),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,RNASE1,High
"Negative Regulation of DNA Damage Response, Signal Transduction by P53 Class Mediator (GO:0043518)",1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,S100A9,High
Negative Regulation of Alcohol Biosynthetic Process (GO:1902931),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,PLEK,High
Regulation of Cell Communication by Electrical Coupling (GO:0010649),1/13,0.10271574521709599,0.290355824816918,0,0,10.011111111111111,22.783185164726877,CALM2,High
Regulation of miRNA Transcription (GO:1902893),2/66,0.10418696739270243,0.2938360555038428,0,0,3.7671493902439024,8.519665380492338,MRTFA;TEAD1,High
RNA Export From Nucleus (GO:0006405),2/67,0.10683099463534293,0.2950671257295956,0,0,3.7090056285178234,8.295217728550588,THOC2;HNRNPA1,High
Negative Regulation of Cell Motility (GO:2000146),3/139,0.10925981656053756,0.2950671257295956,0,0,2.665734391916276,5.902006838754295,IGFBP5;NEDD9;S100A9,High
Negative Regulation of Fatty Acid Biosynthetic Process (GO:0045717),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,APOC1,High
Regulation of Extracellular Matrix Disassembly (GO:0010715),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,GLMN,High
Regulation of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032645),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,PAEP,High
Regulation of Immune Effector Process (GO:0002697),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,S100A9,High
Regulation of Integrin Activation (GO:0033623),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,PLEK,High
Regulation of Leukocyte Activation (GO:0002694),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,S100A9,High
Regulation of Leukocyte Migration (GO:0002685),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,RNASE1,High
Negative Regulation of Smooth Muscle Cell Migration (GO:0014912),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,IGFBP5,High
Regulation of Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0060211),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,TNRC6A,High
Regulation of Response to Oxidative Stress (GO:1902882),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,GGT7,High
Cellular Response to Superoxide (GO:0071451),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,SOD2,High
Positive Regulation of T Cell Receptor Signaling Pathway (GO:0050862),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,RPS3,High
Smooth Muscle Contraction (GO:0006939),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,MYH11,High
Positive Regulation of Endothelial Cell Chemotaxis (GO:2001028),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,SMOC2,High
Epiboly Involved in Wound Healing (GO:0090505),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,MRTFA,High
Establishment of Protein Localization to Chromosome (GO:0070199),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,H1-5,High
Extrinsic Apoptotic Signaling Pathway in Absence of Ligand (GO:0097192),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,BCL2L1,High
Icosanoid Transport (GO:0071715),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,ABCC6,High
Mitotic G1/S Transition Checkpoint Signaling (GO:0044819),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,RPS27L,High
Regulation of Aerobic Respiration (GO:1903715),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,UQCC2,High
Regulation of cAMP/PKA Signal Transduction (GO:0141161),1/14,0.1101680363222428,0.2950671257295956,0,0,9.24055944055944,20.3823499020957,S100A9,High
Plasma Membrane Bounded Cell Projection Organization (GO:0120036),3/141,0.11276732555065075,0.30136944644977404,0,0,2.6268338223526273,5.732877390022409,PLEK;STX3;RNASE1,High
Regulation of Cell Growth (GO:0001558),4/222,0.11377262680267035,0.3033936714737876,0,0,2.2217691697814024,4.82913376410771,ENO1;S100A9;TEAD1;S100A8,High
Amide Biosynthetic Process (GO:0043604),2/70,0.11486904476454028,0.3056515451995594,0,0,3.5448350071736012,7.670890168326765,GGT7;CERS2,High
- Reg of Endoplasmic Reticulum Stress-Induced Intrinsic Apoptotic Sgnlng Pway (GO:1902236),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,TXNDC12,High
Regulation of Execution Phase of Apoptosis (GO:1900117),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,GLMN,High
Regulation of Oxidative Phosphorylation (GO:0002082),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,UQCC2,High
Astrocyte Development (GO:0014002),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,S100A9,High
Cellular Response to Misfolded Protein (GO:0071218),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,UBR5,High
Defense Response to Protozoan (GO:0042832),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,GBP1,High
Positive Regulation of Mitochondrial Translation (GO:0070131),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,UQCC2,High
Prostaglandin Biosynthetic Process (GO:0001516),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,S100A9,High
Maturation of LSU-rRNA Frm Tricistronic rRNA Trnscpt (GO:0000463),1/15,0.11755880336673992,0.30613593027311575,0,0,8.58008658008658,18.3683919207857,RPL7L1,High
Regulation of Actin Filament Polymerization (GO:0030833),2/71,0.1175821530631698,0.30613593027311575,0,0,3.4932838458819373,7.477786330959557,PRKCE;LMOD1,High
Positive Regulation of Cell-Substrate Adhesion (GO:0010811),2/73,0.12305625875071795,0.30613593027311575,0,0,3.3945379594641016,7.111942780244071,NEDD9;RNASE1,High
Embryonic Organ Development (GO:0048568),2/73,0.12305625875071795,0.30613593027311575,0,0,3.3945379594641016,7.111942780244071,RBP4;TEAD1,High
Heterochromatin Formation (GO:0031507),2/73,0.12305625875071795,0.30613593027311575,0,0,3.3945379594641016,7.111942780244071,UBR5;POLE3,High
Protein Modification by Small Protein Conjugation (GO:0032446),5/316,0.1234115803713294,0.30613593027311575,0,0,1.9495316650356493,4.0788692744728525,HERC5;EID3;RNF213;UBD;UBC,High
Regulation of Fibrinolysis (GO:0051917),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,GLMN,High
Negative Regulation of Intrinsic Apoptotic Signaling Pathway by P53 Class Mediator (GO:1902254),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,S100A9,High
Negative Regulation of Release of Cytochrome C From Mitochondria (GO:0090201),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,BCL2L1,High
Regulation of Non-Canonical Wnt Signaling Pathway (GO:2000050),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,RNF213,High
Nitric Oxide Mediated Signal Transduction (GO:0007263),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,FPR1,High
Regulation of Ryanodine-Sensitive Calcium-Release Channel Activity (GO:0060314),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,CALM2,High
Regulation of Superoxide Anion Generation (GO:0032928),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,PRKCE,High
Regulation of Triglyceride Biosynthetic Process (GO:0010866),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,PLIN5,High
Response to Cadmium Ion (GO:0046686),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,MT2A,High
Ribosomal Small Subunit Assembly (GO:0000028),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,RPS27L,High
Positive Regulation of Collagen Biosynthetic Process (GO:0032967),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,RUNX1,High
Epoxygenase P450 Pathway (GO:0019373),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,CYP2C19,High
Positive Regulation of Lipid Storage (GO:0010884),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,PLIN5,High
Positive Regulation of Lymphocyte Chemotaxis (GO:0140131),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,NEDD9,High
Positive Regulation of Muscle Contraction (GO:0045933),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,ENO1,High
Glycolytic Process Through Glucose-6-Phosphate (GO:0061620),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,ENO1,High
Positive Regulation of Superoxide Anion Generation (GO:0032930),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,PRKCE,High
Lipopolysaccharide-Mediated Signaling Pathway (GO:0031663),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,PRKCE,High
Protein Localization to Vacuole (GO:0072665),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,GBP1,High
Membrane Repolarization During Cardiac Muscle Cell Action Potential (GO:0086013),1/16,0.12488855116916608,0.30613593027311575,0,0,8.007676767676768,16.658638477439094,DLG1,High
Myeloid Leukocyte Differentiation (GO:0002573),2/74,0.12581636227641732,0.30613593027311575,0,0,3.3472222222222223,6.938563645130339,UBD;RUNX1,High
Positive Regulation of Protein Localization to Nucleus (GO:1900182),2/75,0.12859124741393105,0.30613593027311575,0,0,3.3012028065486136,6.771151645525317,UBR5;CCT8,High
DNA Biosynthetic Process (GO:0071897),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,POLD2,High
Regulation of Endothelial Cell Chemotaxis (GO:2001026),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,SMOC2,High
Negative Regulation of Fibroblast Proliferation (GO:0048147),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,FTH1,High
Negative Regulation of Ion Transmembrane Transporter Activity (GO:0032413),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,CALM2,High
acetyl-CoA Metabolic Process (GO:0006084),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,TDO2,High
Regulation of Mitochondrial Membrane Permeability (GO:0046902),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,BCL2L1,High
Aromatic Amino Acid Family Catabolic Process (GO:0009074),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,FAH,High
Regulation of Protein Tyrosine Kinase Activity (GO:0061097),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,NEDD9,High
Calcineurin-Mediated Signaling (GO:0097720),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,CALM2,High
Cellular Response to Cadmium Ion (GO:0071276),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,MT2A,High
Cellular Response to Copper Ion (GO:0071280),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,MT2A,High
Cellular Response to Zinc Ion (GO:0071294),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,MT2A,High
Cytoskeleton-Dependent Intracellular Transport (GO:0030705),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,TUBA1C,High
Defense Response to Symbiont (GO:0140546),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,GSDMB,High
Positive Regulation of Cartilage Development (GO:0061036),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,ZBTB16,High
Positive Regulation of Collagen Metabolic Process (GO:0010714),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,RUNX1,High
Positive Regulation of Dendrite Morphogenesis (GO:0050775),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,SS18L1,High
Ventricular Cardiac Muscle Cell Action Potential (GO:0086005),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,DLG1,High
Positive Regulation of Potassium Ion Transport (GO:0043268),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,DLG1,High
Positive Regulation of Smooth Muscle Cell Migration (GO:0014911),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,IGFBP5,High
Killing by Host of Symbiont Cells (GO:0051873),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,GSDMB,High
Leukotriene Biosynthetic Process (GO:0019370),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,GGT7,High
Prostanoid Biosynthetic Process (GO:0046457),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,S100A9,High
Lymphocyte Migration (GO:0072676),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,NEDD9,High
Protein Localization to Synapse (GO:0035418),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,DLG1,High
miRNA-mediated Gene Silencing by Inhibition of Translation (GO:0035278),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,TNRC6A,High
Modified Amino Acid Catabolic Process (GO:0042219),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,GGT7,High
Negative Regulation of Anoikis (GO:2000811),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,BCL2L1,High
Reg of Cardiac Muscle Contraction by Reg of the Release of Sequestered Calcium Ion (GO:0010881),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,CALM2,High
Regulation of Cartilage Development (GO:0061035),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,ZBTB16,High
Negative Regulation of Cation Transmembrane Transport (GO:1904063),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,PRKCE,High
Negative Regulation of Cellular Senescence (GO:2000773),1/17,0.13215778044759025,0.30613593027311575,0,0,7.506818181818182,15.191989083592048,S100A9,High
Regulation of Apoptotic Process (GO:0042981),9/704,0.13230874764254758,0.30613593027311575,0,0,1.5786188883288275,3.1929415426041063,HSPA9;CXCL10;MGMT;UBD;RPS3;S100A9;IFIT3;IFIT2;BCL2L1,High
Regulation of Non-Canonical NF-kappaB Signal Transduction (GO:1901222),2/77,0.13418364277919426,0.3087583741392662,0,0,3.2128455284552846,6.453147870185375,DLG1;RPS3,High
Nucleosome Organization (GO:0034728),2/77,0.13418364277919426,0.3087583741392662,0,0,3.2128455284552846,6.453147870185375,POLE3;CABIN1,High
Positive Regulation of Cytokine Production (GO:0001819),5/325,0.13430730712192626,0.3087583741392662,0,0,1.8938276397515528,3.8020952758569426,GLMN;RPS3;PAEP;S100A9;RUNX1,High
Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),3/153,0.13467543553345648,0.3087583741392662,0,0,2.4152147239263804,4.842233994487036,CXCL10;CXCL11;CXCL9,High
Cell Chemotaxis (GO:0060326),2/78,0.13700030821833967,0.3087583741392662,0,0,3.170410783055199,6.302054110836488,RNASE1;CCL15,High
DNA Damage Response (GO:0006974),6/421,0.13866913242302334,0.3087583741392662,0,0,1.7547289156626507,3.466755670807475,EID3;MGMT;UBR5;POLE3;RPS3;BCL2L1,High
Regulation of Defense Response to Virus (GO:0050688),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,HERC5,High
NAD Metabolic Process (GO:0019674),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,GPD1,High
Rac Protein Signal Transduction (GO:0016601),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,RNASE1,High
Negative Regulation of Reproductive Process (GO:2000242),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,PAEP,High
Positive Regulation of Antigen Receptor-Mediated Signaling Pathway (GO:0050857),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,RPS3,High
Positive Regulation of Calcium Ion Transmembrane Transporter Activity (GO:1901021),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,CALM2,High
Positive Regulation of Cell Activation (GO:0050867),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,PLEK,High
Positive Regulation of Fatty Acid Metabolic Process (GO:0045923),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,MID1IP1,High
Positive Regulation of Focal Adhesion Assembly (GO:0051894),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,RNASE1,High
Extracellular Matrix Assembly (GO:0085029),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,MYH11,High
Fluid Transport (GO:0042044),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,AQP7,High
Water Transport (GO:0006833),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,AQP7,High
Positive Regulation of Triglyceride Metabolic Process (GO:0090208),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,PLIN5,High
Protein Branched Polyubiquitination (GO:0141198),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,UBR5,High
Mitochondrial Calcium Ion Transmembrane Transport (GO:0006851),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,HSPA9,High
Regulation of Bicellular Tight Junction Assembly (GO:2000810),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,RNASE1,High
Regulation of Calcium Ion Transmembrane Transporter Activity (GO:1901019),1/18,0.13936698781759904,0.3087583741392662,0,0,7.06488413547237,13.922375947326568,CALM2,High
Protein Metabolic Process (GO:0019538),8/614,0.13949622622468483,0.3087583741392662,0,0,1.6065505284705686,3.1644510604540046,RPL7A;UBD;MMP2;GLMN;RPS3;RPL38;RPL27;RPS20,High
Signal Transduction in Response to DNA Damage (GO:0042770),2/80,0.1426725072251806,0.31517820569376515,0,0,3.0888055034396498,6.014532684528838,RPS27L;PRPF19,High
Neuron Development (GO:0048666),3/159,0.14614190366037844,0.31517820569376515,0,0,2.3216139688532325,4.46487502058447,THOC2;STX3;RUNX1,High
Regulation of Insulin-Like Growth Factor Receptor Signaling Pathway (GO:0043567),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,IGFBP5,High
Actin Nucleation (GO:0045010),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,LMOD1,High
Negative Regulation of Reactive Oxygen Species Metabolic Process (GO:2000378),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,PLIN5,High
Negative Regulation of Type I Interferon-Mediated Signaling Pathway (GO:0060339),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,STAT2,High
Regulation of Smooth Muscle Cell Migration (GO:0014910),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,IGFBP5,High
Oxoacid Metabolic Process (GO:0043436),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,S100A9,High
Regulation of Tissue Remodeling (GO:0034103),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,RUNX1,High
Positive Regulation of Activated T Cell Proliferation (GO:0042104),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,RPS3,High
Positive Regulation of Axon Extension (GO:0045773),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,GOLGA4,High
Positive Regulation of Endothelial Cell Apoptotic Process (GO:2000353),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,ECSCR,High
Superoxide Anion Generation (GO:0042554),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,RNASE1,High
Positive Regulation of Neutrophil Chemotaxis (GO:0090023),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,RNASE1,High
Maintenance of Gastrointestinal Epithelium (GO:0030277),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,RBP4,High
Negative Regulation of Calcium Ion Transmembrane Transporter Activity (GO:1901020),1/19,0.14651666588215062,0.31517820569376515,0,0,6.672053872053872,12.814454064766325,CALM2,High
Skeletal System Development (GO:0001501),3/160,0.1480835705586127,0.3179899830942841,0,0,2.306709390019929,4.4057653375612125,RBP4;ZBTB16;PRELP,High
Negative Regulation of Blood Vessel Morphogenesis (GO:2000181),2/82,0.14839384183400742,0.31809818284557806,0,0,3.011280487804878,5.745178217064716,CXCL10;ECSCR,High
Response to Lipopolysaccharide (GO:0032496),3/161,0.15003366141833674,0.32105105170637094,0,0,2.291993476741477,4.347672342649334,CXCL10;CXCL9;S100A8,High
Positive Regulation of Programmed Cell Death (GO:0043068),4/248,0.15172802508137967,0.3219440738608752,0,0,1.9823922282938677,3.738128968448508,HSPA9;UBD;IFIT2;BCL2L1,High
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),5/340,0.15338257697225216,0.3219440738608752,0,0,1.8076388245109853,3.3889973767895554,PSMB4;UBXN2B;UBR5;PSMB1;PSMB9,High
Regulation of Collagen Biosynthetic Process (GO:0032965),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,RUNX1,High
Negative Regulation of Phosphate Metabolic Process (GO:0045936),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,PLEK,High
Reg of Mt Outer Membrane Permeabilization Inv in Apoptotic Sgnlng Pway (GO:1901028),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,BCL2L1,High
Positive Regulation of Monocyte Chemotaxis (GO:0090026),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,CXCL10,High
Positive Regulation of Osteoclast Differentiation (GO:0045672),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,NEDD9,High
Heart Trabecula Morphogenesis (GO:0061384),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,RBP4,High
Positive Regulation of Protein Processing (GO:0010954),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,ENO1,High
High-Density Lipoprotein Particle Remodeling (GO:0034375),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,APOC1,High
Hippo Signaling (GO:0035329),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,TEAD1,High
Iron Ion Transport (GO:0006826),1/20,0.15360730321466595,0.3219440738608752,0,0,6.320574162679426,11.84068497759772,FTH1,High
Positive Regulation of Response to External Stimulus (GO:0032103),3/163,0.15395864212524701,0.32212885121590146,0,0,2.2631134969325153,4.234446645459006,STX3;S100A9;S100A8,High
Positive Regulation of Gene Expression (GO:0010628),6/436,0.15553935230976537,0.3244597467021307,0,0,1.6922093023255813,3.148958696283894,UBR5;GLMN;RPS3;RPS27L;S100A9;ACTG2,High
Actomyosin Structure Organization (GO:0031032),2/85,0.1570611149927494,0.3244597467021307,0,0,2.9019982368498383,5.371947794296931,LMOD1;MYH11,High
Regulation of Cell Division (GO:0051302),2/85,0.1570611149927494,0.3244597467021307,0,0,2.9019982368498383,5.371947794296931,CALM2;BCL2L1,High
Integrin-Mediated Signaling Pathway (GO:0007229),2/86,0.15997142210853302,0.3244597467021307,0,0,2.8673054587688735,5.255083015037552,PLEK;NEDD9,High
DNA Repair-Dependent Chromatin Remodeling (GO:0140861),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,UBR5,High
Regulation of Fibroblast Growth Factor Receptor Signaling Pathway (GO:0040036),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,SMOC2,High
Regulation of Macrophage Chemotaxis (GO:0010758),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,S100A9,High
Negative Regulation of Signal Transduction by P53 Class Mediator (GO:1901797),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,S100A9,High
Negative Regulation of Telomere Maintenance via Telomerase (GO:0032211),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,HNRNPA1,High
Regulation of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902175),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,SOD2,High
Regulation of Smooth Muscle Contraction (GO:0006940),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,CNN1,High
Response to Copper Ion (GO:0046688),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,MT2A,High
Sensory Perception of Pain (GO:0019233),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,SCN9A,High
Positive Regulation of Extracellular Matrix Organization (GO:1903055),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,RUNX1,High
Endothelial Cell Proliferation (GO:0001935),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,DLG1,High
Positive Regulation of Granulocyte Chemotaxis (GO:0071624),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,RNASE1,High
Positive Regulation of Lipid Catabolic Process (GO:0050996),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,PLIN5,High
Vasodilation (GO:0042311),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,SOD2,High
Intrinsic Apoptotic Signaling Pathway in Response to DNA Damage by P53 Class Mediator (GO:0042771),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,RPS27L,High
Negative Regulation of Calcium Ion Transmembrane Transport (GO:1903170),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,CALM2,High
Negative Regulation of Cation Channel Activity (GO:2001258),1/21,0.16063938439664313,0.3244597467021307,0,0,6.004242424242424,10.979317316507991,CALM2,High
Cytokine-Mediated Signaling Pathway (GO:0019221),4/255,0.1626863714407664,0.3279267493066571,0,0,1.9264177856475333,3.498241839918007,CXCL10;CXCL11;CXCL9;CCL15,High
Cellular Response to Tumor Necrosis Factor (GO:0071356),2/87,0.16289171860984275,0.3279267493066571,0,0,2.833428981348637,5.141737441679395,RPS3;GBP1,High
Regulation of Endothelial Cell Migration (GO:0010594),2/88,0.16582164139750205,0.330901273317558,0,0,2.800340328984685,5.031770567073515,SMOC2;RNASE1,High
Positive Regulation of Endothelial Cell Migration (GO:0010595),2/88,0.16582164139750205,0.330901273317558,0,0,2.800340328984685,5.031770567073515,SMOC2;RNASE1,High
Fc-gamma Receptor Signaling Pathway Involved in Phagocytosis (GO:0038096),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,PRKCE,High
Negative Regulation of Microtubule Depolymerization (GO:0007026),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,MID1IP1,High
Androgen Metabolic Process (GO:0008209),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,UGT2B7,High
Regulation of Steroid Metabolic Process (GO:0019218),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,UGT1A1,High
Epithelial Structure Maintenance (GO:0010669),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,RBP4,High
Post-Transcriptional Gene Silencing (GO:0016441),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,HELZ2,High
Monocarboxylic Acid Catabolic Process (GO:0072329),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,FAH,High
Regulation of Anoikis (GO:2000209),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,BCL2L1,High
Negative Regulation of T Cell Receptor Signaling Pathway (GO:0050860),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,GBP1,High
Regulation of Cardiac Muscle Contraction by Calcium Ion Signaling (GO:0010882),1/22,0.16761339007915518,0.330901273317558,0,0,5.7180375180375185,10.212959370400487,CALM2,High
"RNA Splicing, via Transesterification Reactions With Bulged Adenosine as Nucleophile (GO:0000377)",3/171,0.16997193692372245,0.3332675063177313,0,0,2.154469763365469,3.817983120520309,PRPF19;HNRNPA1;PRPF8,High
Negative Regulation of Interleukin-2 Production (GO:0032703),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,GBP1,High
Negative Regulation of Oxidative Stress-Induced Intrinsic Apoptotic Signaling Pathway (GO:1902176),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,SOD2,High
Regulation of Mitochondrial Translation (GO:0070129),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,UQCC2,High
Negative Regulation of Smoothened Signaling Pathway (GO:0045879),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,UBR5,High
Nuclear Membrane Reassembly (GO:0031468),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,UBXN2B,High
Nucleotide-Sugar Biosynthetic Process (GO:0009226),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,CMAS,High
poly(A)+ mRNA Export From Nucleus (GO:0016973),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,THOC2,High
Cholesterol Efflux (GO:0033344),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,APOC1,High
Retinol Metabolic Process (GO:0042572),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,RBP4,High
Dendritic Cell Differentiation (GO:0097028),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,UBD,High
Positive Regulation of Cell-Substrate Junction Organization (GO:0150117),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,RNASE1,High
Positive Regulation of Lamellipodium Assembly (GO:0010592),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,RNASE1,High
Eye Morphogenesis (GO:0048592),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,MFAP5,High
Translesion Synthesis (GO:0019985),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,POLD2,High
Glial Cell Development (GO:0021782),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,S100A9,High
Hepaticobiliary System Development (GO:0061008),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,UGT1A7,High
Immune Response-Activating Cell Surface Receptor Signaling Pathway (GO:0002429),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,FPR1,High
Iron-Sulfur Cluster Assembly (GO:0016226),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,HSPA9,High
Metallo-Sulfur Cluster Assembly (GO:0031163),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,HSPA9,High
Purine Ribonucleotide Transport (GO:0015868),1/23,0.17452979701770077,0.3332675063177313,0,0,5.457851239669422,9.527551478192855,ABCC6,High
Positive Regulation of Intracellular Signal Transduction (GO:1902533),8/652,0.1757165792028495,0.3350110481998252,0,0,1.5087664124538092,2.623568156023662,UNC5CL;UBD;RPS3;AKR1C3;S100A4;RPS20;S100A9;S100A8,High
Positive Regulation of DNA-binding Transcription Factor Activity (GO:0051091),3/174,0.176097808026349,0.33521573409681366,0,0,2.1163491550963296,3.675496827365201,RPS3;S100A9;S100A8,High
Positive Regulation of Cell Adhesion (GO:0045785),2/92,0.17763051556232484,0.335885372887118,0,0,2.6753387533875337,4.623118173211031,STX3;RNASE1,High
Regulation of Insulin Secretion (GO:0050796),2/93,0.18060330493553856,0.335885372887118,0,0,2.645805414098097,4.528169862943641,RBP4;UQCC2,High
Positive Regulation of DNA Repair (GO:0045739),2/93,0.18060330493553856,0.335885372887118,0,0,2.645805414098097,4.528169862943641,MGMT;RPS3,High
Positive Regulation of Cellular Component Biogenesis (GO:0044089),2/93,0.18060330493553856,0.335885372887118,0,0,2.645805414098097,4.528169862943641,PLEK;RPS3,High
Negative Regulation of Angiogenesis (GO:0016525),2/93,0.18060330493553856,0.335885372887118,0,0,2.645805414098097,4.528169862943641,CXCL10;ECSCR,High
ATP Biosynthetic Process (GO:0006754),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,ATP5PD,High
Negative Regulation of Extrinsic Apoptotic Signaling Pathway in Absence of Ligand (GO:2001240),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,BCL2L1,High
Negative Regulation of Extrinsic Apoptotic Signaling Pathway via Death Domain Receptors (GO:1902042),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,BCL2L1,High
Fc Receptor Mediated Stimulatory Signaling Pathway (GO:0002431),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,PRKCE,High
Regulation of Intracellular Steroid Hormone Receptor Signaling Pathway (GO:0033143),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,KDM5D,High
"RNA Splicing, via Transesterification Reactions (GO:0000375)",1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,PRPF8,High
Regulation of Lipid Storage (GO:0010883),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,PLIN5,High
Adenine Nucleotide Transport (GO:0051503),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,ABCC6,High
Negative Regulation of Response to Wounding (GO:1903035),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,CERS2,High
Negative Regulation of Signal Transduction in Absence of Ligand (GO:1901099),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,BCL2L1,High
Regulation of Release of Sequestered Calcium Ion Into Cytosol by Sarcoplasmic Reticulum (GO:0010880),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,CALM2,High
Cellular Response to Steroid Hormone Stimulus (GO:0071383),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,AKR1C3,High
Regulation of Cholesterol Transport (GO:0032374),1/24,0.1813890780052165,0.335885372887118,0,0,5.220289855072464,8.911613987167629,APOC1,High
Regulation of Immune Response (GO:0050776),2/94,0.18358365031126736,0.33943563139122546,0,0,2.616914103923648,4.435891465321197,CXCL10;AKR1C1,High
Response to Calcium Ion (GO:0051592),2/95,0.18657122421462904,0.3407494723277274,0,0,2.5886441122475743,4.346183875855971,AKR1C3;CALM2,High
Positive Regulation of Immune Response (GO:0050778),2/95,0.18657122421462904,0.3407494723277274,0,0,2.5886441122475743,4.346183875855971,CXCL10;AKR1C1,High
Negative Regulation of Protein Depolymerization (GO:1901880),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,MID1IP1,High
Bile Acid Biosynthetic Process (GO:0006699),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,AKR1C4,High
Regulation of Protein Processing (GO:0070613),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,RUNX1,High
Cardiac Muscle Cell Development (GO:0055013),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,MYH11,High
Regulation of Vascular Endothelial Growth Factor Signaling Pathway (GO:1900746),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,SMOC2,High
Chaperone Cofactor-Dependent Protein Refolding (GO:0051085),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,HSPA9,High
Cholesterol Biosynthetic Process (GO:0006695),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,SC5D,High
Sulfur Compound Catabolic Process (GO:0044273),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,GGT7,High
Positive Regulation of Neutrophil Migration (GO:1902624),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,RNASE1,High
Icosanoid Biosynthetic Process (GO:0046456),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,AKR1C3,High
Lamellipodium Assembly (GO:0030032),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,RNASE1,High
Receptor Clustering (GO:0043113),1/25,0.18819170203720892,0.3407494723277274,0,0,5.002525252525253,8.355688634491692,DLG1,High
Regulation of Actin Filament-Based Process (GO:0032970),2/96,0.18956570392639305,0.34273031256411385,0,0,2.5609756097560976,4.258952613626056,NEDD9;RNASE1,High
Regulation of Organelle Organization (GO:0033043),2/97,0.19256677165144387,0.34530286012750844,0,0,2.5338896020539154,4.174107558163646,S100A9;S100A8,High
Regulation of Protein Localization (GO:0032880),2/97,0.19256677165144387,0.34530286012750844,0,0,2.5338896020539154,4.174107558163646,DLG1;NEDD9,High
Muscle Contraction (GO:0006936),2/97,0.19256677165144387,0.34530286012750844,0,0,2.5338896020539154,4.174107558163646,LMOD1;MYH11,High
Regulation of Lipid Catabolic Process (GO:0050994),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,APOC1,High
Actin Filament Polymerization (GO:0030041),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,RNASE1,High
Regulation of Neutrophil Chemotaxis (GO:0090022),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,RNASE1,High
Respiratory Tube Development (GO:0030323),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,RBP4,High
Positive Regulation of Rho Protein Signal Transduction (GO:0035025),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,RNASE1,High
Positive Regulation of T Cell Migration (GO:2000406),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,CXCL10,High
Establishment or Maintenance of Apical/Basal Cell Polarity (GO:0035088),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,DLG1,High
Regulation of T Cell Migration (GO:2000404),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,CXCL10,High
Negative Regulation of DNA Biosynthetic Process (GO:2000279),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,HNRNPA1,High
Regulation of Cardiac Muscle Cell Contraction (GO:0086004),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,DLG1,High
Regulation of Chondrocyte Differentiation (GO:0032330),1/26,0.19493813427133033,0.34530286012750844,0,0,4.802181818181818,7.8519179804021215,ZBTB16,High
"Wnt Signaling Pathway, Planar Cell Polarity Pathway (GO:0060071)",1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,RNASE1,High
Regulation of Mitochondrial Fission (GO:0090140),1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,STAT2,High
Regulation of Protein Localization to Cell Periphery (GO:1904375),1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,GBP1,High
Cardiac Muscle Cell Contraction (GO:0086003),1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,SCN9A,High
Cardiac Muscle Cell Differentiation (GO:0055007),1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,MYH11,High
"Wound Healing, Spreading of Cells (GO:0044319)",1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,MRTFA,High
Protein Quality Control for Misfolded or Incompletely Synthesized Proteins (GO:0006515),1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,UBR5,High
miRNA-mediated Post-Transcriptional Gene Silencing (GO:0035195),1/27,0.2016288360937524,0.3528947950699941,0,0,4.617249417249417,7.393724850129072,TNRC6A,High
Negative Regulation of Apoptotic Process (GO:0043066),6/475,0.2032720821792398,0.3528947950699941,0,0,1.5483742004264391,2.4668850911619935,HSPA9;MGMT;SOD2;S100A9;IFIT3;BCL2L1,High
Sensory Perception of Light Stimulus (GO:0050953),2/101,0.2046307300154978,0.3528947950699941,0,0,2.4310174919931016,3.8569265261597705,LUM;CRYBB3,High
Visual Perception (GO:0007601),2/101,0.2046307300154978,0.3528947950699941,0,0,2.4310174919931016,3.8569265261597705,LUM;CRYBB3,High
Phospholipase C-activating G Protein-Coupled Receptor Signaling Pathway (GO:0007200),2/102,0.20766013379146972,0.3528947950699941,0,0,2.4065853658536587,3.782797242613618,PLEK;FPR1,High
Positive Regulation of Protein Localization (GO:1903829),2/102,0.20766013379146972,0.3528947950699941,0,0,2.4065853658536587,3.782797242613618,NEDD9;STX3,High
Regulation of Extrinsic Apoptotic Signaling Pathway in Absence of Ligand (GO:2001239),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,BCL2L1,High
Regulation of Lipid Biosynthetic Process (GO:0046890),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,MID1IP1,High
Regulation of Microtubule Depolymerization (GO:0031114),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,MID1IP1,High
Regulation of Monocyte Chemotaxis (GO:0090025),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,CXCL10,High
Negative Regulation of Telomere Maintenance via Telomere Lengthening (GO:1904357),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,HNRNPA1,High
Nuclear Membrane Organization (GO:0071763),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,UBXN2B,High
Regulation of Striated Muscle Contraction (GO:0006942),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,CALM2,High
Positive Regulation of ATP Metabolic Process (GO:1903580),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,ENO1,High
Response to Zinc Ion (GO:0010043),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,MT2A,High
Positive Regulation of Fibroblast Proliferation (GO:0048146),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,S100A9,High
Establishment of Protein Localization to Mitochondrial Membrane (GO:0090151),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,TIMM10,High
Toll-Like Receptor 4 Signaling Pathway (GO:0034142),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,PRKCE,High
Positive Regulation of Mitotic Cell Cycle (GO:0045931),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,SMOC2,High
Hematopoietic Progenitor Cell Differentiation (GO:0002244),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,PLEK,High
Positive Regulation of Signal Transduction by P53 Class Mediator (GO:1901798),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,RPS20,High
Long-Term Synaptic Potentiation (GO:0060291),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,CALM2,High
Regulation of DNA Biosynthetic Process (GO:2000278),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,SMOC2,High
Regulation of Cardiac Muscle Cell Action Potential (GO:0098901),1/28,0.2082642650600524,0.3528947950699941,0,0,4.446015712682379,6.975565240010467,DLG1,High
Regulation of Cell Migration (GO:0030334),6/479,0.20845011179379555,0.3528947950699941,0,0,1.534963002114165,2.4069072366206896,IGFBP5;NEDD9;SOD2;RNASE1;S100A9;CCL15,High
Regulation of Actin Cytoskeleton Organization (GO:0032956),2/104,0.2137329909232959,0.358269927873365,0,0,2.359158297465328,3.640246717176701,NEDD9;RNASE1,High
Generation of Neurons (GO:0048699),3/192,0.21402733847202307,0.358269927873365,0,0,1.9130392443275879,2.9492398631422634,THOC2;RNASE1;RUNX1,High
Regulation of Dendrite Morphogenesis (GO:0048814),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,SS18L1,High
Fc-gamma Receptor Signaling Pathway (GO:0038094),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,PRKCE,High
Regulation of Platelet Activation (GO:0010543),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,PLEK,High
Organelle Fusion (GO:0048284),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,STX3,High
Positive Regulation of Protein Import Into Nucleus (GO:0042307),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,UBR5,High
Intracellular Zinc Ion Homeostasis (GO:0006882),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,MT2A,High
Protein Localization to Cell Junction (GO:1902414),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,DLG1,High
Regulation of Androgen Receptor Signaling Pathway (GO:0060765),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,KDM5D,High
Regulation of Blood Coagulation (GO:0030193),1/29,0.21484487504824337,0.358269927873365,0,0,4.287012987012987,6.59273586213286,GLMN,High
Positive Regulation of Protein-Containing Complex Assembly (GO:0031334),2/105,0.21677587696770784,0.3609981951135706,0,0,2.336135448733128,3.5716971262941293,PLEK;RPS3,High
Regulation of Mitochondrion Organization (GO:0010821),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,STAT2,High
Positive Regulation of B Cell Proliferation (GO:0030890),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,S100A9,High
Positive Regulation of Cation Channel Activity (GO:2001259),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,CALM2,High
Positive Regulation of Response to Wounding (GO:1903036),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,PRKCE,High
Lamellipodium Organization (GO:0097581),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,RNASE1,High
Pyroptotic Inflammatory Response (GO:0070269),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,GSDMB,High
Negative Regulation of Antigen Receptor-Mediated Signaling Pathway (GO:0050858),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,GBP1,High
Regulation of Cell Morphogenesis (GO:0022604),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,CAPZB,High
Regulation of Chemotaxis (GO:0050920),1/30,0.22137111624035788,0.3641911912341372,0,0,4.138975966562174,6.24122281400424,STX3,High
Positive Regulation of DNA Metabolic Process (GO:0051054),2/108,0.22592705172461391,0.36888937112466824,0,0,2.2696732627703637,3.376236828057308,SMOC2;RPS3,High
Positive Regulation of Translation (GO:0045727),2/108,0.22592705172461391,0.36888937112466824,0,0,2.2696732627703637,3.376236828057308,UQCC2;RPS27L,High
Golgi to Plasma Membrane Protein Transport (GO:0043001),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,GOLGA4,High
Regulation of Immunoglobulin Production (GO:0002637),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,RBP4,High
Regulation of Macrophage Activation (GO:0043030),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,S100A9,High
Regulation of Protein Localization to Cell Surface (GO:2000008),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,STX3,High
Regulation of Protein Modification Process (GO:0031399),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,STAT2,High
Chromosome Condensation (GO:0030261),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,H1-5,High
Collagen Catabolic Process (GO:0030574),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,MMP2,High
Establishment of Mitotic Spindle Orientation (GO:0000132),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,UBXN2B,High
Positive Regulation of Lamellipodium Organization (GO:1902745),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,RNASE1,High
Negative Regulation of Carbohydrate Metabolic Process (GO:0045912),1/31,0.22784343510641275,0.36888937112466824,0,0,4.00080808080808,5.917581525697768,PLEK,High
Regulation of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),2/109,0.22898405314031509,0.3697578905590312,0,0,2.2483473900159563,3.3142954410931664,GLMN;FHIT,High
Positive Regulation of Vasculature Development (GO:1904018),2/109,0.22898405314031509,0.3697578905590312,0,0,2.2483473900159563,3.3142954410931664,SMOC2;RUNX1,High
rRNA Processing (GO:0006364),2/110,0.23204392201366295,0.37286999216436445,0,0,2.227416440831075,3.2538736547085048,RPL7A;RPL27,High
Regulation of Translation (GO:0006417),3/201,0.23361124105542816,0.37286999216436445,0,0,1.825246328313813,2.6540850427581524,IGFBP5;RPS3;RPS27L,High
"DNA Damage Response, Signal Transduction by P53 Class Mediator (GO:0030330)",1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,RPS27L,High
Regulation of Extrinsic Apoptotic Signaling Pathway via Death Domain Receptors (GO:1902041),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,BCL2L1,High
Regulation of Lamellipodium Assembly (GO:0010591),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,RNASE1,High
Negative Regulation of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032435),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,FHIT,High
Respiratory System Development (GO:0060541),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,RBP4,High
Chondrocyte Differentiation (GO:0002062),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,RUNX1,High
Endodermal Cell Differentiation (GO:0035987),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,MMP2,High
Positive Regulation of Locomotion (GO:0040017),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,STX3,High
Negative Regulation of G1/S Transition of Mitotic Cell Cycle (GO:2000134),1/32,0.2342622744888858,0.37286999216436445,0,0,3.8715542521994135,5.6188407336471915,DLG1,High
Positive Regulation of Cellular Component Organization (GO:0051130),2/111,0.23510640195292518,0.37372757920828625,0,0,2.2068695457596776,3.194922763509127,RPS3;RUNX1,High
Cellular Response to Metal Ion (GO:0071248),2/112,0.2381712405425084,0.3781084285655386,0,0,2.1866962305986695,3.1373960175110254,MT2A;AKR1C3,High
Positive Regulation of Canonical NF-kappaB Signal Transduction (GO:0043123),3/204,0.24021146952689523,0.37905889590734865,0,0,1.7977291456826299,2.563985343713817,UNC5CL;UBD;S100A4,High
Actin Filament Bundle Assembly (GO:0051017),1/33,0.24062807362745908,0.37905889590734865,0,0,3.750378787878788,5.342425086287716,NEDD9,High
Epithelial Tube Morphogenesis (GO:0060562),1/33,0.24062807362745908,0.37905889590734865,0,0,3.750378787878788,5.342425086287716,COL4A1,High
Vasculogenesis (GO:0001570),1/33,0.24062807362745908,0.37905889590734865,0,0,3.750378787878788,5.342425086287716,GLMN,High
Protein Localization to Chromatin (GO:0071168),1/33,0.24062807362745908,0.37905889590734865,0,0,3.750378787878788,5.342425086287716,H1-5,High
Regulation of Activated T Cell Proliferation (GO:0046006),1/33,0.24062807362745908,0.37905889590734865,0,0,3.750378787878788,5.342425086287716,RPS3,High
Lipid Transport (GO:0006869),2/113,0.24123818944823663,0.3795315474095651,0,0,2.1668863985937157,3.081248526152713,AKR1C1;AKR1C4,High
Regulation of Intracellular Signal Transduction (GO:1902531),4/302,0.24256509953126637,0.38112924496311945,0,0,1.6186925180213771,2.2928539189782065,DLG1;AKR1C3;CALM2;GBP1,High
Negative Regulation of Microtubule Polymerization or Depolymerization (GO:0031111),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,MID1IP1,High
Actin Filament Bundle Organization (GO:0061572),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,NEDD9,High
Regulation of Response to Biotic Stimulus (GO:0002831),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,HERC5,High
Integrated Stress Response Signaling (GO:0140467),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,HERC5,High
Liver Development (GO:0001889),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,UGT1A7,High
Lung Development (GO:0030324),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,RBP4,High
"Regulation of DNA Damage Response, Signal Transduction by P53 Class Mediator (GO:0043516)",1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,S100A9,High
Regulation of Cardiac Muscle Contraction (GO:0055117),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,CALM2,High
Regulation of Cell Cycle Phase Transition (GO:1901987),1/34,0.2469412681410595,0.3832784701918002,0,0,3.6365472910927457,5.0860923201364825,UBD,High
Negative Regulation of Growth (GO:0045926),2/115,0.24737744399634165,0.3832784701918002,0,0,2.1283185840707963,2.9729205211528766,MT2A;ENO1,High
Intrinsic Apoptotic Signaling Pathway (GO:0097193),2/115,0.24737744399634165,0.3832784701918002,0,0,2.1283185840707963,2.9729205211528766,FHIT;BCL2L1,High
Protein Complex Oligomerization (GO:0051259),2/116,0.25044927218527135,0.3859521832865777,0,0,2.1095421480530594,2.9206587522846523,AKR1C1;CUTC,High
Regulation of DNA Metabolic Process (GO:0051052),2/116,0.25044927218527135,0.3859521832865777,0,0,2.1095421480530594,2.9206587522846523,EID3;POLE3,High
Negative Regulation of Myeloid Leukocyte Differentiation (GO:0002762),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,RUNX1,High
Regulation of Mitochondrial Membrane Potential (GO:0051881),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,BCL2L1,High
Regulation of p38MAPK Cascade (GO:1900744),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,DLG1,High
Regulation of Protein Localization to Membrane (GO:1905475),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,GBP1,High
Cellular Response to cAMP (GO:0071320),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,IGFBP5,High
Cellular Response to Hydrogen Peroxide (GO:0070301),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,RPS3,High
Positive Regulation of Axonogenesis (GO:0050772),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,GOLGA4,High
Dendrite Morphogenesis (GO:0048813),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,FARP1,High
Substrate Adhesion-Dependent Cell Spreading (GO:0034446),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,RNASE1,High
Positive Regulation of Mononuclear Cell Migration (GO:0071677),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,CXCL10,High
Regulation of Cellular Senescence (GO:2000772),1/35,0.25320229017902113,0.3859521832865777,0,0,3.5294117647058822,4.847881919337103,S100A9,High
Positive Regulation of Cellular Process (GO:0048522),7/622,0.25938267801456866,0.390943454798021,0,0,1.3758040599273917,1.8565798706720824,AKR1C3;NEDD9;STX3;S100A9;TEAD1;S100A8;PLIN5,High
Negative Regulation of Hydrolase Activity (GO:0051346),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,PLIN5,High
Carboxylic Acid Metabolic Process (GO:0019752),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,S100A9,High
Regulation of Type I Interferon-Mediated Signaling Pathway (GO:0060338),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,STAT2,High
Positive Regulation of Epithelial Cell Migration (GO:0010634),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,PRKCE,High
Endoderm Formation (GO:0001706),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,MMP2,High
Establishment of Mitotic Spindle Localization (GO:0040001),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,UBXN2B,High
Establishment or Maintenance of Epithelial Cell Apical/Basal Polarity (GO:0045197),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,DLG1,High
Negative Regulation of Cell Cycle G1/S Phase Transition (GO:1902807),1/36,0.25941156821878103,0.390943454798021,0,0,3.4283982683982686,4.626072903688683,DLG1,High
Positive Regulation of Cell Cycle Process (GO:0090068),2/119,0.2596707751231953,0.390943454798021,0,0,2.05513862830936,2.7710270564124277,UBXN2B;PRKCE,High
Negative Regulation of Catabolic Process (GO:0009895),2/120,0.26274586339738165,0.39508714594397437,0,0,2.0376188507647788,2.723416178294795,APOC1;BCL2L1,High
Regulation of Release of Cytochrome C From Mitochondria (GO:0090199),1/37,0.26556952735753014,0.39678678424270675,0,0,3.332996632996633,4.419148907217865,BCL2L1,High
Cardiac Muscle Cell Action Potential (GO:0086001),1/37,0.26556952735753014,0.39678678424270675,0,0,3.332996632996633,4.419148907217865,SCN9A,High
Cardiac Muscle Cell Action Potential Involved in Contraction (GO:0086002),1/37,0.26556952735753014,0.39678678424270675,0,0,3.332996632996633,4.419148907217865,SCN9A,High
Regulation of Sodium Ion Transport (GO:0002028),1/37,0.26556952735753014,0.39678678424270675,0,0,3.332996632996633,4.419148907217865,DLG1,High
Regulatory ncRNA-mediated Gene Silencing (GO:0031047),1/37,0.26556952735753014,0.39678678424270675,0,0,3.332996632996633,4.419148907217865,HELZ2,High
Cellular Response to Oxidative Stress (GO:0034599),2/121,0.26582121166586564,0.39678678424270675,0,0,2.0203935232629635,2.676882683516871,RPS3;SOD2,High
DNA Damage Checkpoint Signaling (GO:0000077),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,PRPF19,High
Regulation of Erythrocyte Differentiation (GO:0045646),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,HSPA9,High
Regulation of Potassium Ion Transport (GO:0043266),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,DLG1,High
Striated Muscle Tissue Development (GO:0014706),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,RBP4,High
Positive Regulation of Immunoglobulin Production (GO:0002639),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,RBP4,High
Glutathione Metabolic Process (GO:0006749),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,GGT7,High
Protein K11-linked Ubiquitination (GO:0070979),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,UBR5,High
Membrane Assembly (GO:0071709),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,UBXN2B,High
Purine Nucleotide Metabolic Process (GO:0006163),1/38,0.27167658917265325,0.4005938900986133,0,0,3.2427518427518427,4.225769139294853,FHIT,High
Cellular Response to Molecule of Bacterial Origin (GO:0071219),2/123,0.2719718322483232,0.4005938900986133,0,0,1.9867970167304978,2.5869225180894824,CXCL10;CXCL9,High
Response to Cytokine (GO:0034097),2/123,0.2719718322483232,0.4005938900986133,0,0,1.9867970167304978,2.5869225180894824,UBD;BCL2L1,High
Regulation of Mitotic Cell Cycle (GO:0007346),2/124,0.2750466853546344,0.4046359890313372,0,0,1.9704118352658937,2.5434360315764994,SMOC2;UBD,High
Proteolysis (GO:0006508),4/321,0.27712243502913897,0.405179263840549,0,0,1.5201931689839157,1.9508576103948716,UBD;MMP2;GLMN;PSMB1,High
Base-Excision Repair (GO:0006284),1/39,0.2777331718645593,0.405179263840549,0,0,3.15725677830941,4.0447441032211655,RPS3,High
Semaphorin-Plexin Signaling Pathway (GO:0071526),1/39,0.2777331718645593,0.405179263840549,0,0,3.15725677830941,4.0447441032211655,RNASE1,High
Negative Regulation of G Protein-Coupled Receptor Signaling Pathway (GO:0045744),1/39,0.2777331718645593,0.405179263840549,0,0,3.15725677830941,4.0447441032211655,PLEK,High
Regulation of Axon Extension (GO:0030516),1/39,0.2777331718645593,0.405179263840549,0,0,3.15725677830941,4.0447441032211655,GOLGA4,High
Negative Regulation of T Cell Proliferation (GO:0042130),1/39,0.2777331718645593,0.405179263840549,0,0,3.15725677830941,4.0447441032211655,GLMN,High
Negative Regulation of Cell-Substrate Adhesion (GO:0010812),1/39,0.2777331718645593,0.405179263840549,0,0,3.15725677830941,4.0447441032211655,GBP1,High
Negative Regulation of Cellular Process (GO:0048523),6/531,0.2795101896133206,0.4072862762936957,0,0,1.3792142857142857,1.758107249066349,FTH1;GLMN;ENO1;SOD2;S100A9;IFIT3,High
Protein-Containing Complex Assembly (GO:0065003),4/323,0.2808098416923751,0.4079047763713791,0,0,1.510507372576338,1.918461516133907,MID1IP1;RPL38;TEAD1;GBP1,High
Positive Regulation of Angiogenesis (GO:0045766),2/126,0.28119445483832534,0.4079047763713791,0,0,1.9384343036978757,2.459308734682276,SMOC2;RUNX1,High
Regulation of ERK1 and ERK2 Cascade (GO:0070372),3/223,0.2826320631282271,0.4079047763713791,0,0,1.6408812046848857,2.0734328448357453,DLG1;S100A9;GBP1,High
Regulation of Potassium Ion Transmembrane Transport (GO:1901379),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,DLG1,High
Branching Morphogenesis of an Epithelial Tube (GO:0048754),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,COL4A1,High
Positive Regulation of Cytokinesis (GO:0032467),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,PRKCE,High
Embryonic Skeletal System Development (GO:0048706),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,RBP4,High
Establishment of Spindle Orientation (GO:0051294),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,UBXN2B,High
Positive Regulation of Proteolysis Involved in Protein Catabolic Process (GO:1903052),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,ECSCR,High
Regulation of DNA Recombination (GO:0000018),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,H1-5,High
Regulation of Apoptotic Signaling Pathway (GO:2001233),1/40,0.283739690105335,0.4079047763713791,0,0,3.076146076146076,3.8750151991082595,RPS3,High
Regulation of Anatomical Structure Morphogenesis (GO:0022603),2/127,0.2842669724222111,0.4079047763713791,0,0,1.9228292682926829,2.418614333098294,CAPZB;STAT2,High
Negative Regulation of MAPK Cascade (GO:0043409),2/127,0.2842669724222111,0.4079047763713791,0,0,1.9228292682926829,2.418614333098294,DLG1;GBP1,High
mRNA Processing (GO:0006397),3/226,0.2894011525138328,0.41231230658268686,0,0,1.618558969985419,2.0069184085430196,PRPF19;HNRNPA1;PRPF8,High
Regulation of Protein Import Into Nucleus (GO:0042306),1/41,0.2896965552786852,0.41231230658268686,0,0,2.999090909090909,3.7156375027236566,UBR5,High
Connective Tissue Development (GO:0061448),1/41,0.2896965552786852,0.41231230658268686,0,0,2.999090909090909,3.7156375027236566,ZBTB16,High
Positive Regulation of Immune System Process (GO:0002684),1/41,0.2896965552786852,0.41231230658268686,0,0,2.999090909090909,3.7156375027236566,CXCL10,High
Positive Regulation of Insulin Secretion (GO:0032024),1/41,0.2896965552786852,0.41231230658268686,0,0,2.999090909090909,3.7156375027236566,RBP4,High
Establishment of Protein Localization to Plasma Membrane (GO:0061951),1/41,0.2896965552786852,0.41231230658268686,0,0,2.999090909090909,3.7156375027236566,GOLGA4,High
Visual System Development (GO:0150063),1/41,0.2896965552786852,0.41231230658268686,0,0,2.999090909090909,3.7156375027236566,RBP4,High
Positive Regulation of Defense Response (GO:0031349),2/130,0.29347673263918717,0.41398113349382604,0,0,1.8774771341463414,2.3017060816727546,S100A9;S100A8,High
Protein Polyubiquitination (GO:0000209),3/228,0.29392093631695776,0.41398113349382604,0,0,1.6040081799591002,1.9640189488365143,RNF213;UBR5;PRPF19,High
Acylglycerol Metabolic Process (GO:0006639),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,APOC1,High
Response to cAMP (GO:0051591),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,IGFBP5,High
Ceramide Biosynthetic Process (GO:0046513),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,CERS2,High
Response to Hydrogen Peroxide (GO:0042542),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,RPS3,High
Ribosome Assembly (GO:0042255),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,RPS27L,High
Type I Interferon-Mediated Signaling Pathway (GO:0060337),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,STAT2,High
Positive Regulation of Ossification (GO:0045778),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,ZBTB16,High
Keratinocyte Differentiation (GO:0030216),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,AKR1C3,High
Protein Destabilization (GO:0031648),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,ISOC2,High
Negative Regulation of DNA Recombination (GO:0045910),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,H1-5,High
Regulation of Cellular Component Size (GO:0032535),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,RNASE1,High
Regulation of Chromosome Organization (GO:0033044),1/42,0.29560417538693134,0.41398113349382604,0,0,2.9257945306725794,3.5657651687993317,EID3,High
Regulation of Epithelial Cell Migration (GO:0010632),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,PRKCE,High
Negative Regulation of Lymphocyte Proliferation (GO:0050672),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,GLMN,High
Negative Regulation of Mitotic Cell Cycle Phase Transition (GO:1901991),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,DLG1,High
RNA Transport (GO:0050658),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,HNRNPA1,High
Negative Regulation of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,FHIT,High
Non-Canonical Wnt Signaling Pathway (GO:0035567),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,RNASE1,High
Cellular Response to Glucose Starvation (GO:0042149),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,HNRNPA1,High
Cellular Response to Type I Interferon (GO:0071357),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,STAT2,High
Ephrin Receptor Signaling Pathway (GO:0048013),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,MMP2,High
Positive Regulation of Monoatomic Ion Transport (GO:0043270),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,DLG1,High
Positive Regulation of Production of Molecular Mediator of Immune Response (GO:0002702),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,RBP4,High
Import Into the Mitochondrion (GO:0170036),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,HSPA9,High
Positive Regulation of Stress Fiber Assembly (GO:0051496),1/43,0.3014629550579916,0.41599848589738636,0,0,2.855988455988456,3.4246390029225693,RNASE1,High
Negative Regulation of Organelle Organization (GO:0010639),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,BCL2L1,High
Negative Regulation of Protein Localization (GO:1903828),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,UBXN2B,High
Regulation of Monoatomic Cation Transmembrane Transport (GO:1904062),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,DLG1,High
Regulation of Ossification (GO:0030278),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,ZBTB16,High
Organelle Disassembly (GO:1903008),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,NEDD9,High
Positive Regulation of Cell Division (GO:0051781),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,PRKCE,High
Protein Sumoylation (GO:0016925),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,EID3,High
Regulated Exocytosis (GO:0045055),1/44,0.3072732956921061,0.42007570721086573,0,0,2.789429175475687,3.291575837390745,PLEK,High
Cellular Response to Lipid (GO:0071396),3/234,0.3075064000497841,0.42007570721086573,0,0,1.5618675802724882,1.8418469924520766,CXCL10;CXCL9;AKR1C3,High
Protein Targeting (GO:0006605),2/136,0.3118446212481897,0.4233763188850972,0,0,1.792864943574809,2.089136277174256,ANKRD10;TIMM10,High
Regulation of Nitric Oxide Biosynthetic Process (GO:0045428),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,RNASE1,High
Cellular Response to Ketone (GO:1901655),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,AKR1C3,High
Response to Amyloid-Beta (GO:1904645),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,MMP2,High
Collagen Fibril Organization (GO:0030199),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,LUM,High
Positive Regulation of Cell-Matrix Adhesion (GO:0001954),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,RNASE1,High
Establishment of Protein Localization to Mitochondrion (GO:0072655),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,TIMM10,High
Extracellular Matrix Disassembly (GO:0022617),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,MMP2,High
Regulation of B Cell Proliferation (GO:0030888),1/45,0.3130355952540956,0.4233763188850972,0,0,2.7258953168044076,3.1659594191318527,S100A9,High
Regulation of Protein Phosphorylation (GO:0001932),2/137,0.31489719478256767,0.42542402473936297,0,0,1.7794941282746162,2.0562215860056794,STAT2;RNASE1,High
Regulation of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/46,0.31875024868156443,0.427327825176599,0,0,2.665185185185185,3.0472325582161406,HERC5,High
Negative Regulation of Proteasomal Protein Catabolic Process (GO:1901799),1/46,0.31875024868156443,0.427327825176599,0,0,2.665185185185185,3.0472325582161406,FHIT,High
Regulation of Osteoclast Differentiation (GO:0045670),1/46,0.31875024868156443,0.427327825176599,0,0,2.665185185185185,3.0472325582161406,NEDD9,High
Development of Primary Male Sexual Characteristics (GO:0046546),1/46,0.31875024868156443,0.427327825176599,0,0,2.665185185185185,3.0472325582161406,AKR1C3,High
Positive Regulation of Nucleocytoplasmic Transport (GO:0046824),1/46,0.31875024868156443,0.427327825176599,0,0,2.665185185185185,3.0472325582161406,UBR5,High
Male Gonad Development (GO:0008584),1/46,0.31875024868156443,0.427327825176599,0,0,2.665185185185185,3.0472325582161406,AKR1C3,High
Regulation of Cell-Substrate Adhesion (GO:0010810),1/46,0.31875024868156443,0.427327825176599,0,0,2.665185185185185,3.0472325582161406,RNASE1,High
DNA Integrity Checkpoint Signaling (GO:0031570),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,PRPF19,High
Regulation of Endothelial Cell Apoptotic Process (GO:2000351),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,ECSCR,High
Bicellular Tight Junction Assembly (GO:0070830),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,DLG1,High
Cell Surface Receptor Signaling Pathway via JAK-STAT (GO:0007259),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,STAT2,High
Cellular Defense Response (GO:0006968),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,CXCL9,High
Cellular Response to Type II Interferon (GO:0071346),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,GBP1,High
Chromosome Organization (GO:0051276),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,H1-5,High
Ribosomal Large Subunit Biogenesis (GO:0042273),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,RPL7A,High
Double-Strand Break Repair via Nonhomologous End Joining (GO:0006303),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,PRPF19,High
Positive Regulation of mRNA Catabolic Process (GO:0061014),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,TNRC6A,High
Monoatomic Anion Transport (GO:0006820),1/47,0.3244176475329849,0.42974805257616183,0,0,2.607114624505929,2.9348903503973744,CLIC1,High
Blood Circulation (GO:0008015),1/48,0.3300381801688704,0.4339062647977415,0,0,2.5515151515151517,2.8284742975844512,CXCL10,High
Nuclear Receptor-Mediated Steroid Hormone Signaling Pathway (GO:0030518),1/48,0.3300381801688704,0.4339062647977415,0,0,2.5515151515151517,2.8284742975844512,UBR5,High
Secondary Alcohol Metabolic Process (GO:1902652),1/48,0.3300381801688704,0.4339062647977415,0,0,2.5515151515151517,2.8284742975844512,UGT1A3,High
Erythrocyte Differentiation (GO:0030218),1/48,0.3300381801688704,0.4339062647977415,0,0,2.5515151515151517,2.8284742975844512,HSPA9,High
Positive Regulation of Peptide Hormone Secretion (GO:0090277),1/48,0.3300381801688704,0.4339062647977415,0,0,2.5515151515151517,2.8284742975844512,RBP4,High
Hexose Metabolic Process (GO:0019318),1/48,0.3300381801688704,0.4339062647977415,0,0,2.5515151515151517,2.8284742975844512,ALDOB,High
Membrane Lipid Biosynthetic Process (GO:0046467),1/48,0.3300381801688704,0.4339062647977415,0,0,2.5515151515151517,2.8284742975844512,CERS2,High
Actin Polymerization or Depolymerization (GO:0008154),1/49,0.3356122319023523,0.4393469217630794,0,0,2.4982323232323234,2.727567195504404,RNASE1,High
Arachidonate Metabolic Process (GO:0019369),1/49,0.3356122319023523,0.4393469217630794,0,0,2.4982323232323234,2.727567195504404,CYP2C19,High
Cellular Component Disassembly (GO:0022411),1/49,0.3356122319023523,0.4393469217630794,0,0,2.4982323232323234,2.727567195504404,MMP2,High
Regulation of Wound Healing (GO:0061041),1/49,0.3356122319023523,0.4393469217630794,0,0,2.4982323232323234,2.727567195504404,PRKCE,High
Positive Regulation of Macromolecule Biosynthetic Process (GO:0010557),4/355,0.34060043347528746,0.4423192023628335,0,0,1.3705462347437656,1.4761402956895862,SMOC2;UBR5;RPS3;ACTG2,High
Negative Regulation of Protein Binding (GO:0032091),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,IFIT2,High
Nuclear Export (GO:0051168),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,HNRNPA1,High
Nucleocytoplasmic Transport (GO:0006913),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,HNRNPA1,High
Positive Regulation of Developmental Growth (GO:0048639),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,GOLGA4,High
Positive Regulation of Fat Cell Differentiation (GO:0045600),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,ZBTB16,High
Triglyceride Metabolic Process (GO:0006641),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,APOC1,High
Positive Regulation of Non-Canonical NF-kappaB Signal Transduction (GO:1901224),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,RPS3,High
Lipid Modification (GO:0030258),1/50,0.34114018472714763,0.4423192023628335,0,0,2.4471243042671613,2.6317886779390967,CYP3A5,High
Positive Regulation of Cell Motility (GO:2000147),3/249,0.34153988445453964,0.4423192023628335,0,0,1.465509501720784,1.5743833967452527,NEDD9;SOD2;CCL15,High
Negative Regulation of Protein Metabolic Process (GO:0051248),2/146,0.34221918679542757,0.4423192023628335,0,0,1.6675135501355014,1.788081199977077,IGFBP5;RPS3,High
Regulation of Cell Cycle Process (GO:0010564),2/146,0.34221918679542757,0.4423192023628335,0,0,1.6675135501355014,1.788081199977077,CALM2;BCL2L1,High
Positive Regulation of Metabolic Process (GO:0009893),2/147,0.3452354223953395,0.44472310187214487,0,0,1.6559293523969723,1.761128409519575,AKR1C1;AKR1C3,High
Cardiac Muscle Tissue Development (GO:0048738),1/51,0.34662241763564233,0.44472310187214487,0,0,2.3980606060606062,2.5407913150697836,RBP4,High
Regulation of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),1/51,0.34662241763564233,0.44472310187214487,0,0,2.3980606060606062,2.5407913150697836,GLMN,High
Epithelial to Mesenchymal Transition (GO:0001837),1/51,0.34662241763564233,0.44472310187214487,0,0,2.3980606060606062,2.5407913150697836,S100A4,High
Inorganic Anion Transport (GO:0015698),1/51,0.34662241763564233,0.44472310187214487,0,0,2.3980606060606062,2.5407913150697836,CLIC1,High
Myofibril Assembly (GO:0030239),1/51,0.34662241763564233,0.44472310187214487,0,0,2.3980606060606062,2.5407913150697836,LMOD1,High
Negative Regulation of T Cell Activation (GO:0050868),1/51,0.34662241763564233,0.44472310187214487,0,0,2.3980606060606062,2.5407913150697836,GLMN,High
Negative Regulation of Protein Ubiquitination (GO:0031397),1/52,0.3520593064661331,0.4498127255892974,0,0,2.350920974450386,2.4542571947138705,RPS3,High
Regulation of Telomere Maintenance (GO:0032204),1/52,0.3520593064661331,0.4498127255892974,0,0,2.350920974450386,2.4542571947138705,EID3,High
Cholesterol Transport (GO:0030301),1/52,0.3520593064661331,0.4498127255892974,0,0,2.350920974450386,2.4542571947138705,APOC1,High
Sensory Perception (GO:0007600),1/52,0.3520593064661331,0.4498127255892974,0,0,2.350920974450386,2.4542571947138705,SCN9A,High
Phosphate-Containing Compound Metabolic Process (GO:0006796),2/150,0.35425702947096266,0.4521487008054831,0,0,1.6221160184574819,1.6833226041672213,PPA1;ALDOB,High
Regulation of Focal Adhesion Assembly (GO:0051893),1/53,0.35745122403485163,0.4533889100711486,0,0,2.3055944055944058,2.371894913920962,RNASE1,High
Regulation of Smoothened Signaling Pathway (GO:0008589),1/53,0.35745122403485163,0.4533889100711486,0,0,2.3055944055944058,2.371894913920962,UBR5,High
Positive Regulation of B Cell Activation (GO:0050871),1/53,0.35745122403485163,0.4533889100711486,0,0,2.3055944055944058,2.371894913920962,S100A9,High
Ceramide Metabolic Process (GO:0006672),1/53,0.35745122403485163,0.4533889100711486,0,0,2.3055944055944058,2.371894913920962,CERS2,High
Cytoplasmic Microtubule Organization (GO:0031122),1/53,0.35745122403485163,0.4533889100711486,0,0,2.3055944055944058,2.371894913920962,DLG1,High
Positive Regulation of Small GTPase Mediated Signal Transduction (GO:0051057),1/53,0.35745122403485163,0.4533889100711486,0,0,2.3055944055944058,2.371894913920962,RNASE1,High
Apical Junction Assembly (GO:0043297),1/54,0.36279854007800766,0.4573279228171796,0,0,2.261978273299028,2.293436927928128,DLG1,High
Regulation of Signal Transduction by P53 Class Mediator (GO:1901796),1/54,0.36279854007800766,0.4573279228171796,0,0,2.261978273299028,2.293436927928128,RPS20,High
Regulation of Smooth Muscle Cell Proliferation (GO:0048660),1/54,0.36279854007800766,0.4573279228171796,0,0,2.261978273299028,2.293436927928128,IGFBP5,High
Plasma Membrane Bounded Cell Projection Morphogenesis (GO:0120039),1/54,0.36279854007800766,0.4573279228171796,0,0,2.261978273299028,2.293436927928128,PPP1R12B,High
Tight Junction Assembly (GO:0120192),1/54,0.36279854007800766,0.4573279228171796,0,0,2.261978273299028,2.293436927928128,DLG1,High
Gonad Development (GO:0008406),1/54,0.36279854007800766,0.4573279228171796,0,0,2.261978273299028,2.293436927928128,AKR1C3,High
Regulation of Metabolic Process (GO:0019222),1/55,0.36810162135550845,0.46163563989666223,0,0,2.2199775533108865,2.2186372062244897,RNASE1,High
Regulation of Peptide Hormone Secretion (GO:0090276),1/55,0.36810162135550845,0.46163563989666223,0,0,2.2199775533108865,2.2186372062244897,UQCC2,High
Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),1/55,0.36810162135550845,0.46163563989666223,0,0,2.2199775533108865,2.2186372062244897,STAT2,High
Interferon-Mediated Signaling Pathway (GO:0140888),1/55,0.36810162135550845,0.46163563989666223,0,0,2.2199775533108865,2.2186372062244897,STAT2,High
"Regulation of Alternative mRNA Splicing, via Spliceosome (GO:0000381)",1/55,0.36810162135550845,0.46163563989666223,0,0,2.2199775533108865,2.2186372062244897,HNRNPA1,High
Adenylate Cyclase-Inhibiting G Protein-Coupled Receptor Signaling Pathway (GO:0007193),1/56,0.3733608314752076,0.4663200589037287,0,0,2.179504132231405,2.147269157873668,OXER1,High
Cellular Response to Alcohol (GO:0097306),1/56,0.3733608314752076,0.4663200589037287,0,0,2.179504132231405,2.147269157873668,AKR1C3,High
Sulfur Compound Biosynthetic Process (GO:0044272),1/56,0.3733608314752076,0.4663200589037287,0,0,2.179504132231405,2.147269157873668,GGT7,High
Epidermal Cell Differentiation (GO:0009913),1/56,0.3733608314752076,0.4663200589037287,0,0,2.179504132231405,2.147269157873668,AKR1C3,High
Neuron Projection Morphogenesis (GO:0048812),2/157,0.37513296240325716,0.4680558063013117,0,0,1.5483084185680567,1.5180773087619719,FARP1;PPP1R12B,High
Negative Regulation of Innate Immune Response (GO:0045824),1/57,0.37857653134967145,0.4713913269298045,0,0,2.1404761904761904,2.0791237858807836,STAT2,High
Cellular Response to Interleukin-1 (GO:0071347),1/57,0.37857653134967145,0.4713913269298045,0,0,2.1404761904761904,2.0791237858807836,GBP1,High
Negative Regulation of Protein Modification by Small Protein Conjugation or Removal (GO:1903321),1/58,0.3837490786466901,0.4758955139448315,0,0,2.102817650186071,2.0140080507306575,RPS3,High
Sprouting Angiogenesis (GO:0002040),1/58,0.3837490786466901,0.4758955139448315,0,0,2.102817650186071,2.0140080507306575,RNF213,High
Eye Development (GO:0001654),1/58,0.3837490786466901,0.4758955139448315,0,0,2.102817650186071,2.0140080507306575,RBP4,High
Mesenchymal Cell Differentiation (GO:0048762),1/58,0.3837490786466901,0.4758955139448315,0,0,2.102817650186071,2.0140080507306575,S100A4,High
Cellular Response to Calcium Ion (GO:0071277),1/59,0.3888788283239834,0.4794268302342975,0,0,2.066457680250784,1.951743405292569,AKR1C3,High
Renal System Development (GO:0072001),1/59,0.3888788283239834,0.4794268302342975,0,0,2.066457680250784,1.951743405292569,RBP4,High
Response to Interleukin-1 (GO:0070555),1/59,0.3888788283239834,0.4794268302342975,0,0,2.066457680250784,1.951743405292569,GBP1,High
mRNA Transport (GO:0051028),1/59,0.3888788283239834,0.4794268302342975,0,0,2.066457680250784,1.951743405292569,THOC2,High
Mitotic DNA Damage Checkpoint Signaling (GO:0044773),1/59,0.3888788283239834,0.4794268302342975,0,0,2.066457680250784,1.951743405292569,RPS27L,High
Regulation of Canonical NF-kappaB Signal Transduction (GO:0043122),3/270,0.38894676668517764,0.4794268302342975,0,0,1.3487971324188324,1.273686385006068,UNC5CL;UBD;S100A4,High
Neuron Migration (GO:0001764),1/60,0.39396613233835115,0.48318090779773726,0,0,2.031330251669235,1.8921644903481358,RNASE1,High
Response to Reactive Oxygen Species (GO:0000302),1/60,0.39396613233835115,0.48318090779773726,0,0,2.031330251669235,1.8921644903481358,RPS3,High
Response to Retinoic Acid (GO:0032526),1/60,0.39396613233835115,0.48318090779773726,0,0,2.031330251669235,1.8921644903481358,RBP4,High
Positive Regulation of Cell Cycle (GO:0045787),1/60,0.39396613233835115,0.48318090779773726,0,0,2.031330251669235,1.8921644903481358,SMOC2,High
Protein Targeting to Mitochondrion (GO:0006626),1/60,0.39396613233835115,0.48318090779773726,0,0,2.031330251669235,1.8921644903481358,TIMM10,High
Cellular Response to Oxygen-Containing Compound (GO:1901701),4/384,0.39518489948084723,0.484190507472029,0,0,1.264067576348278,1.1735622638834966,CXCL10;CXCL9;IGFBP5;RPS3,High
Phospholipid Transport (GO:0015914),1/61,0.3990113397472151,0.4874150497510891,0,0,1.9973737373737375,1.8351179648112526,APOC1,High
post-Golgi Vesicle-Mediated Transport (GO:0006892),1/61,0.3990113397472151,0.4874150497510891,0,0,1.9973737373737375,1.8351179648112526,VPS35L,High
mRNA Export From Nucleus (GO:0006406),1/61,0.3990113397472151,0.4874150497510891,0,0,1.9973737373737375,1.8351179648112526,THOC2,High
Negative Regulation of Signal Transduction (GO:0009968),3/277,0.4045896851389135,0.4932447954283169,0,0,1.313868613138686,1.1888958594028554,IGFBP5;UBR5;PLEK,High
Cellular Component Assembly (GO:0022607),3/277,0.4045896851389135,0.4932447954283169,0,0,1.313868613138686,1.1888958594028554,NEDD9;RNASE1;TEAD1,High
Spliceosomal Complex Assembly (GO:0000245),1/63,0.4089768470915394,0.49760204854875173,0,0,1.9327468230694038,1.7280626204540348,PRPF19,High
Positive Regulation of Peptidyl-Tyrosine Phosphorylation (GO:0050731),1/63,0.4089768470915394,0.49760204854875173,0,0,1.9327468230694038,1.7280626204540348,NEDD9,High
Regulation of Macromolecule Biosynthetic Process (GO:0010556),2/170,0.4131409486465741,0.5006037007623059,0,0,1.427555168408827,1.2619108947087072,KDM4B;STX3,High
Brain Development (GO:0007420),2/170,0.4131409486465741,0.5006037007623059,0,0,1.427555168408827,1.2619108947087072,KDM4B;COL4A1,High
Aerobic Electron Transport Chain (GO:0019646),1/64,0.4138978310224294,0.5006037007623059,0,0,1.9019721019721019,1.6777982914911853,NDUFA1,High
Endocytic Recycling (GO:0032456),1/64,0.4138978310224294,0.5006037007623059,0,0,1.9019721019721019,1.6777982914911853,VPS35L,High
Epigenetic Regulation of Gene Expression (GO:0040029),1/64,0.4138978310224294,0.5006037007623059,0,0,1.9019721019721019,1.6777982914911853,GLMN,High
Positive Regulation of Neurogenesis (GO:0050769),1/64,0.4138978310224294,0.5006037007623059,0,0,1.9019721019721019,1.6777982914911853,SS18L1,High
Regulation of Endocytosis (GO:0030100),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,RAB4A,High
Cellular Response to Virus (GO:0098586),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,CXCL10,High
Positive Regulation of T Cell Proliferation (GO:0042102),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,RPS3,High
Positive Regulation of Cell Junction Assembly (GO:1901890),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,RNASE1,High
Fat Cell Differentiation (GO:0045444),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,STEAP4,High
Protein Autoubiquitination (GO:0051865),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,RNF213,High
Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,NDUFA1,High
Negative Regulation of NF-kappaB Transcription Factor Activity (GO:0032088),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,COMMD6,High
Negative Regulation of Autophagy (GO:0010507),1/65,0.4187780864775593,0.5016836027794753,0,0,1.8721590909090908,1.629553718672261,BCL2L1,High
Regulation of Cytokine Production (GO:0001817),2/172,0.4188894134318822,0.5016836027794753,0,0,1.4106169296987088,1.2274459566930713,GLMN;S100A9,High
Negative Regulation of Binding (GO:0051100),1/66,0.42361794850255324,0.5068508005543746,0,0,1.8432634032634032,1.5832218755256053,IFIT2,High
Negative Regulation of Cytokine-Mediated Signaling Pathway (GO:0001960),1/67,0.4284177495076014,0.5101005110868717,0,0,1.81524334251607,1.5387028350226102,STAT2,High
Neurogenesis (GO:0022008),1/67,0.4284177495076014,0.5101005110868717,0,0,1.81524334251607,1.5387028350226102,THOC2,High
Regulation of Protein Serine/Threonine Kinase Activity (GO:0071900),1/67,0.4284177495076014,0.5101005110868717,0,0,1.81524334251607,1.5387028350226102,HERC5,High
Chordate Embryonic Development (GO:0043009),1/67,0.4284177495076014,0.5101005110868717,0,0,1.81524334251607,1.5387028350226102,RBP4,High
Response to Molecule of Bacterial Origin (GO:0002237),1/67,0.4284177495076014,0.5101005110868717,0,0,1.81524334251607,1.5387028350226102,S100A8,High
Central Nervous System Development (GO:0007417),3/288,0.42893233625773003,0.5102168897759587,0,0,1.2624475298676139,1.0686064085905604,KDM4B;COL4A1;ZBTB16,High
Double-Strand Break Repair (GO:0006302),2/176,0.43030057220506795,0.5113474760961196,0,0,1.3779086066722737,1.1619507949224792,EID3;PRPF19,High
Cellular Response to Cytokine Stimulus (GO:0071345),3/289,0.43112874244180677,0.5118347048969656,0,0,1.2579690248401905,1.0583903862128228,MT2A;RPS3;GBP1,High
Action Potential (GO:0001508),1/68,0.4331778189740353,0.5132716848249944,0,0,1.7880597014925372,1.495903205296807,SCN9A,High
Extrinsic Apoptotic Signaling Pathway (GO:0097191),1/68,0.4331778189740353,0.5132716848249944,0,0,1.7880597014925372,1.495903205296807,BCL2L1,High
Autophagosome Organization (GO:1905037),1/69,0.43789848385299784,0.5170154236924923,0,0,1.7616755793226382,1.454735614856356,UBXN2B,High
Skin Development (GO:0043588),1/69,0.43789848385299784,0.5170154236924923,0,0,1.7616755793226382,1.454735614856356,AKR1C3,High
Positive Regulation of Intracellular Protein Transport (GO:0090316),1/69,0.43789848385299784,0.5170154236924923,0,0,1.7616755793226382,1.454735614856356,UBR5,High
Positive Regulation of Multicellular Organismal Process (GO:0051240),4/407,0.43802695618391707,0.5170154236924923,0,0,1.1905155776123517,0.9827406401138439,ZBTB16;GLMN;ENO1;S100A9,High
Regulation of Heart Contraction (GO:0008016),1/70,0.4425800684201329,0.5208826959098488,0,0,1.736056214317084,1.4151182471112724,CALM2,High
Peptidyl-Serine Phosphorylation (GO:0018105),1/70,0.4425800684201329,0.5208826959098488,0,0,1.736056214317084,1.4151182471112724,PRKCE,High
Fatty Acid Biosynthetic Process (GO:0006633),1/70,0.4425800684201329,0.5208826959098488,0,0,1.736056214317084,1.4151182471112724,ACACA,High
Neuron Differentiation (GO:0030182),2/181,0.44439741037429786,0.522519145339232,0,0,1.339078893582232,1.0860412544461298,THOC2;RUNX1,High
Cell Surface Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),3/296,0.4464173079964746,0.524330289829033,0,0,1.2274754496534686,0.9899602957938748,MMP2;NEDD9;RNASE1,High
Phagocytosis (GO:0006909),1/71,0.4472228942659399,0.524330289829033,0,0,1.7111688311688311,1.3769744163255409,C1ORF43,High
Cellular Response to Reactive Oxygen Species (GO:0034614),1/71,0.4472228942659399,0.524330289829033,0,0,1.7111688311688311,1.3769744163255409,RPS3,High
Negative Regulation of Intracellular Signal Transduction (GO:1902532),3/297,0.448588489998593,0.5254280495294525,0,0,1.2232377613622136,0.9806077132699008,PLEK;BCL2L1;PLIN5,High
Negative Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001237),1/72,0.4518272802787947,0.527203613976401,0,0,1.686982501067008,1.340232181311951,BCL2L1,High
Autophagosome Assembly (GO:0000045),1/72,0.4518272802787947,0.527203613976401,0,0,1.686982501067008,1.340232181311951,UBXN2B,High
Kidney Development (GO:0001822),1/72,0.4518272802787947,0.527203613976401,0,0,1.686982501067008,1.340232181311951,ZBTB16,High
Regulation of G Protein-Coupled Receptor Signaling Pathway (GO:0008277),1/72,0.4518272802787947,0.527203613976401,0,0,1.686982501067008,1.340232181311951,PLEK,High
Spindle Assembly (GO:0051225),1/73,0.45639354285208683,0.5315182649390622,0,0,1.6634680134680135,1.3048239922013845,RPS3,High
Regulation of DNA Replication (GO:0006275),1/73,0.45639354285208683,0.5315182649390622,0,0,1.6634680134680135,1.3048239922013845,POLE3,High
DNA Repair (GO:0006281),3/302,0.4593930529731884,0.5345029437634815,0,0,1.2024745060221187,0.9353437252665301,EID3;MGMT;RPS3,High
Sensory Organ Development (GO:0007423),1/74,0.4609219957197416,0.5352642530938935,0,0,1.6405977584059777,1.2706863691544725,RBP4,High
Negative Regulation of Apoptotic Signaling Pathway (GO:2001234),1/74,0.4609219957197416,0.5352642530938935,0,0,1.6405977584059777,1.2706863691544725,BCL2L1,High
Regulation of Fat Cell Differentiation (GO:0045598),1/75,0.4654129501307578,0.5374202367547618,0,0,1.6183456183456184,1.2377596073077237,ZBTB16,High
Regulation of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),1/75,0.4654129501307578,0.5374202367547618,0,0,1.6183456183456184,1.2377596073077237,RNASE1,High
Regulation of Stress Fiber Assembly (GO:0051492),1/75,0.4654129501307578,0.5374202367547618,0,0,1.6183456183456184,1.2377596073077237,RNASE1,High
Peptidyl-Serine Modification (GO:0018209),1/75,0.4654129501307578,0.5374202367547618,0,0,1.6183456183456184,1.2377596073077237,PRKCE,High
Gland Development (GO:0048732),1/75,0.4654129501307578,0.5374202367547618,0,0,1.6183456183456184,1.2377596073077237,UGT1A7,High
Import Into Nucleus (GO:0051170),1/75,0.4654129501307578,0.5374202367547618,0,0,1.6183456183456184,1.2377596073077237,HNRNPA1,High
Negative Regulation of Supramolecular Fiber Organization (GO:1902904),1/76,0.4698667146306185,0.5410318520299879,0,0,1.5966868686868687,1.2059875079648261,MID1IP1,High
Positive Regulation of Protein Secretion (GO:0050714),1/76,0.4698667146306185,0.5410318520299879,0,0,1.5966868686868687,1.2059875079648261,RBP4,High
Regulation of Rho Protein Signal Transduction (GO:0035023),1/76,0.4698667146306185,0.5410318520299879,0,0,1.5966868686868687,1.2059875079648261,RNASE1,High
Negative Regulation of Cytokine Production (GO:0001818),2/191,0.4720020398006791,0.5427432865305278,0,0,1.2675829139243773,0.9516657236997839,RNASE1;GBP1,High
Protein Transport (GO:0015031),3/308,0.4722398694076897,0.5427432865305278,0,0,1.1784572060746255,0.8841589957542522,HSPA9;GOLGA4;STX3,High
Cellular Response to UV (GO:0034644),1/77,0.4742835954373444,0.5440704037631767,0,0,1.5755980861244019,1.1753171301465062,MMP2,High
Positive Regulation of Lymphocyte Proliferation (GO:0050671),1/77,0.4742835954373444,0.5440704037631767,0,0,1.5755980861244019,1.1753171301465062,S100A9,High
Regulation of Protein Binding (GO:0043393),1/78,0.47866389608016313,0.5485810943840072,0,0,1.5550570641479733,1.1456985650168554,IFIT2,High
Regulation of Programmed Cell Death (GO:0043067),2/195,0.4828136348367981,0.5525249451472087,0,0,1.2410590168077846,0.9036455368802819,CXCL10;RPS3,High
Sphingolipid Metabolic Process (GO:0006665),1/79,0.48300791773489654,0.5525249451472087,0,0,1.5350427350427351,1.1170847263401216,CERS2,High
Cholesterol Homeostasis (GO:0042632),1/80,0.487315959090938,0.5564129980665188,0,0,1.5155350978135789,1.089431159241575,AKR1C1,High
Negative Regulation of Cellular Component Organization (GO:0051129),1/80,0.487315959090938,0.5564129980665188,0,0,1.5155350978135789,1.089431159241575,GLMN,High
Negative Regulation of Neuron Apoptotic Process (GO:0043524),1/81,0.4915883163019557,0.5586853288334204,0,0,1.4965151515151516,1.0626958638325408,SOD2,High
Aerobic Respiration (GO:0009060),1/81,0.4915883163019557,0.5586853288334204,0,0,1.4965151515151516,1.0626958638325408,NDUFA1,High
Positive Regulation of JNK Cascade (GO:0046330),1/81,0.4915883163019557,0.5586853288334204,0,0,1.4965151515151516,1.0626958638325408,UNC5CL,High
Sterol Homeostasis (GO:0055092),1/81,0.4915883163019557,0.5586853288334204,0,0,1.4965151515151516,1.0626958638325408,AKR1C1,High
Regulation of Catabolic Process (GO:0009894),1/81,0.4915883163019557,0.5586853288334204,0,0,1.4965151515151516,1.0626958638325408,GLMN,High
Organelle Organization (GO:0006996),4/437,0.4925318037909513,0.5592383375140301,0,0,1.1063211017021641,0.7834924491374994,UBXN2B;CAPZB;NEDD9;PLIN5,High
Regulation of Vesicle-Mediated Transport (GO:0060627),1/82,0.4958252832404141,0.5614154918466853,0,0,1.477964833520389,1.0368391317180785,RAB4A,High
Response to Insulin (GO:0032868),1/82,0.4958252832404141,0.5614154918466853,0,0,1.477964833520389,1.0368391317180785,TBC1D4,High
Positive Regulation of Tumor Necrosis Factor Production (GO:0032760),1/82,0.4958252832404141,0.5614154918466853,0,0,1.477964833520389,1.0368391317180785,S100A9,High
Regulation of Cell Differentiation (GO:0045595),2/201,0.4987744721285764,0.5640859291515967,0,0,1.203272459860277,0.8369978212220193,UQCC2;RUNX1,High
Organophosphate Metabolic Process (GO:0019637),1/83,0.5000271512495771,0.5640859291515967,0,0,1.4598669623059868,1.0118233966428425,ALDOB,High
Sphingolipid Biosynthetic Process (GO:0030148),1/83,0.5000271512495771,0.5640859291515967,0,0,1.4598669623059868,1.0118233966428425,CERS2,High
Regulation of T Cell Proliferation (GO:0042129),1/83,0.5000271512495771,0.5640859291515967,0,0,1.4598669623059868,1.0118233966428425,GLMN,High
Positive Regulation of Protein Metabolic Process (GO:0051247),2/202,0.50140413907606185,0.5651184771906995,0,0,1.1971951219512196,0.8264750784316479,PAEP;RPS27L,High
Positive Regulation of Synaptic Transmission (GO:0050806),1/84,0.504194209352044,0.5672184855210495,0,0,1.442205184373859,0.9876130952043071,CALM2,High
Monoatomic Cation Homeostasis (GO:0055080),1/84,0.504194209352044,0.5672184855210495,0,0,1.442205184373859,0.9876130952043071,CUTC,High
Peptidyl-Lysine Modification (GO:0018205),1/85,0.5083267442555275,0.5687312019824183,0,0,1.424963924963925,0.9641745386765581,EID3,High
Cell Morphogenesis Involved in Neuron Differentiation (GO:0048667),1/85,0.5083267442555275,0.5687312019824183,0,0,1.424963924963925,0.9641745386765581,FARP1,High
Cellular Respiration (GO:0045333),1/85,0.5083267442555275,0.5687312019824183,0,0,1.424963924963925,0.9641745386765581,NDUFA1,High
Ribosomal Small Subunit Biogenesis (GO:0042274),1/85,0.5083267442555275,0.5687312019824183,0,0,1.424963924963925,0.9641745386765581,RPS27L,High
Positive Regulation of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),1/85,0.5083267442555275,0.5687312019824183,0,0,1.424963924963925,0.9641745386765581,S100A9,High
Long-Chain Fatty Acid Metabolic Process (GO:0001676),1/85,0.5083267442555275,0.5687312019824183,0,0,1.424963924963925,0.9641745386765581,CYP2C19,High
Intracellular Protein Transport (GO:0006886),3/326,0.5099219533326421,0.5699949505745698,0,0,1.1117590077684287,0.7487670209039602,HSPA9;TIMM10;STX3,High
Neuron Projection Development (GO:0031175),2/206,0.5118343693060148,0.5716106460132866,0,0,1.1734815877570541,0.7859442263981719,STX3;PPP1R12B,High
Regulation of Innate Immune Response (GO:0045088),1/86,0.5124250401417375,0.5717486318445639,0,0,1.4081283422459894,0.9414757949953488,S100A9,High
Positive Regulation of Biosynthetic Process (GO:0009891),1/87,0.5164893790414128,0.5741898273811892,0,0,1.3916842847075406,0.9194865778454283,RUNX1,High
Defense Response to Gram-negative Bacterium (GO:0050829),1/87,0.5164893790414128,0.5741898273811892,0,0,1.3916842847075406,0.9194865778454283,GSDMB,High
Sodium Ion Transmembrane Transport (GO:0035725),1/87,0.5164893790414128,0.5741898273811892,0,0,1.3916842847075406,0.9194865778454283,SCN9A,High
Synapse Assembly (GO:0007416),1/87,0.5164893790414128,0.5741898273811892,0,0,1.3916842847075406,0.9194865778454283,FARP1,High
Regulation of Mitotic Cell Cycle Phase Transition (GO:1901990),1/88,0.52052004066895885,0.577621513852045,0,0,1.3756182514803204,0.8981781453111252,UBD,High
Positive Regulation of Protein Kinase Activity (GO:0045860),1/88,0.52052004066895885,0.577621513852045,0,0,1.3756182514803204,0.8981781453111252,NEDD9,High
Intracellular Monoatomic Cation Homeostasis (GO:0030003),2/210,0.5221215162454121,0.5788738549677396,0,0,1.1506801125703565,0.7477751422217018,MT2A;CCL15,High
Positive Regulation of Canonical Wnt Signaling Pathway (GO:0090263),1/89,0.5245173023042216,0.581003781013907,0,0,1.3599173553719008,0.8775232056971533,UBR5,High
Protein Stabilization (GO:0050821),2/212,0.5272108361593648,0.58328339183133,0,0,1.1396051103368177,0.7295236151995624,H1-5;CCT8,High
Chloride Transport (GO:0006821),1/90,0.5284814391674387,0.58328339183133,0,0,1.344569288389513,0.8574958288022387,CLIC1,High
Positive Regulation of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),1/90,0.5284814391674387,0.58328339183133,0,0,1.344569288389513,0.8574958288022387,RNASE1,High
Mitochondrial Respiratory Chain Complex Assembly (GO:0033108),1/90,0.5284814391674387,0.58328339183133,0,0,1.344569288389513,0.8574958288022387,UQCC2,High
Regulation of Double-Strand Break Repair (GO:2000779),1/91,0.5324127239411499,0.5860370270719132,0,0,1.3295622895622896,0.838071365624585,MGMT,High
Calcium-Mediated Signaling (GO:0019722),1/91,0.5324127239411499,0.5860370270719132,0,0,1.3295622895622896,0.838071365624585,CALM2,High
Protein K48-linked Ubiquitination (GO:0070936),1/91,0.5324127239411499,0.5860370270719132,0,0,1.3295622895622896,0.838071365624585,UBR5,High
RNA Splicing (GO:0008380),1/92,0.5363114274183616,0.5887400781704705,0,0,1.3148851148851148,0.8192263708643077,PRPF8,High
Sensory Perception of Mechanical Stimulus (GO:0050954),1/92,0.5363114274183616,0.5887400781704705,0,0,1.3148851148851148,0.8192263708643077,TIMM10,High
Glucose Homeostasis (GO:0042593),1/92,0.5363114274183616,0.5887400781704705,0,0,1.3148851148851148,0.8192263708643077,RBP4,High
Cellular Response to Peptide Hormone Stimulus (GO:0071375),1/94,0.5440121615938746,0.5950588791697073,0,0,1.286477680026067,0.7831866117878795,TBC1D4,High
Positive Regulation of Double-Strand Break Repair (GO:2000781),1/94,0.5440121615938746,0.5950588791697073,0,0,1.286477680026067,0.7831866117878795,MGMT,High
Lipid Biosynthetic Process (GO:0008610),1/94,0.5440121615938746,0.5950588791697073,0,0,1.286477680026067,0.7831866117878795,ACACA,High
Mitochondrial Translation (GO:0032543),1/94,0.5440121615938746,0.5950588791697073,0,0,1.286477680026067,0.7831866117878795,MRPL45,High
Sensory Perception of Sound (GO:0007605),1/96,0.5515857626593321,0.6022667024933297,0,0,1.2592663476874004,0.7492105176514541,TIMM10,High
Sodium Ion Transport (GO:0006814),1/96,0.5515857626593321,0.6022667024933297,0,0,1.2592663476874004,0.7492105176514541,SCN9A,High
"Regulation of mRNA Splicing, via Spliceosome (GO:0048024)",1/97,0.5553255416347704,0.6058096817833859,0,0,1.2460858585858585,0.7329486685984987,HNRNPA1,High
Defense Response to Gram-positive Bacterium (GO:0050830),1/98,0.5590343169918047,0.6071499591818713,0,0,1.2331771321462044,0.7171472772890255,RNASE1,High
Positive Regulation of Hydrolase Activity (GO:0051345),1/98,0.5590343169918047,0.6071499591818713,0,0,1.2331771321462044,0.7171472772890255,PLIN5,High
Positive Regulation of Proteasomal Protein Catabolic Process (GO:1901800),1/98,0.5590343169918047,0.6071499591818713,0,0,1.2331771321462044,0.7171472772890255,ECSCR,High
Positive Regulation of Protein Modification Process (GO:0031401),1/98,0.5590343169918047,0.6071499591818713,0,0,1.2331771321462044,0.7171472772890255,RNASE1,High
rRNA Metabolic Process (GO:0016072),1/98,0.5590343169918047,0.6071499591818713,0,0,1.2331771321462044,0.7171472772890255,RPL27,High
Regulation of Protein Secretion (GO:0050708),1/99,0.5627123442559727,0.6095220436896555,0,0,1.2205318491032777,0.7017895987611994,UQCC2,High
Positive Regulation of Neuron Projection Development (GO:0010976),1/99,0.5627123442559727,0.6095220436896555,0,0,1.2205318491032777,0.7017895987611994,S100A9,High
Positive Regulation of Protein Catabolic Process (GO:0045732),1/99,0.5627123442559727,0.6095220436896555,0,0,1.2205318491032777,0.7017895987611994,ECSCR,High
Cellular Response to Chemical Stress (GO:0062197),1/100,0.566359876814798,0.6123891247538098,0,0,1.2081420263238445,0.6868596439049133,SOD2,High
Mitochondrial Gene Expression (GO:0140053),1/100,0.566359876814798,0.6123891247538098,0,0,1.2081420263238445,0.6868596439049133,MRPL45,High
Cell Junction Assembly (GO:0034329),1/101,0.5699771660218432,0.6144461541570808,0,0,1.196,0.6723421383658332,FARP1,High
mRNA Metabolic Process (GO:0016071),1/101,0.5699771660218432,0.6144461541570808,0,0,1.196,0.6723421383658332,PRPF8,High
Recombinational Repair (GO:0000725),1/101,0.5699771660218432,0.6144461541570808,0,0,1.196,0.6723421383658332,EID3,High
Negative Regulation of Transcription by RNA Polymerase II (GO:0000122),6/732,0.5702702868647417,0.6144461541570808,0,0,0.9869834710743801,0.5543341767172406,H1-5;DLG1;ZBTB16;POLE3;ENO1;RUNX1,High
Regulation of Defense Response (GO:0031347),1/103,0.5771220091594975,0.6212817407310686,0,0,1.17243018419489,0.6444867252522097,HERC5,High
Regulation of RNA Splicing (GO:0043484),1/104,0.5806500555564001,0.6245304639727889,0,0,1.1609885260370698,0.6311215101192602,HNRNPA1,High
Calcium Ion Homeostasis (GO:0055074),1/105,0.5841488433543327,0.6270907219529438,0,0,1.1497668997668997,0.6181140642911073,CCL15,High
Organic Anion Transport (GO:0015711),1/105,0.5841488433543327,0.6270907219529438,0,0,1.1497668997668997,0.6181140642911073,ABCC6,High
Negative Regulation of Gene Expression (GO:0010629),3/364,0.5845674131930627,0.6270907219529438,0,0,0.9927943850585457,0.5330145965253832,IGFBP5;RPS3;S100A9,High
Cell-Matrix Adhesion (GO:0007160),1/107,0.5910596061351994,0.6334999631431558,0,0,1.127958833619211,0.5931240799056291,RNASE1,High
Cellular Response to Insulin Stimulus (GO:0032869),1/108,0.5944720574801863,0.6365999985614593,0,0,1.1173605210988389,0.5811186092324172,TBC1D4,High
Regulation of Gene Expression (GO:0010468),9/1127,0.59567184211776,0.6373272156924286,0,0,0.9596527010243496,0.49716282589514393,KDM4B;KDM5D;UBR5;GLMN;RPS3;STX3;HNRNPA1;S100A9;ACTG2,High
Protein Localization (GO:0008104),3/371,0.5975156258706538,0.6387415948171881,0,0,0.9735596158975727,0.5013587107701818,HSPA9;STX3;PRPF19,High
"Negative Regulation of Gene Expression, Epigenetic (GO:0045814)",1/110,0.6012122768382878,0.6421324841623598,0,0,1.0967472894078398,0.5580329182600923,POLE3,High
Regulation of G1/S Transition of Mitotic Cell Cycle (GO:2000045),1/111,0.6045405096637111,0.6451243102252681,0,0,1.0867217630853994,0.5469324987546905,DLG1,High
Regulation of Protein Ubiquitination (GO:0031396),1/113,0.6111143693366455,0.6515714181777474,0,0,1.0672077922077923,0.5255690524209823,RPS3,High
Positive Regulation of Wnt Signaling Pathway (GO:0030177),1/114,0.6143604497508266,0.6536334894035112,0,0,1.0577098417806383,0.5152881753235423,UBR5,High
Double-Strand Break Repair via Homologous Recombination (GO:0000724),1/114,0.6143604497508266,0.6536334894035112,0,0,1.0577098417806383,0.5152881753235423,EID3,High
Regulation of Inflammatory Response (GO:0050727),2/249,0.6146504463263409,0.6536334894035112,0,0,0.9670682334353707,0.47067361080102804,S100A9;S100A8,High
Regulation of JNK Cascade (GO:0046328),1/115,0.6175795964766342,0.6561783212564238,0,0,1.0483785220627326,0.5052632165483975,UNC5CL,High
Positive Regulation of Signal Transduction (GO:0009967),2/256,0.6297419493192301,0.668520508210527,0,0,0.9400806606491262,0.4347357400225408,SMOC2;RPS3,High
Ribonucleoprotein Complex Biogenesis (GO:0022613),1/120,0.6332790354250868,0.6716928417333676,0,0,1.0040743570155335,0.4587054858360159,RPL38,High
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),1/121,0.6363411814292402,0.6737730156309603,0,0,0.9956565656565657,0.4500570897153849,NEDD9,High
Negative Regulation of Cell Growth (GO:0030308),1/121,0.6363411814292402,0.6737730156309603,0,0,0.9956565656565657,0.4500570897153849,ENO1,High
Negative Regulation of DNA-binding Transcription Factor Activity (GO:0043433),1/122,0.6393779109402595,0.6764032523689522,0,0,0.9873779113448535,0.44161423930588267,COMMD6,High
Protein-Containing Complex Organization (GO:0043933),1/123,0.6423894335931022,0.6790023028652479,0,0,0.9792349726775956,0.43337078259421263,TEAD1,High
Regulation of Protein-Containing Complex Assembly (GO:0043254),1/126,0.6512748319607857,0.6872072364827602,0,0,0.9555878787878788,0.40977859316128235,RPS3,High
Regulation of Cell Motility (GO:2000145),1/126,0.6512748319607857,0.6872072364827602,0,0,0.9555878787878788,0.40977859316128235,RNASE1,High
Golgi Organization (GO:0007030),1/128,0.6570761645483539,0.6927314602990399,0,0,0.9404438081603436,0.3949443986815018,UBXN2B,High
Regulation of Neuron Apoptotic Process (GO:0043523),1/129,0.6599407546017128,0.6951527397870021,0,0,0.9330492424242425,0.38778012983311483,SOD2,High
Regulation of DNA Repair (GO:0006282),1/130,0.6627815583518013,0.6975448215155674,0,0,0.9257693211181584,0.38077801067123,RPS3,High
Regulation of Tumor Necrosis Factor Production (GO:0032680),1/131,0.6655987720659962,0.6999079871209445,0,0,0.9186013986013986,0.37393344938138173,S100A9,High
Regulation of Response to External Stimulus (GO:0032101),1/132,0.6683925904926911,0.7004388105848064,0,0,0.9115429100161925,0.36724201358307795,HERC5,High
Circulatory System Development (GO:0072359),1/132,0.6683925904926911,0.7004388105848064,0,0,0.9115429100161925,0.36724201358307795,RBP4,High
Epithelial Cell Differentiation (GO:0030855),1/132,0.6683925904926911,0.7004388105848064,0,0,0.9115429100161925,0.36724201358307795,AKR1C1,High
Protein Localization to Plasma Membrane (GO:0072659),1/132,0.6683925904926911,0.7004388105848064,0,0,0.9115429100161925,0.36724201358307795,DLG1,High
Protein Localization to Cell Periphery (GO:1990778),1/136,0.6793377501239691,0.7112997486327958,0,0,0.884354657687991,0.3419241011071334,DLG1,High
Positive Regulation of RNA Biosynthetic Process (GO:1902680),4/555,0.6801124889249293,0.7115022961060798,0,0,0.8641079070601152,0.3331110659929494,ZBTB16;SS18L1;TEAD1;RUNX1,High
Intracellular Calcium Ion Homeostasis (GO:0006874),1/140,0.6899237524013201,0.7211500195894242,0,0,0.8587311968606932,0.31873885750709796,CCL15,High
Cellular Response to Starvation (GO:0009267),1/141,0.6925155160694256,0.7232414604684104,0,0,0.8525541125541125,0.3132493838746386,HNRNPA1,High
Regulation of Cell Adhesion (GO:0030155),1/142,0.69508574585611,0.7253068652411583,0,0,0.8464646464646465,0.3078761768205509,STX3,High
RNA Processing (GO:0006396),2/291,0.6983763260681407,0.7281197811817752,0,0,0.8247531437252089,0.29608404653662784,RPL27;PRPF8,High
Synapse Organization (GO:0050808),1/144,0.7001623136638775,0.7293605718507115,0,0,0.8345412163593982,0.29746645335926203,FARP1,High
Negative Regulation of Wnt Signaling Pathway (GO:0030178),1/146,0.7051548610607404,0.7339366921244441,0,0,0.8229467084639498,0.2874864249220546,RNF213,High
Positive Regulation of Transcription by RNA Polymerase II (GO:0045944),7/983,0.713079906932573,0.7415546355866349,0,0,0.8506418187442004,0.28765456297879777,HELZ2;CXCL10;SS18L1;STAT2;MRTFA;TEAD1;RUNX1,High
Protein Localization to Organelle (GO:0033365),1/151,0.7172776559642419,0.7452868004246452,0,0,0.7953131313131313,0.26427640300603367,GBP1,High
Axon Guidance (GO:0007411),1/152,0.7196420910268143,0.7471093464095171,0,0,0.7900060204695967,0.2599129969675919,RNASE1,High
Positive Regulation of ERK1 and ERK2 Cascade (GO:0070374),1/153,0.7219868700935675,0.7489084144021413,0,0,0.7847687400318979,0.25563710314328797,S100A9,High
Negative Regulation of Response to External Stimulus (GO:0032102),1/154,0.7243121555739982,0.7506842323645841,0,0,0.7795999207763914,0.25144656513657426,CERS2,High
Negative Regulation of DNA-templated Transcription (GO:0045892),7/1006,0.7352925639166923,0.7605048714981484,0,0,0.8300438803583458,0.2552275472750314,H1-5;DLG1;ZMYM2;ZBTB16;POLE3;ENO1;RUNX1,High
Epithelium Development (GO:0060429),1/159,0.7356517711223919,0.7605048714981484,0,0,0.7547372458764864,0.23170313390836342,AKR1C1,High
Regulation of Cellular Component Organization (GO:0051128),1/159,0.7356517711223919,0.7605048714981484,0,0,0.7547372458764864,0.23170313390836342,RAB4A,High
Ribosome Biogenesis (GO:0042254),1/161,0.7400566994161825,0.7644129958526644,0,0,0.7452272727272727,0.22433462935289336,RPL27,High
+ Reg of Phosphatidylinositol 3-Kinase/Prot Kinase B Signal Transduction (GO:0051897),1/162,0.7422317255829081,0.765367845082965,0,0,0.7405608883869753,0.22075659893878302,AKR1C3,High
Macroautophagy (GO:0016236),1/162,0.7422317255829081,0.765367845082965,0,0,0.7405608883869753,0.22075659893878302,RNF213,High
Negative Regulation of RNA Biosynthetic Process (GO:1902679),3/470,0.751710605239708,0.7744897144893961,0,0,0.7632716333206343,0.2178406723303041,ZMYM2;ZBTB16;ENO1,High
Cellular Response to Nitrogen Compound (GO:1901699),1/169,0.7569586637607237,0.7792408784214683,0,0,0.7094516594516594,0.19754442540469666,IGFBP5,High
Heart Development (GO:0007507),1/171,0.7610105788283097,0.7820965142618397,0,0,0.7010338680926916,0.19145797166578538,RBP4,High
Positive Regulation of Protein Phosphorylation (GO:0001934),1/171,0.7610105788283097,0.7820965142618397,0,0,0.7010338680926916,0.19145797166578538,RNASE1,High
Nervous System Development (GO:0007399),3/480,0.7643065301252545,0.7848248262359996,0,0,0.7468842844465023,0.20075230281017187,FARP1;DLG1;ZBTB16,High
Membrane Organization (GO:0061024),1/173,0.7649953411652511,0.7848736777755804,0,0,0.6928118393234672,0.18559427033833895,UBXN2B,High
Positive Regulation of Cell Population Proliferation (GO:0008284),3/484,0.7691989213258693,0.7885255273893333,0,0,0.74052013315817,0.19431667991332055,AKR1C3;STX3;S100A9,High
Regulation of Neuron Projection Development (GO:0010975),1/176,0.7708489885020411,0.7895557840389107,0,0,0.6808311688311688,0.1771950188802368,S100A9,High
Small GTPase-mediated Signal Transduction (GO:0007264),1/188,0.7928493136077664,0.8114110032240017,0,0,0.6367525522605737,0.14780433711161947,RNASE1,High
Anterograde Trans-Synaptic Signaling (GO:0098916),1/189,0.7945849663516312,0.8125079355174575,0,0,0.6333333333333333,0.14562572518136305,DLG1,High
Intracellular Signaling Cassette (GO:0141124),2/354,0.7953612630595748,0.812622859753689,0,0,0.6749584257206208,0.15453770400718733,FPR1;RNASE1,High
Positive Regulation of MAPK Cascade (GO:0043410),2/362,0.8054885590353729,0.8222835665215149,0,0,0.6596883468834689,0.14269473228843274,UNC5CL;S100A9,High
Endomembrane System Organization (GO:0010256),1/196,0.8063364071861087,0.8224631353298308,0,0,0.6103807303807304,0.1313870432262866,UBXN2B,High
Protein Localization to Membrane (GO:0072657),1/199,0.8111658513102943,0.8267002514602834,0,0,0.6010407101316192,0.12578744879694537,DLG1,High
Negative Regulation of Macromolecule Biosynthetic Process (GO:0010558),1/202,0.815875568350011,0.8308083990519246,0,0,0.5919794964571083,0.12046393550827257,S100A9,High
Regulation of Signal Transduction (GO:0009966),1/211,0.8293155037984267,0.8437923330417907,0,0,0.5663492063492064,0.10599486634323241,IGFBP5,High
Regulation of Canonical Wnt Signaling Pathway (GO:0060828),1/216,0.8363559657411337,0.8501712478981813,0,0,0.5530373502466526,0.09882830550553276,UBR5,High
Positive Regulation of DNA-templated Transcription (GO:0045893),8/1274,0.8369741451938796,0.8501712478981813,0,0,0.7426160337552743,0.13215750798577866,HELZ2;CXCL10;ZBTB16;SS18L1;STAT2;MRTFA;TEAD1;RUNX1,High
Regulation of Phosphatidylinositol 3-Kinase/Protein Kinase B Signal Transduction (GO:0051896),1/219,0.8404408862277692,0.8529847800520644,0,0,0.5453433416736169,0.094796302476361,AKR1C3,High
Negative Regulation of Cell Differentiation (GO:0045596),1/220,0.8417798747630559,0.8536359293371835,0,0,0.5428255154282552,0.09349449190986782,ZBTB16,High
Cilium Organization (GO:0044782),1/230,0.8545704667627068,0.8651730780128645,0,0,0.518856689162366,0.08154160493672777,NEDD9,High
Regulation of Autophagy (GO:0010506),1/230,0.8545704667627068,0.8651730780128645,0,0,0.518856689162366,0.08154160493672777,BCL2L1,High
Negative Regulation of Multicellular Organismal Process (GO:0051241),1/243,0.8696734130635582,0.879735750074211,0,0,0.4906586526421237,0.06851435992002841,PAEP,High
Positive Regulation of Developmental Process (GO:0051094),1/245,0.8718542679100562,0.8812135622806844,0,0,0.48658718330849476,0.06672715680072322,ZBTB16,High
Chemical Synaptic Transmission (GO:0007268),1/260,0.8870948143746011,0.895877931348607,0,0,0.45805545805545805,0.05487660541610791,DLG1,High
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),1/277,0.9021995129129495,0.9103810418841305,0,0,0.4294685990338164,0.04420073380368507,RNASE1,High
Positive Regulation of Cell Differentiation (GO:0045597),1/297,0.9174166900410908,0.9249132801627691,0,0,0.40004095004095,0.034480931316011,ZBTB16,High
Phosphorylation (GO:0016310),1/298,0.9181124472203959,0.9249132801627691,0,0,0.3986736047342108,0.034060840619209866,PRKCE,High
Monoatomic Cation Transmembrane Transport (GO:0098655),1/304,0.9221663100119051,0.9282331936304045,0,0,0.39065906590659066,0.03165498381458305,SCN9A,High
Inorganic Cation Transmembrane Transport (GO:0098662),1/307,0.9241177906513566,0.9294331764644703,0,0,0.38676965735789265,0.03052221232962677,SCN9A,High
Regulation of Cell Cycle (GO:0051726),1/318,0.9308661285440367,0.9354516759752882,0,0,0.373138323296052,0.0267315568048091,GLMN,High
Regulation of Transcription by RNA Polymerase II (GO:0006357),13/2250,0.942296882176868,0.9461619227108173,0,0,0.66838173206997,0.03972519640267867,ZBTB16;SS18L1;STAT2;MRTFA;ENO1;SOD2;RUNX1;HELZ2;H1-5;CXCL10;DLG1;POLE3;TEAD1,High
Organelle Assembly (GO:0070925),1/346,0.9454709845722266,0.9485708894396765,0,0,0.34236275801493193,0.01919699170784031,UBXN2B,High
Protein Phosphorylation (GO:0006468),1/373,0.9566382725937038,0.9589887351799292,0,0,0.31707396546106226,0.014055869722619616,PRKCE,High
Regulation of RNA Biosynthetic Process (GO:2001141),1/465,0.9801858757399777,0.9817901079424982,0,0,0.2530041797283177,0.005063386862679437,KDM5D,High
Protein Modification Process (GO:0036211),1/545,0.9900016592927101,0.9908111455227123,0,0,0.21490641711229946,0.0021595214747558884,PRKCE,High
Regulation of DNA-templated Transcription (GO:0006355),9/2139,0.9943032500304294,0.9943032500304294,0,0,0.47646900511348345,0.002722085693868003,KDM5D;ZMYM2;ZBTB16;SS18L1;STAT2;ENO1;SOD2;TEAD1;RUNX1,High
Icosanoid Binding (GO:0050542),4/7,1.5710170055771868e-7,2.8512297973122407e-5,0,0,163.21810699588477,2557.035657566031,OXER1;STX3;S100A9;S100A8,High
Monocarboxylic Acid Binding (GO:0033293),6/32,2.2628807915176513e-7,2.8512297973122407e-5,0,0,28.56923076923077,437.15085507811517,UGT1A1;AKR1C3;UGT1A3;AKR1C4;UGT1A7;UGT2B7,High
Retinoid Binding (GO:0005501),5/32,6.228645177216888e-6,4.593874016663573e-4,0,0,22.78237865194387,273.077603457396,RBP4;UGT1A1;UGT1A3;UGT1A7;UGT2B7,High
Glucuronosyltransferase Activity (GO:0015020),5/33,7.291863518513608e-6,4.593874016663573e-4,0,0,21.967613132209404,259.8494349861243,UGT2B10;UGT1A1;UGT1A3;UGT1A7;UGT2B7,High
Icosatetraenoic Acid Binding (GO:0050543),3/6,1.10262361996153e-5,4.6310192038384254e-4,0,0,121.66257668711657,1388.806662206498,STX3;S100A9;S100A8,High
Arachidonate Binding (GO:0050544),3/6,1.10262361996153e-5,4.6310192038384254e-4,0,0,121.66257668711657,1388.806662206498,STX3;S100A9;S100A8,High
Retinoic Acid Binding (GO:0001972),4/23,3.583089065766689e-5,0.001289912063676008,0,0,25.750487329434698,263.60001799914767,UGT1A1;UGT1A3;UGT1A7;UGT2B7,High
RAGE Receptor Binding (GO:0050786),3/9,4.54679243942918e-5,0.0014322396184201917,0,0,60.82208588957055,608.129834932478,S100A4;S100A9;S100A8,High
Aldose Reductase (NADPH) Activity (GO:0004032),3/10,6.455817881760927e-5,0.0018076290068930595,0,0,52.13058720420683,502.95297266417015,AKR1C1;AKR1C3;AKR1C4,High
Aldo-Keto Reductase (NADPH) Activity (GO:0004033),3/14,1.9109818003117487e-4,0.004273538355628077,0,0,33.16731734523145,284.0025587223868,AKR1C1;AKR1C3;AKR1C4,High
UDP-glycosyltransferase Activity (GO:0008194),5/65,2.0489807044129658e-4,0.004273538355628077,0,0,10.234989648033126,86.92574579031839,UGT2B10;UGT1A1;UGT1A3;UGT2B7;UGT1A7,High
Chemoattractant Activity (GO:0042056),4/36,2.1914600433410456e-4,0.004273538355628077,0,0,15.279320987654321,128.74008051582524,CXCL10;S100A4;S100A9;CCL15,High
CXCR Chemokine Receptor Binding (GO:0045236),3/15,2.3741879753489317e-4,0.004273538355628077,0,0,30.401840490797547,253.72418105754255,CXCL10;CXCL9;CXCL11,High
"Oxidoreductase Activity, Acting on NAD(P)H, Quinone or Similar Compound as Acceptor (GO:0016655)",3/15,2.3741879753489317e-4,0.004273538355628077,0,0,30.401840490797547,253.72418105754255,AKR1C1;AKR1C3;AKR1C4,High
"Oxidoreductase Activity, Acting on the CH-OH Group of Donors, NAD or NADP as Acceptor (GO:0016616)",5/70,2.903914776077028e-4,0.004878576823809408,0,0,9.445293836598184,76.9251235674631,LDHA;AKR1C1;GPD1;AKR1C3;AKR1C4,High
Chemokine Activity (GO:0008009),4/42,4.0061341352190717e-4,0.0063096612629700375,0,0,12.862897985705004,100.6201950937783,CXCL10;CXCL9;CXCL11;CCL15,High
Chemokine Receptor Binding (GO:0042379),4/46,5.692084360034161e-4,0.008437677992521226,0,0,11.635508524397414,86.93195445963957,CXCL10;CXCL9;CXCL11;CCL15,High
Alcohol Dehydrogenase [NAD(P)+] Activity (GO:0018455),3/22,7.700004546135333e-4,0.010780006364589466,0,0,19.19438165967065,137.60681493907595,AKR1C1;AKR1C3;AKR1C4,High
"Steroid Dehydrogenase Activity, Acting on the CH-OH Group of Donors, NAD or NADP as Acceptor (GO:0033764)",3/24,9.997567321736792e-4,0.013259931395145641,0,0,17.364592462751972,119.95458001250671,AKR1C1;AKR1C3;AKR1C4,High
Alcohol Dehydrogenase (NADP+) Activity (GO:0008106),3/25,0.0011291976051592011,0.014227889825005934,0,0,16.574456218627997,112.47837007331985,AKR1C1;AKR1C3;AKR1C4,High
Androsterone Dehydrogenase [NAD(P)+] Activity (GO:0047023),2/7,0.0013991842644018836,0.015506434149836747,0,0,48.363414634146345,317.8378744968035,AKR1C3;AKR1C4,High
Retinal Dehydrogenase Activity (GO:0001758),2/7,0.0013991842644018836,0.015506434149836747,0,0,48.363414634146345,317.8378744968035,AKR1C3;AKR1C4,High
Hexosyltransferase Activity (GO:0016758),5/99,0.0014152697835168458,0.015506434149836747,0,0,6.521739130434782,42.78544634563678,UGT2B10;UGT1A1;UGT1A3;UGT2B7;UGT1A7,High
Bile Acid Binding (GO:0032052),2/8,0.001855415818156856,0.01948186609064699,0,0,40.300813008130085,253.47786536035218,AKR1C3;AKR1C4,High
Toll-like Receptor Binding (GO:0035325),2/11,0.003585399012736539,0.03614082204838431,0,0,26.863143631436316,151.2632862407391,S100A9;S100A8,High
Ubiquitin-Protein Transferase Inhibitor Activity (GO:0055105),2/13,0.005029652586137185,0.04874894045025271,0,0,21.97671840354767,116.30968042089769,GLMN;RPS20,High
Transcription Corepressor Binding (GO:0001222),3/46,0.006562575377164179,0.06027676159651361,0,0,8.47096590098445,42.57822721610337,ZBTB16;ENO1;RUNX1,High
Ubiquitin-Ubiquitin Ligase Activity (GO:0034450),2/15,0.006697417955168179,0.06027676159651361,0,0,18.593808630393998,93.08122344256823,UBR5;PRPF19,High
Nucleoside Monophosphate Kinase Activity (GO:0050145),2/18,0.009601370877517652,0.08343260210808442,0,0,15.105182926829269,70.1764049009769,DLG1;CMPK2,High
Histone Demethylase Activity (GO:0032452),2/21,0.012965787679204827,0.10891261650532055,0,0,12.718228498074454,55.26631293087005,KDM4B;KDM5D,High
"Oxidoreductase Activity, Acting on the Aldehyde or Oxo Group of Donors, NAD or NADP as Acceptor (GO:0016620)",2/22,0.014185370094036713,0.11488340727756434,0,0,12.081707317073171,51.4142385392671,AKR1C3;AKR1C4,High
Steroid Hydroxylase Activity (GO:0008395),2/23,0.01545253984792937,0.11488340727756434,0,0,11.505807200929151,47.97900774627138,CYP2C19;CYP3A5,High
K63-linked Polyubiquitin Modification-Dependent Protein Binding (GO:0070530),2/23,0.01545253984792937,0.11488340727756434,0,0,11.505807200929151,47.97900774627138,MINDY2;PRPF8,High
Channel Activity (GO:0015267),3/63,0.01550014225173487,0.11488340727756434,0,0,6.065644171779141,25.27496956375001,GSDMB;AQP7;BCL2L1,High
Actin Monomer Binding (GO:0003785),2/24,0.01676643292366346,0.1179419018204789,0,0,10.982261640798226,44.89961965764408,PRKCE;MRTFA,High
Cadherin Binding (GO:0045296),7/317,0.01684884311721127,0.1179419018204789,0,0,2.77273280584297,11.322380331541854,RPL7A;LDHA;DLG1;CAPZB;ENO1;CCT8;CLIC1,High
Histone H3 Demethylase Activity (GO:0141052),2/25,0.018126196217959568,0.12345409316015706,0,0,10.50424178154825,42.12618059130718,KDM4B;KDM5D,High
"Oxidoreductase, Paired Donors, W Incorp or Reduction of O2, NAD(P)H as One Donor, and Incorp of O (GO:0016709)",2/26,0.019530987419333175,0.126832980762983,0,0,10.066056910569106,39.617513445035065,AKR1C3;AKR1C4,High
Cytokine Activity (GO:0005125),5/186,0.019628913689509274,0.126832980762983,0,0,3.3720531210322227,13.25470323965091,CXCL10;CXCL11;CXCL9;S100A9;CCL15,High
Protein Phosphatase Regulator Activity (GO:0019888),3/75,0.024533121031748647,0.15455866250001646,0,0,5.051635991820041,18.730108355434638,PPP1R12B;CALM2;CABIN1,High
Protein Homodimerization Activity (GO:0042803),11/680,0.02668383520155131,0.16400796270221782,0,0,2.03302955783789,7.36708376038346,UGT1A1;ZBTB16;GLMN;PLEK;UGT1A3;ENO1;TIMM10;SSBP1;GBP1;UGT1A7;RUNX1,High
pre-mRNA Binding (GO:0036002),2/33,0.030556765083200918,0.17435236496181106,0,0,7.790322580645161,27.173963088287994,HNRNPA1;PRPF8,High
Ubiquitin-Like Protein Conjugating Enzyme Binding (GO:0044390),2/34,0.03229271278042159,0.17435236496181106,0,0,7.546493902439025,25.906462189344023,ZMYM2;RPS3,High
Hsp90 Protein Binding (GO:0051879),2/35,0.034066574059665906,0.17435236496181106,0,0,7.317442719881744,24.728848441514916,RPS3;GBP1,High
"Oxidoreductase, Paired Donors, W Incorp or Reduc of O2, Reduced Flavin or Flavoprotein as One Donor, and Incorp of O (GO:0016712)",2/36,0.03587760819925143,0.17435236496181106,0,0,7.1018651362984215,23.63246403210629,CYP2C19;CYP3A5,High
Transition Metal Ion Binding (GO:0046914),8/458,0.037645165120892846,0.17435236496181106,0,0,2.181040787623066,7.152833949578077,MT2A;ZMYM2;FTH1;TIMM10;SOD2;S100A9;S100A8;CUTC,High
Ferroxidase Activity (GO:0004322),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,FTH1,High
Sphingosine N-acyltransferase Activity (GO:0050291),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,CERS2,High
Glycerol Channel Activity (GO:0015254),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,AQP7,High
Supercoiled DNA Binding (GO:0097100),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,RPS3,High
BH Domain Binding (GO:0051400),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,BCL2L1,High
BH3 Domain Binding (GO:0051434),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,BCL2L1,High
DNA-methyltransferase Activity (GO:0009008),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,MGMT,High
Myosin Phosphatase Regulator Activity (GO:0017020),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,PPP1R12B,High
"Oxidoreductase Activity, Acting on Metal Ions, NAD or NADP as Acceptor (GO:0016723)",1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,STEAP4,High
"Oxidoreductase Activity, Acting on Metal Ions, Oxygen as Acceptor (GO:0016724)",1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,FTH1,High
Phosphatidylcholine-Sterol O-acyltransferase Activator Activity (GO:0060228),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,APOC1,High
Cyclase Activator Activity (GO:0010853),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,CALM2,High
Retinol Binding (GO:0019841),1/5,0.04082059338391608,0.17435236496181106,0,0,30.045454545454547,96.1024470343946,RBP4,High
Protein Kinase C Binding (GO:0005080),2/39,0.04152648330379965,0.17441122987595853,0,0,6.525049439683586,20.75894825813934,PLEK;UGT1A7,High
2-Oxoglutarate-Dependent Dioxygenase Activity (GO:0016706),2/42,0.04748415348842961,0.1821483677437446,0,0,6.034756097560976,18.390069721084554,KDM4B;KDM5D,High
ABC-type Glutathione S-conjugate Transporter Activity (GO:0015431),1/6,0.048783752727057296,0.1821483677437446,0,0,24.035151515151515,72.5947611380124,ABCC6,High
Threonine-Type Peptidase Activity (GO:0070003),1/6,0.048783752727057296,0.1821483677437446,0,0,24.035151515151515,72.5947611380124,GGT7,High
Insulin-Like Growth Factor II Binding (GO:0031995),1/6,0.048783752727057296,0.1821483677437446,0,0,24.035151515151515,72.5947611380124,IGFBP5,High
"Oxidoreductase Activity, Acting on a Sulfur Group of Donors, Disulfide as Acceptor (GO:0016671)",1/6,0.048783752727057296,0.1821483677437446,0,0,24.035151515151515,72.5947611380124,TXNDC12,High
Ferric Iron Binding (GO:0008199),1/6,0.048783752727057296,0.1821483677437446,0,0,24.035151515151515,72.5947611380124,FTH1,High
Calcium Ion Binding (GO:0005509),6/324,0.05360604769090584,0.1821483677437446,0,0,2.3014150943396228,6.7341554887862545,SMOC2;S100A4;S100A9;CALM2;S100A8;RUNX1,High
Single-Stranded RNA Binding (GO:0003727),2/45,0.053732121920829885,0.1821483677437446,0,0,5.61287577992059,16.410613471214077,DDX60L;HNRNPA1,High
Transcription Coregulator Binding (GO:0001221),3/103,0.054433967724253074,0.1821483677437446,0,0,3.6320245398773006,10.57197685891461,ZBTB16;ENO1;RUNX1,High
Small Ribosomal Subunit rRNA Binding (GO:0070181),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,RPS3,High
Glycerol Transmembrane Transporter Activity (GO:0015168),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,AQP7,High
Histone H3K4 Demethylase Activity (GO:0032453),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,KDM5D,High
Urea Transmembrane Transporter Activity (GO:0015204),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,AQP7,High
K48-linked Polyubiquitin Modification-Dependent Protein Binding (GO:0036435),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,MINDY2,High
U1 snRNA Binding (GO:0030619),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,PRPF8,High
Omega Peptidase Activity (GO:0008242),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,GGT7,High
Oxidized DNA Binding (GO:0032356),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,RPS3,High
Estrogen 16-Alpha-Hydroxylase Activity (GO:0101020),1/7,0.05668119832554333,0.1821483677437446,0,0,20.02828282828283,57.487435010574046,CYP3A5,High
Guanylate Kinase Activity (GO:0004385),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,DLG1,High
Leucine Zipper Domain Binding (GO:0043522),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,MRTFA,High
Long-Chain Fatty Acid Binding (GO:0036041),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,OXER1,High
Metal-Dependent Deubiquitinase Activity (GO:0140492),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,PRPF8,High
Adenylate Cyclase Binding (GO:0008179),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,CALM2,High
Adenylate Cyclase Regulator Activity (GO:0010854),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,CALM2,High
Phospholipase Inhibitor Activity (GO:0004859),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,APOC1,High
Cytidylyltransferase Activity (GO:0070567),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,CMAS,High
Death Domain Binding (GO:0070513),1/8,0.06451346874924052,0.1821483677437446,0,0,17.166233766233766,47.050608420266336,BCL2L1,High
Actin Binding (GO:0003779),4/187,0.07065308694208232,0.1821483677437446,0,0,2.651420090400054,7.026192916895351,CAPZB;PRKCE;MRTFA;GBP1,High
GTPase Activity (GO:0003924),5/266,0.07122158212090812,0.1821483677437446,0,0,2.3289545703338805,6.153003388570978,AGAP9;RAB4A;AGAP5;RNASE1;GBP1,High
Histone H3K36 Demethylase Activity (GO:0051864),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,KDM4B,High
Thioesterase Binding (GO:0031996),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,RNASE1,High
DNA N-glycosylase Activity (GO:0019104),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,RPS3,High
G-rich Strand Telomeric DNA Binding (GO:0098505),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,HNRNPA1,High
GDP Phosphatase Activity (GO:0004382),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,GBP1,High
Lipase Inhibitor Activity (GO:0055102),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,APOC1,High
S-methyltransferase Activity (GO:0008172),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,MGMT,High
Oxidized Purine DNA Binding (GO:0032357),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,RPS3,High
All-Trans-Retinol Dehydrogenase (NADP+) Activity (GO:0052650),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,AKR1C3,High
pre-mRNA Intronic Binding (GO:0097157),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,PRPF8,High
Retinoic Acid 4-Hydroxylase Activity (GO:0008401),1/9,0.07228109831100976,0.1821483677437446,0,0,15.01969696969697,39.45963700558561,CYP3A5,High
Protein Kinase Binding (GO:0019901),8/527,0.07306200043410649,0.18229330801381025,0,0,1.8843442842857492,4.930286718354175,DLG1;PLEK;RPS3;NEDD9;RNASE1;CALM2;UGT1A7;BCL2L1,High
Ribonucleoside Triphosphate Phosphatase Activity (GO:0017111),5/274,0.07856928409557089,0.18837498599925004,0,0,2.2587683853240668,5.74579729240136,AGAP9;RAB4A;AGAP5;RNASE1;GBP1,High
Polyubiquitin Modification-Dependent Protein Binding (GO:0031593),2/56,0.07884502059081663,0.18837498599925004,0,0,4.467028003613369,11.347462220737667,MINDY2;PRPF8,High
Ubiquitin Ligase Inhibitor Activity (GO:1990948),1/10,0.07998461707111014,0.18837498599925004,0,0,13.35016835016835,33.721469913824805,RPS20,High
Platelet-Derived Growth Factor Binding (GO:0048407),1/10,0.07998461707111014,0.18837498599925004,0,0,13.35016835016835,33.721469913824805,COL4A1,High
Complement Receptor Activity (GO:0004875),1/10,0.07998461707111014,0.18837498599925004,0,0,13.35016835016835,33.721469913824805,FPR1,High
Dipeptidyl-Peptidase Activity (GO:0008239),1/10,0.07998461707111014,0.18837498599925004,0,0,13.35016835016835,33.721469913824805,GLMN,High
Pyrophosphatase Activity (GO:0016462),2/59,0.08622354278874728,0.1986877223205766,0,0,4.231279418057339,10.370070459461067,PPA1;FHIT,High
Single-Stranded Telomeric DNA Binding (GO:0043047),1/11,0.087624550803351825,0.1986877223205766,0,0,12.014545454545454,29.25174245169941,HNRNPA1,High
DNA-(apurinic or Apyrimidinic Site) Endonuclease Activity (GO:0003906),1/11,0.087624550803351825,0.1986877223205766,0,0,12.014545454545454,29.25174245169941,RPS3,High
Calcium Channel Inhibitor Activity (GO:0019855),1/11,0.087624550803351825,0.1986877223205766,0,0,12.014545454545454,29.25174245169941,CALM2,High
Ubiquitin-Like Protein Ligase Binding (GO:0044389),5/284,0.08830565436470071,0.1986877223205766,0,0,2.176695830272268,5.282734421449504,HSPA9;STAT2;UBC;GLMN;FHIT,High
GTP Binding (GO:0005525),4/206,0.09283522545345672,0.20681688029135836,0,0,2.3997066373303997,5.703932601532937,TUBA1C;RAB4A;RNASE1;GBP1,High
Titin Binding (GO:0031432),1/12,0.09520142108649829,0.20681688029135836,0,0,10.92176308539945,25.685370030735868,CALM2,High
Insulin-Like Growth Factor I Binding (GO:0031994),1/12,0.09520142108649829,0.20681688029135836,0,0,10.92176308539945,25.685370030735868,IGFBP5,High
LRR Domain Binding (GO:0030275),1/12,0.09520142108649829,0.20681688029135836,0,0,10.92176308539945,25.685370030735868,MRTFA,High
Receptor Ligand Activity (GO:0048018),6/380,0.09740256612178809,0.20874490157022732,0,0,1.9512032085561497,4.544162464481276,CXCL10;CXCL9;IGFBP5;S100A4;S100A9;CCL15,High
Histone H3K9 Demethylase Activity (GO:0032454),1/13,0.10271574521709599,0.20874490157022732,0,0,10.011111111111111,22.783185164726877,KDM4B,High
Tropomyosin Binding (GO:0005523),1/13,0.10271574521709599,0.20874490157022732,0,0,10.011111111111111,22.783185164726877,LMOD1,High
"Intramolecular Oxidoreductase Activity, Transposing C=C Bonds (GO:0016863)",1/13,0.10271574521709599,0.20874490157022732,0,0,10.011111111111111,22.783185164726877,S100A9,High
Water Channel Activity (GO:0015250),1/13,0.10271574521709599,0.20874490157022732,0,0,10.011111111111111,22.783185164726877,AQP7,High
Metalloendopeptidase Inhibitor Activity (GO:0008191),1/13,0.10271574521709599,0.20874490157022732,0,0,10.011111111111111,22.783185164726877,RARRES1,High
U6 snRNA Binding (GO:0017070),1/13,0.10271574521709599,0.20874490157022732,0,0,10.011111111111111,22.783185164726877,PRPF8,High
Diacylglycerol-Dependent Serine/Threonine Kinase Activity (GO:0004697),1/13,0.10271574521709599,0.20874490157022732,0,0,10.011111111111111,22.783185164726877,PRKCE,High
GDP Binding (GO:0019003),2/66,0.10418696739270243,0.21004092626368812,0,0,3.7671493902439024,8.519665380492338,RAB4A;GBP1,High
Protein Heterodimerization Activity (GO:0046982),4/216,0.10569045461161204,0.21138090922322408,0,0,2.285348241323084,5.135727573808736,UGT1A1;UGT1A3;UGT1A7;RUNX1,High
Nucleoside Diphosphate Kinase Activity (GO:0004550),1/14,0.1101680363222428,0.2168933215094155,0,0,9.24055944055944,20.3823499020957,CMPK2,High
Nucleoside Diphosphate Phosphatase Activity (GO:0017110),1/14,0.1101680363222428,0.2168933215094155,0,0,9.24055944055944,20.3823499020957,GBP1,High
"Hydrolase Activity, Hydrolyzing N-glycosyl Compounds (GO:0016799)",1/15,0.11755880336673992,0.2261436522780035,0,0,8.58008658008658,18.3683919207857,RPS3,High
Insulin-Like Growth Factor Binding (GO:0005520),1/15,0.11755880336673992,0.2261436522780035,0,0,8.58008658008658,18.3683919207857,IGFBP5,High
Water Transmembrane Transporter Activity (GO:0005372),1/15,0.11755880336673992,0.2261436522780035,0,0,8.58008658008658,18.3683919207857,AQP7,High
Ubiquitin Protein Ligase Activity (GO:0061630),5/313,0.11987546266425778,0.2288531559954012,0,0,1.968823102363475,4.176468160697097,HERC5;RNF213;ANKIB1;UBR5;PRPF19,High
Phosphatidylglycerol Binding (GO:1901611),1/16,0.12488855116916608,0.23663093905736732,0,0,8.007676767676768,16.658638477439094,GSDMB,High
Guanyl Ribonucleotide Binding (GO:0032561),4/232,0.1278273765506956,0.24039178276697978,0,0,2.123240199263591,4.3676633688801925,TUBA1C;RAB4A;RNASE1;GBP1,High
K48-linked Deubiquitinase Activity (GO:1990380),1/17,0.13215778044759025,0.24669452350216847,0,0,7.506818181818182,15.191989083592048,MINDY2,High
Ubiquitin-Like Protein Ligase Activity (GO:0061659),5/326,0.13554400446496556,0.2490814250357089,0,0,1.8878311178189278,3.7727529655260015,HERC5;RNF213;ANKIB1;UBR5;PRPF19,High
Metal Ion Binding (GO:0046872),7/516,0.1386351577455121,0.2490814250357089,0,0,1.6714855864872546,3.3027043514237517,SMOC2;MT2A;S100A4;S100A9;CALM2;S100A8;RUNX1,High
DNA Nuclease Activity (GO:0004536),1/18,0.13936698781759904,0.2490814250357089,0,0,7.06488413547237,13.922375947326568,RPS3,High
Voltage-Gated Sodium Channel Activity (GO:0005248),1/18,0.13936698781759904,0.2490814250357089,0,0,7.06488413547237,13.922375947326568,SCN9A,High
All-Trans-Retinol Dehydrogenase (NAD+) Activity (GO:0004745),1/18,0.13936698781759904,0.2490814250357089,0,0,7.06488413547237,13.922375947326568,AKR1C3,High
Bile Acid Transmembrane Transporter Activity (GO:0015125),1/18,0.13936698781759904,0.2490814250357089,0,0,7.06488413547237,13.922375947326568,AKR1C4,High
DNA-directed DNA Polymerase Activity (GO:0003887),1/19,0.14651666588215062,0.26001549156550674,0,0,6.672053872053872,12.814454064766325,POLE3,High
Zinc Ion Binding (GO:0008270),5/338,0.1507756805393039,0.2657025978734586,0,0,1.8186820360733404,3.440877495198963,MT2A;ZMYM2;TIMM10;S100A9;S100A8,High
Nucleobase-Containing Compound Kinase Activity (GO:0019205),1/20,0.15360730321466595,0.26792147425491303,0,0,6.320574162679426,11.84068497759772,CMPK2,High
Ubiquitin Binding (GO:0043130),2/84,0.15416116574191424,0.26792147425491303,0,0,2.9375371802498513,5.492479803733308,UBXN2B;UBR5,High
Glutamate Receptor Binding (GO:0035254),1/21,0.16063938439664313,0.2698741657863605,0,0,6.004242424242424,10.979317316507991,DLG1,High
DNA Polymerase Activity (GO:0034061),1/21,0.16063938439664313,0.2698741657863605,0,0,6.004242424242424,10.979317316507991,POLE3,High
Alcohol Dehydrogenase (NAD+) Activity (GO:0004022),1/21,0.16063938439664313,0.2698741657863605,0,0,6.004242424242424,10.979317316507991,AKR1C3,High
Phosphatase Activator Activity (GO:0019211),1/21,0.16063938439664313,0.2698741657863605,0,0,6.004242424242424,10.979317316507991,CALM2,High
Protein Phosphatase Activator Activity (GO:0072542),1/21,0.16063938439664313,0.2698741657863605,0,0,6.004242424242424,10.979317316507991,CALM2,High
"Oxidoreductase, Single Donors W Incorp of O2, Incorp of Two Atoms of O (GO:0016702)",1/22,0.16761339007915518,0.27972565761554374,0,0,5.7180375180375185,10.212959370400487,TDO2,High
Ferrous Iron Binding (GO:0008198),1/23,0.17452979701770077,0.28746084214680123,0,0,5.457851239669422,9.527551478192855,FTH1,High
DNA Endonuclease Activity (GO:0004520),1/23,0.17452979701770077,0.28746084214680123,0,0,5.457851239669422,9.527551478192855,RPS3,High
Ubiquitin Protein Ligase Binding (GO:0031625),4/268,0.183764676207187,0.3001538538821307,0,0,1.8303404414515525,3.1007784122367283,HSPA9;UBC;GLMN;FHIT,High
Cation Binding (GO:0043169),2/95,0.18657122421462904,0.3001538538821307,0,0,2.5886441122475743,4.346183875855971,MT2A;APOC1,High
Nuclear Androgen Receptor Binding (GO:0050681),1/25,0.18819170203720892,0.3001538538821307,0,0,5.002525252525253,8.355688634491692,KDM5D,High
Adenylyltransferase Activity (GO:0070566),1/25,0.18819170203720892,0.3001538538821307,0,0,5.002525252525253,8.355688634491692,FHIT,High
"Phosphatidylinositol-3,4-Bisphosphate Binding (GO:0043325)",1/25,0.18819170203720892,0.3001538538821307,0,0,5.002525252525253,8.355688634491692,PLEK,High
Single-Stranded DNA Binding (GO:0003697),2/97,0.19256677165144387,0.30520016639096764,0,0,2.5338896020539154,4.174107558163646,SSBP1;HNRNPA1,High
"Phosphotransferase Activity, Phosphate Group as Acceptor (GO:0016776)",1/26,0.19493813427133033,0.3070275614773453,0,0,4.802181818181818,7.8519179804021215,CMPK2,High
Phosphatidylinositol-4-Phosphate Binding (GO:0070273),1/27,0.2016288360937524,0.3155929608423951,0,0,4.617249417249417,7.393724850129072,GSDMB,High
Ubiquitin Conjugating Enzyme Binding (GO:0031624),1/28,0.2082642650600524,0.32197910917259637,0,0,4.446015712682379,6.975565240010467,ZMYM2,High
NF-kappaB Binding (GO:0051059),1/28,0.2082642650600524,0.32197910917259637,0,0,4.446015712682379,6.975565240010467,COMMD6,High
FAD Binding (GO:0071949),1/29,0.21484487504824337,0.328126718255499,0,0,4.287012987012987,6.59273586213286,STEAP4,High
Phosphatidylcholine Binding (GO:0031210),1/29,0.21484487504824337,0.328126718255499,0,0,4.287012987012987,6.59273586213286,APOC1,High
Wide Pore Channel Activity (GO:0022829),1/30,0.22137111624035788,0.334045037680061,0,0,4.138975966562174,6.24122281400424,GSDMB,High
miRNA Binding (GO:0035198),1/30,0.22137111624035788,0.334045037680061,0,0,4.138975966562174,6.24122281400424,HNRNPA1,High
Iron-Sulfur Cluster Binding (GO:0051536),1/31,0.22784343510641275,0.3397428736497989,0,0,4.00080808080808,5.917581525697768,RPS3,High
Phosphatase Inhibitor Activity (GO:0019212),1/31,0.22784343510641275,0.3397428736497989,0,0,4.00080808080808,5.917581525697768,CABIN1,High
Deubiquitinase Activity (GO:0101005),2/111,0.23510640195292518,0.34851066642433615,0,0,2.2068695457596776,3.194922763509127,MINDY2;PRPF8,High
3'-5'-RNA Exonuclease Activity (GO:0000175),1/33,0.24062807362745908,0.3525481078727889,0,0,3.750378787878788,5.342425086287716,HELZ2,High
Hsp70 Protein Binding (GO:0030544),1/33,0.24062807362745908,0.3525481078727889,0,0,3.750378787878788,5.342425086287716,RPS3,High
Anion Binding (GO:0043168),5/402,0.24232555535321132,0.35298288987866616,0,0,1.5204875072359467,2.155250272425913,RAB4A;GSDMB;AKR1C1;PLEK;GBP1,High
Nucleosomal DNA Binding (GO:0031492),1/34,0.2469412681410595,0.3535749975656079,0,0,3.6365472910927457,5.0860923201364825,H1-5,High
Carboxypeptidase Activity (GO:0004180),1/34,0.2469412681410595,0.3535749975656079,0,0,3.6365472910927457,5.0860923201364825,MINDY2,High
Protein Phosphatase Inhibitor Activity (GO:0004864),1/34,0.2469412681410595,0.3535749975656079,0,0,3.6365472910927457,5.0860923201364825,CABIN1,High
Ubiquitin-Protein Transferase Activity (GO:0004842),5/409,0.253168725107358,0.3584661636242321,0,0,1.4936043293770371,2.0517629452379564,HERC5;RNF213;ANKIB1;UBR5;PRPF19,High
N-acyltransferase Activity (GO:0016410),1/35,0.25320229017902113,0.3584661636242321,0,0,3.5294117647058822,4.847881919337103,CERS2,High
Transcription Coactivator Binding (GO:0001223),1/36,0.25941156821878103,0.3652051127996247,0,0,3.4283982683982686,4.626072903688683,RUNX1,High
GTPase Activator Activity (GO:0005096),3/214,0.2624240387272127,0.3673936542180978,0,0,1.7116564417177915,2.2898430589836405,AGAP9;TBC1D4;AGAP5,High
Metallopeptidase Activity (GO:0008237),2/122,0.26889660506775415,0.3743753838512378,0,0,2.0034552845528455,2.631394950750871,MMP2;PRPF8,High
"Hydrolase Activity, Acting on Carbon-Nitrogen (But Not Peptide) Bonds, in Linear Amides (GO:0016811)",1/39,0.2777331718645593,0.3845536225816975,0,0,3.15725677830941,4.0447441032211655,FHIT,High
Sodium Channel Activity (GO:0005272),1/40,0.283739690105335,0.3886000103616545,0,0,3.076146076146076,3.8750151991082595,SCN9A,High
Ion Channel Inhibitor Activity (GO:0008200),1/40,0.283739690105335,0.3886000103616545,0,0,3.076146076146076,3.8750151991082595,CALM2,High
Methyltransferase Activity (GO:0008168),1/41,0.2896965552786852,0.3946136861093442,0,0,2.999090909090909,3.7156375027236566,MGMT,High
snRNA Binding (GO:0017069),1/43,0.3014629550579916,0.40195060674398875,0,0,2.855988455988456,3.4246390029225693,PRPF8,High
CCR Chemokine Receptor Binding (GO:0048020),1/43,0.3014629550579916,0.40195060674398875,0,0,2.855988455988456,3.4246390029225693,CCL15,High
rRNA Binding (GO:0019843),1/43,0.3014629550579916,0.40195060674398875,0,0,2.855988455988456,3.4246390029225693,RPS3,High
Regulatory RNA Binding (GO:0061980),1/43,0.3014629550579916,0.40195060674398875,0,0,2.855988455988456,3.4246390029225693,HNRNPA1,High
Serine-Type Endopeptidase Activity (GO:0004252),2/136,0.3118446212481897,0.41085921877100046,0,0,1.792864943574809,2.089136277174256,MMP2;GLMN,High
Calcium Channel Regulator Activity (GO:0005246),1/45,0.3130355952540956,0.41085921877100046,0,0,2.7258953168044076,3.1659594191318527,CALM2,High
Copper Ion Binding (GO:0005507),1/45,0.3130355952540956,0.41085921877100046,0,0,2.7258953168044076,3.1659594191318527,CUTC,High
Hydro-Lyase Activity (GO:0016836),1/46,0.31875024868156443,0.41404671478223837,0,0,2.665185185185185,3.0472325582161406,ENO1,High
Monocarboxylic Acid Transmembrane Transporter Activity (GO:0008028),1/46,0.31875024868156443,0.41404671478223837,0,0,2.665185185185185,3.0472325582161406,AKR1C4,High
Microtubule Binding (GO:0008017),3/243,0.32792550470018883,0.42378065222793637,0,0,1.5026073619631901,1.6753603515966826,RPS3;S100A9;S100A8,High
Damaged DNA Binding (GO:0003684),1/48,0.3300381801688704,0.42433480307426197,0,0,2.5515151515151517,2.8284742975844512,RPS3,High
Serine-Type Peptidase Activity (GO:0008236),2/149,0.351254476450103,0.44807548095689664,0,0,1.633233781317405,1.708761557256031,MMP2;GLMN,High
Manganese Ion Binding (GO:0030145),1/52,0.3520593064661331,0.44807548095689664,0,0,2.350920974450386,2.4542571947138705,SOD2,High
Kinase Binding (GO:0019900),5/472,0.3547770926122919,0.4481478032675752,0,0,1.287922114195273,1.3346293757973162,DLG1;RPS3;RNASE1;CALM2;BCL2L1,High
Potassium Channel Regulator Activity (GO:0015459),1/53,0.35745122403485163,0.4481478032675752,0,0,2.3055944055944058,2.371894913920962,DLG1,High
Exopeptidase Activity (GO:0008238),1/53,0.35745122403485163,0.4481478032675752,0,0,2.3055944055944058,2.371894913920962,GLMN,High
Iron Ion Binding (GO:0005506),1/57,0.37857653134967145,0.47228359356493665,0,0,2.1404761904761904,2.0791237858807836,FTH1,High
Flavin Adenine Dinucleotide Binding (GO:0050660),1/58,0.3837490786466901,0.47637816659589116,0,0,2.102817650186071,2.0140080507306575,STEAP4,High
Endonuclease Activity (GO:0004519),1/59,0.3888788283239834,0.48037972910609716,0,0,2.066457680250784,1.951743405292569,RPS3,High
Nuclease Activity (GO:0004518),1/61,0.3990113397472151,0.4904919883721863,0,0,1.9973737373737375,1.8351179648112526,RNASE1,High
Protein Serine/Threonine Kinase Activator Activity (GO:0043539),1/70,0.4425800684201329,0.5414086273877353,0,0,1.736056214317084,1.4151182471112724,CALM2,High
Double-Stranded RNA Binding (GO:0003725),1/71,0.4472228942659399,0.5444452625846226,0,0,1.7111688311688311,1.3769744163255409,DDX60L,High
RNA Nuclease Activity (GO:0004540),1/72,0.4518272802787947,0.5474061280300782,0,0,1.686982501067008,1.340232181311951,RNASE1,High
ATPase Binding (GO:0051117),1/74,0.4609219957197416,0.5557528369443774,0,0,1.6405977584059777,1.2706863691544725,ALDOB,High
GTPase Regulator Activity (GO:0030695),4/424,0.46915060426380695,0.5585208117307352,0,0,1.1413286302175192,0.863793395571259,AGAP9;FARP1;TBC1D4;AGAP5,High
"Phosphatidylinositol-4,5-Bisphosphate Binding (GO:0005546)",1/76,0.4698667146306185,0.5585208117307352,0,0,1.5966868686868687,1.2059875079648261,GSDMB,High
Chloride Channel Activity (GO:0005254),1/76,0.4698667146306185,0.5585208117307352,0,0,1.5966868686868687,1.2059875079648261,CLIC1,High
mRNA Binding (GO:0003729),3/310,0.4764919461767205,0.5635993492700183,0,0,1.1706600587518234,0.8678155204410553,RPS3;THOC2;HNRNPA1,High
Endopeptidase Activity (GO:0004175),3/311,0.47861214580866634,0.5635993492700183,0,0,1.1667994582105012,0.8597733631217234,MMP2;GLMN;PSMB9,High
G Protein-Coupled Peptide Receptor Activity (GO:0008528),1/80,0.487315959090938,0.571179635771704,0,0,1.5155350978135789,1.089431159241575,FPR1,High
Protein Tyrosine Kinase Binding (GO:1990782),1/82,0.4958252832404141,0.5784628304471497,0,0,1.477964833520389,1.0368391317180785,NEDD9,High
Tubulin Binding (GO:0015631),3/326,0.5099219533326421,0.5896397722178897,0,0,1.1117590077684287,0.7487670209039602,RPS3;S100A9;S100A8,High
Monoatomic Anion Channel Activity (GO:0005253),1/86,0.5124250401417375,0.5896397722178897,0,0,1.4081283422459894,0.9414757949953488,CLIC1,High
Chloride Transmembrane Transporter Activity (GO:0015108),1/86,0.5124250401417375,0.5896397722178897,0,0,1.4081283422459894,0.9414757949953488,CLIC1,High
"DNA-binding Transcription Repressor Activity, RNA Polymerase II-specific (GO:0001227)",2/210,0.5221215162454121,0.5980664640629266,0,0,1.1506801125703565,0.7477751422217018,ZBTB16;ENO1,High
Phosphatidylinositol Bisphosphate Binding (GO:1902936),1/96,0.5515857626593321,0.6289575212224058,0,0,1.2592663476874004,0.7492105176514541,GSDMB,High
GTPase Binding (GO:0051020),2/225,0.5593951086929093,0.6343230620325738,0,0,1.0724598053155419,0.6229910880882154,GOLGA4;ENO1,High
Metalloendopeptidase Activity (GO:0004222),1/99,0.5627123442559727,0.6343230620325738,0,0,1.2205318491032777,0.7017895987611994,MMP2,High
Growth Factor Receptor Binding (GO:0070851),1/100,0.566359876814798,0.6343230620325738,0,0,1.2081420263238445,0.6868596439049133,GLMN,High
Histone Deacetylase Binding (GO:0042826),1/100,0.566359876814798,0.6343230620325738,0,0,1.2081420263238445,0.6868596439049133,H1-5,High
mRNA 3'-UTR Binding (GO:0003730),1/105,0.5841488433543327,0.6513518076340347,0,0,1.1497668997668997,0.6181140642911073,HNRNPA1,High
Protein Kinase Activator Activity (GO:0030295),1/107,0.5910596061351994,0.6561542764144064,0,0,1.127958833619211,0.5931240799056291,CALM2,High
Cytokine Receptor Binding (GO:0005126),1/109,0.5978562032888148,0.6607884352139533,0,0,1.1069584736251403,0.5694249920837137,S100A9,High
Phosphatidylinositol Phosphate Binding (GO:1901981),1/112,0.6078411312551987,0.6688906771891269,0,0,1.0768768768768768,0.5361142456989609,GSDMB,High
Protein Kinase Regulator Activity (GO:0019887),1/113,0.6111143693366455,0.6695687872731941,0,0,1.0672077922077923,0.5255690524209823,CXCL10,High
Nuclear Receptor Binding (GO:0016922),1/116,0.6207720315678814,0.6742868618754574,0,0,1.039209486166008,0.4954861077366164,KDM5D,High
Phosphatase Binding (GO:0019902),1/116,0.6207720315678814,0.6742868618754574,0,0,1.039209486166008,0.4954861077366164,DLG1,High
Ion Channel Regulator Activity (GO:0099106),1/119,0.630191261510353,0.6757795655345061,0,0,1.0126348228043143,0.46756581691301136,DLG1,High
Protease Binding (GO:0002020),1/119,0.630191261510353,0.6757795655345061,0,0,1.0126348228043143,0.46756581691301136,GLMN,High
Endopeptidase Inhibitor Activity (GO:0004866),1/119,0.630191261510353,0.6757795655345061,0,0,1.0126348228043143,0.46756581691301136,RARRES1,High
G Protein-Coupled Receptor Activity (GO:0004930),2/259,0.6360686164508387,0.679191912481404,0,0,0.928964600930056,0.42030895048104516,FPR1;OXER1,High
G Protein-Coupled Receptor Binding (GO:0001664),1/143,0.6976346195889986,0.7417887094364035,0,0,0.840460947503201,0.3026161846250428,FPR1,High
DNA-binding Transcription Factor Binding (GO:0140297),2/294,0.703743147521002,0.7451398032575315,0,0,0.8161543601737388,0.28674917190832955,RPS3;RUNX1,High
"DNA-binding Transcription Activator Activity, RNA Polymerase II-specific (GO:0001228)",2/318,0.743883023855489,0.7843452803831935,0,0,0.7532417412781722,0.22286275068116654,ZBTB16;RUNX1,High
Small GTPase Binding (GO:0031267),1/199,0.8111658513102943,0.8517241438758091,0,0,0.6010407101316192,0.12578744879694537,GOLGA4,High
Guanyl-Nucleotide Exchange Factor Activity (GO:0005085),1/206,0.8219740383525439,0.8594915255802534,0,0,0.580310421286031,0.11376780840041831,FARP1,High
Transcription Cis-Regulatory Region Binding (GO:0000976),3/548,0.8367976027067949,0.8713760160417865,0,0,0.6513986604378905,0.11606168642816313,RPS3;ENO1;RUNX1,High
RNA Polymerase II-specific DNA-binding Transcription Factor Binding (GO:0061629),1/232,0.857002461671597,0.8887432935853598,0,0,0.514311950675587,0.07936578531997952,COMMD6,High
ATP Binding (GO:0005524),1/281,0.9054509365260617,0.9351378524777358,0,0,0.42324675324675326,0.04203779316219567,ABCC6,High
Double-Stranded DNA Binding (GO:0003690),3/651,0.9100260099712882,0.936026753113325,0,0,0.5449329697795956,0.05137742338427981,H1-5;RPS3;TEAD1,High
Adenyl Ribonucleotide Binding (GO:0032559),1/318,0.9308661285440367,0.953570180459745,0,0,0.373138323296052,0.0267315568048091,ABCC6,High
RNA Polymerase II Transcription Regulatory Region Sequence-Specific DNA Binding (GO:0000977),6/1236,0.9481740674489146,0.9665068381915816,0,0,0.5671951219512195,0.030184523839304058,ZBTB16;STAT2;RPS3;ENO1;TEAD1;RUNX1,High
Protein Serine/Threonine Kinase Activity (GO:0004674),1/359,0.9511654598075883,0.9665068381915816,0,0,0.3297105129507364,0.01650769752358961,PRKCE,High
Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000987),4/1035,0.974951323039174,0.9855214430728437,0,0,0.45031193495467664,0.01142339352643179,ZBTB16;STAT2;TEAD1;RUNX1,High
RNA Polymerase II Cis-Regulatory Region Sequence-Specific DNA Binding (GO:0000978),4/1054,0.9776998443182974,0.9855214430728437,0,0,0.44171663727219285,0.009961842600806231,ZBTB16;STAT2;TEAD1;RUNX1,High
Sequence-Specific Double-Stranded DNA Binding (GO:1990837),2/706,0.9821713156233576,0.9860843487533311,0,0,0.33138165188470065,0.005961400173017729,TEAD1;RUNX1,High
Sequence-Specific DNA Binding (GO:0043565),1/718,0.997742431618819,0.997742431618819,0,0,0.16159080343180762,3.652146923767667e-4,TEAD1,High
Metabolism,41/2181,3.662848422889584e-7,3.0841183720730297e-4,0,0,2.711977570093458,40.19111312787882,FH;RPS27L;PRELP;ENO1;CYP2C19;CYP3A5;ACACA;HELZ2;RPL7A;LDHA;PSMB4;TDO2;UBC;PSMB1;RPS3;SC5D;RPL38;UGT1A3;UGT1A7;UGT2B10;HSPA9;GGT7;RAB4A;ATP5PD;UGT1A1;UQCC2;LUM;AKR1C1;MID1IP1;NDUFA1;AKR1C3;AKR1C4;FAH;RBP4;PPA1;GPD1;RPL27;RPS20;ALDOB;UGT2B7;CERS2,High
Aspirin ADME,6/43,1.411738885929317e-6,5.943420709762424e-4,0,0,20.064527027027026,270.282990691405,UGT2B10;UGT1A1;UGT1A3;CYP2C19;UGT1A7;UGT2B7,High
Glucuronidation,5/26,2.1181384916496083e-6,5.944908699896567e-4,0,0,29.30050280981958,382.81027589877516,UGT2B10;UGT1A1;UGT1A3;UGT1A7;UGT2B7,High
Drug ADME,8/109,3.548128630148602e-6,7.288325240681974e-4,0,0,9.892467727785437,124.14147021132241,UGT2B10;GGT7;UGT1A1;AKR1C1;UGT1A3;CYP2C19;UGT2B7;UGT1A7,High
SARS-CoV-1-host Interactions,8/112,4.348354528431798e-6,7.288325240681974e-4,0,0,9.605647517039921,118.58856794085634,UBC;RPS3;RPS27L;NPIPB3;RPS20;HNRNPA1;RUNX1;BCL2L1,High
Nervous System Development,17/567,5.1935809316023566e-6,7.288325240681974e-4,0,0,4.000341671751068,48.676506016242115,MMP2;RPS27L;RPL7A;TUBA1C;DLG1;PSMB4;COL4A1;SCN9A;UBC;PSMB1;RPS3;COL6A3;RPL38;RPL27;MYH11;RPS20;TEAD1,High
Regulation of Expression of SLITs and ROBOs,9/164,9.486251844272637e-6,0.0011410605789825086,0,0,7.278035750975961,84.17533777751692,RPL7A;PSMB4;UBC;PSMB1;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Axon Guidance,16/541,1.1819643110115527e-5,0.0012440174373396593,0,0,3.9230984126984128,44.51048495034464,MMP2;RPS27L;RPL7A;TUBA1C;DLG1;PSMB4;COL4A1;SCN9A;UBC;PSMB1;RPS3;COL6A3;RPL38;RPL27;MYH11;RPS20,High
SARS-CoV-1 Infection,8/157,5.096488539103407e-5,0.00476804816658341,0,0,6.689321213150964,66.11975056392404,UBC;RPS3;RPS27L;NPIPB3;RPS20;HNRNPA1;RUNX1;BCL2L1,High
Prednisone ADME,3/10,6.455817881760927e-5,0.0051065874976605665,0,0,52.13058720420683,502.95297266417015,AKR1C1;UGT1A3;UGT2B7,High
Signaling by ROBO Receptors,9/210,6.671313833048245e-5,0.0051065874976605665,0,0,5.599296511075197,53.83784430619304,RPL7A;PSMB4;UBC;PSMB1;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Cellular Responses to Stress,18/787,9.880729591103787e-5,0.006932978596424491,0,0,3.015235651776614,27.807525679306597,HSPA9;RPS27L;SOD2;CABIN1;HELZ2;H1-5;RPL7A;TUBA1C;PSMB4;CAPZB;UBC;PSMB1;RPS3;RPL38;RPL27;RPS20;TNRC6A;BCL2L1,High
Peptide Chain Elongation,6/94,1.3304769832870418e-4,0.008045233379312462,0,0,8.414488636363636,75.0976522471373,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Cellular Responses to Stimuli,19/887,1.4753081228496614e-4,0.008045233379312462,0,0,2.824179441361798,24.91342412141949,HSPA9;RPS27L;SOD2;CABIN1;HELZ2;H1-5;RPL7A;TUBA1C;MT2A;PSMB4;CAPZB;UBC;PSMB1;RPS3;RPL38;RPL27;RPS20;TNRC6A;BCL2L1,High
Synthesis of Bile Acids and Bile Salts via 24-Hydroxycholesterol,3/13,1.510683847110121e-4,0.008045233379312462,0,0,36.485889570552146,320.9947545597437,AKR1C1;AKR1C3;AKR1C4,High
Eukaryotic Translation Termination,6/98,1.6737883844028365e-4,0.008045233379312462,0,0,8.047010869565218,69.97077787050632,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Selenocysteine Synthesis,6/98,1.6737883844028365e-4,0.008045233379312462,0,0,8.047010869565218,69.97077787050632,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Eukaryotic Translation Elongation,6/99,1.769678029505564e-4,0.008045233379312462,0,0,7.96008064516129,68.77145699684077,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Nonsense Mediated Decay (NMD) Independent of the Exon Junction Complex (EJC),6/100,1.869856286711621e-4,0.008045233379312462,0,0,7.875,67.60277051919952,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Synthesis of Bile Acids and Bile Salts via 27-Hydroxycholesterol,3/14,1.9109818003117487e-4,0.008045233379312462,0,0,33.16731734523145,284.0025587223868,AKR1C1;AKR1C3;AKR1C4,High
Viral mRNA Translation,6/102,2.083625508958738e-4,0.008354346088301226,0,0,7.71015625,65.35306513141624,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Formation of a Pool of Free 40S Subunits,6/106,2.568775812209383e-4,0.009052227004200322,0,0,7.40025,61.17720756692646,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Response of EIF2AK4 (GCN2) to Amino Acid Deficiency,6/106,2.568775812209383e-4,0.009052227004200322,0,0,7.40025,61.17720756692646,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Cytokine Signaling in Immune System,17/776,2.580207222099854e-4,0.009052227004200322,0,0,2.867381135545711,23.691652496672948,HSPA9;MMP2;STAT2;FPR1;SOD2;IFIT3;IFIT2;HERC5;CXCL10;TUBA1C;MT2A;PSMB4;UBC;PSMB1;STX3;GBP1;BCL2L1,High
Phase II - Conjugation of Compounds,6/111,3.2954899256852627e-4,0.011099210069707965,0,0,7.0460714285714285,56.4938895254599,UGT2B10;GGT7;UGT1A1;UGT1A3;UGT2B7;UGT1A7,High
SARS-CoV-1 Modulates Host Translation Machinery,4/41,3.648030732995608e-4,0.01181400721993193,0,0,13.21121121121121,104.58196761430013,RPS3;RPS27L;RPS20;HNRNPA1,High
L13a-mediated Translational Silencing of Ceruloplasmin Expression,6/116,4.1742580421013406e-4,0.012770629629419734,0,0,6.724090909090909,52.322866174547165,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
GTP Hydrolysis and Joining of the 60S Ribosomal Subunit,6/117,4.370088587895649e-4,0.012770629629419734,0,0,6.663175675675675,51.543375848180744,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
SRP-dependent Cotranslational Protein Targeting to Membrane,6/119,4.7832160536652896e-4,0.012770629629419734,0,0,6.5445796460176995,50.03479856534526,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Retinoid Metabolism and Transport,4/44,4.796524782369991e-4,0.012770629629419734,0,0,12.218518518518518,93.37940121156761,RBP4;AKR1C1;AKR1C3;AKR1C4,High
Nonsense Mediated Decay (NMD) Enhanced by the Exon Junction Complex (EJC),6/120,5.000870214434372e-4,0.012770629629419734,0,0,6.4868421052631575,49.30472522206401,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Nonsense-Mediated Decay (NMD),6/120,5.000870214434372e-4,0.012770629629419734,0,0,6.4868421052631575,49.30472522206401,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
ER-Phagosome Pathway,5/80,5.396541431898895e-4,0.012770629629419734,0,0,8.181780538302277,61.56447937786588,PSMB4;PSMB1;UBC;S100A9;S100A8,High
MAPK6 MAPK4 Signaling,5/80,5.396541431898895e-4,0.012770629629419734,0,0,8.181780538302277,61.56447937786588,PSMB4;MMP2;PSMB1;UBC;TNRC6A,High
Selenoamino Acid Metabolism,6/122,5.459268669309869e-4,0.012770629629419734,0,0,6.374353448275862,47.890680223082335,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Biological Oxidations,8/222,5.460126682412238e-4,0.012770629629419734,0,0,4.642138885602745,34.87577845191282,UGT2B10;GGT7;UGT1A1;UGT1A3;CYP2C19;CYP3A5;UGT2B7;UGT1A7,High
Cap-dependent Translation Initiation,6/124,5.949691149848671e-4,0.013183263021506793,0,0,6.265677966101695,46.535196904341845,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Eukaryotic Translation Initiation,6/124,5.949691149848671e-4,0.013183263021506793,0,0,6.265677966101695,46.535196904341845,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Disease,32/2131,6.487658973585005e-4,0.014006689373739934,0,0,2.0177341022377395,14.811053327313616,RPS27L;PRELP;ENO1;ACACA;HERC5;RPL7A;TUBA1C;GOLGA4;PSMB4;RNF213;ZMYM2;UBC;PSMB1;RPS3;RPL38;HNRNPA1;UGT1A1;LUM;STAT2;ABCC6;SOD2;MUC3A;RUNX1;RBP4;GEMIN4;NPIPB3;RPL27;RPS20;ALDOB;S100A9;S100A8;BCL2L1,High
Metabolism of Fat-Soluble Vitamins,4/48,6.700381131167424e-4,0.014104302281107428,0,0,11.105499438832773,81.16094404430798,RBP4;AKR1C1;AKR1C3;AKR1C4,High
Transcriptional Regulation by RUNX3,5/86,7.512189960039701e-4,0.015427473039886409,0,0,7.573422283567211,54.481786274523365,PSMB4;PSMB1;UBC;TEAD1;RUNX1,High
Metabolism of Amino Acids and Derivatives,10/358,8.393402961189209e-4,0.01682677450790789,0,0,3.5893751842027704,25.42316516357758,RPL7A;PSMB4;TDO2;PSMB1;RPS3;RPS27L;RPL38;RPL27;RPS20;FAH,High
Synthesis of Bile Acids and Bile Salts via 7Alpha-Hydroxycholesterol,3/23,8.801265209300206e-4,0.01723410536332738,0,0,18.233742331288344,128.28248925631055,AKR1C1;AKR1C3;AKR1C4,High
Metal Sequestration by Antimicrobial Proteins,2/6,0.0010048949461406917,0.01923003510569233,0,0,60.457317073170735,417.3291377931697,S100A9;S100A8,High
SARS-CoV-2 Modulates Host Translation Machinery,4/55,0.0011227512922791607,0.02066922572921842,0,0,9.577826192205277,65.0523378060686,GEMIN4;RPS3;RPS27L;RPS20,High
Gap-filling DNA Repair Synthesis and Ligation in GG-NER,3/25,0.0011291976051592011,0.02066922572921842,0,0,16.574456218627997,112.47837007331985,POLD2;UBC;POLE3,High
Antigen processing-Cross Presentation,5/96,0.0012337955302494411,0.022103315669575095,0,0,6.737765340249812,45.127261839634755,PSMB4;PSMB1;UBC;S100A9;S100A8,High
Mitochondrial Biogenesis,5/97,0.0012922517575472618,0.022205632241934583,0,0,6.664191196327303,44.32599495871743,HELZ2;HSPA9;ATP5PD;SSBP1;SOD2,High
Mitochondrial Protein Degradation,5/97,0.0012922517575472618,0.022205632241934583,0,0,6.664191196327303,44.32599495871743,HSPA9;FH;ATP5PD;TIMM10;SSBP1,High
Signaling by Interleukins,11/452,0.0014254078249547712,0.024003867772238348,0,0,3.1208104747275254,20.45159889921369,HSPA9;CXCL10;PSMB4;MMP2;STAT2;UBC;PSMB1;FPR1;STX3;SOD2;BCL2L1,High
Influenza Viral RNA Transcription and Replication,6/149,0.0015436044056537828,0.025484606069813436,0,0,5.163723776223776,33.428063351050405,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
FLT3 Signaling in Disease,3/28,0.0015793082238047215,0.02557264470083799,0,0,14.583312883435584,94.07357334491708,ZMYM2;UBC;BCL2L1,High
Metabolism of Proteins,30/2067,0.0016808281299523435,0.026702967649431572,0,0,1.9272502815559214,12.312178047832724,FH;CMAS;RPS27L;TIMM10;RPL7A;TUBA1C;PSMB4;CAPZB;UBD;UBC;PSMB1;RPS3;RPL38;CCT8;HSPA9;RAB4A;ATP5PD;IGFBP5;ZBTB16;MMP2;MRTFA;COMMD6;MRPL45;MUC3A;PSMB9;EID3;PPA1;RPL27;RPS20;SSBP1,High
Gap-filling DNA Repair Synthesis and Ligation in TC-NER,4/62,0.0017557605450080585,0.026913744904051674,0,0,8.418901660280971,53.416694777354685,POLD2;UBC;POLE3;PRPF19,High
Defective B4GALT1 Causes B4GALT1-CDG (CDG-2d),2/8,0.001855415818156856,0.026913744904051674,0,0,40.300813008130085,253.47786536035218,LUM;PRELP,High
Defective CHST6 Causes MCDC1,2/8,0.001855415818156856,0.026913744904051674,0,0,40.300813008130085,253.47786536035218,LUM;PRELP,High
Defective ST3GAL3 Causes MCT12 and EIEE15,2/8,0.001855415818156856,0.026913744904051674,0,0,40.300813008130085,253.47786536035218,LUM;PRELP,High
Dual Incision in TC-NER,4/63,0.0018628158299498249,0.026913744904051674,0,0,8.275789914207992,52.018851692054774,POLD2;UBC;POLE3;PRPF19,High
Metabolism of Steroids,6/155,0.0018858799873385378,0.026913744904051674,0,0,4.954278523489933,31.079976335894422,HELZ2;AKR1C1;AKR1C3;SC5D;AKR1C4;ACACA,High
Recognition of DNA Damage by PCNA-containing Replication Complex,3/30,0.0019336358929995464,0.0271353570317603,0,0,13.501704158145875,84.36341592244764,POLD2;UBC;POLE3,High
Synthesis of DNA,5/108,0.002078073535978485,0.027937533835805786,0,0,5.949164807332811,36.74390988229611,PSMB4;UBC;POLD2;PSMB1;POLE3,High
ABC Transporter Disorders,4/65,0.0020903380423465136,0.027937533835805786,0,0,8.003642987249545,49.38591466261071,PSMB4;ABCC6;PSMB1;UBC,High
The Role of GTSE1 in G2 M Progression After G2 Checkpoint,4/65,0.0020903380423465136,0.027937533835805786,0,0,8.003642987249545,49.38591466261071,TUBA1C;PSMB4;PSMB1;UBC,High
Cellular Response to Starvation,6/161,0.00228280262558498,0.030033122042852394,0,0,4.761048387096774,28.958369175811754,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Termination of Translesion DNA Synthesis,3/32,0.0023337809211780225,0.030231439009721462,0,0,12.569282843240956,76.173192602866,POLD2;UBC;POLE3,High
Interferon Signaling,8/280,0.002400056697672766,0.03061890514303741,0,0,3.641474311243485,21.96633045411562,HERC5;TUBA1C;MT2A;STAT2;UBC;GBP1;IFIT3;IFIT2,High
Developmental Biology,22/1385,0.002519337872736672,0.031595290875874614,0,0,2.0704022988505746,12.388788722490094,KDM4B;SS18L1;MMP2;RPS27L;RUNX1;HELZ2;RPL7A;TUBA1C;DLG1;PSMB4;COL4A1;SCN9A;UBC;PSMB1;RPS3;COL6A3;RPL38;RPL27;MYH11;RPS20;TEAD1;TNRC6A,High
Synthesis of Bile Acids and Bile Salts,3/33,0.002551638693063508,0.031595290875874614,0,0,12.149693251533742,72.54605534185774,AKR1C1;AKR1C3;AKR1C4,High
Influenza Infection,6/169,0.002906226925532435,0.03546439233765667,0,0,4.525536809815951,26.433206270139394,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Regulation of Activated PAK-2p34 by Proteasome Mediated Degradation,3/37,0.0035468414741331956,0.04266343601743072,0,0,10.718152291591483,60.46857617279529,PSMB4;PSMB1;UBC,High
Transcription-Coupled Nucleotide Excision Repair (TC-NER),4/76,0.003691998122849232,0.04284406766618563,0,0,6.7770919067215365,37.96247311300933,POLD2;UBC;POLE3;PRPF19,High
Translation,8/302,0.0038024927317800495,0.04284406766618563,0,0,3.3651941789373976,18.751193252470532,RPL7A;PPA1;RPS3;RPS27L;RPL38;RPL27;RPS20;MRPL45,High
Class I MHC Mediated Antigen Processing & Presentation,9/373,0.004042314170724377,0.04284406766618563,0,0,3.0662490375866174,16.897908143897542,HERC5;PSMB4;RNF213;ZBTB16;UBC;GLMN;PSMB1;S100A9;S100A8,High
Interferon Alpha Beta Signaling,4/78,0.00405271084410546,0.04284406766618563,0,0,6.59325992659326,36.318110418554824,STAT2;UBC;IFIT3;IFIT2,High
p53-Independent DNA Damage Response,3/39,0.004121578956010731,0.04284406766618563,0,0,10.121676891615541,55.583380428642826,PSMB4;PSMB1;UBC,High
p53-Independent G1 S DNA Damage Checkpoint,3/39,0.004121578956010731,0.04284406766618563,0,0,10.121676891615541,55.583380428642826,PSMB4;PSMB1;UBC,High
Autodegradation of the E3 Ubiquitin Ligase COP1,3/39,0.004121578956010731,0.04284406766618563,0,0,10.121676891615541,55.583380428642826,PSMB4;PSMB1;UBC,High
Response of Mtb to Phagocytosis,3/39,0.004121578956010731,0.04284406766618563,0,0,10.121676891615541,55.583380428642826,RNF213;UBC;ENO1,High
Translesion Synthesis by Y Family DNA Polymerases Bypasses Lesions on DNA Template,3/39,0.004121578956010731,0.04284406766618563,0,0,10.121676891615541,55.583380428642826,POLD2;UBC;POLE3,High
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,3/39,0.004121578956010731,0.04284406766618563,0,0,10.121676891615541,55.583380428642826,PSMB4;PSMB1;UBC,High
Ubiquitin-dependent Degradation of Cyclin D,3/39,0.004121578956010731,0.04284406766618563,0,0,10.121676891615541,55.583380428642826,PSMB4;PSMB1;UBC,High
Regulation of Apoptosis,3/40,0.004428896656576308,0.044929288973942785,0,0,9.847620626761731,53.37021189592656,PSMB4;PSMB1;UBC,High
Vpu Mediated Degradation of CD4,3/40,0.004428896656576308,0.044929288973942785,0,0,9.847620626761731,53.37021189592656,PSMB4;PSMB1;UBC,High
Metabolism of RNA,14/761,0.004520388035478492,0.04531150864134393,0,0,2.353431268935391,12.706545945826194,RPS27L;THOC2;PRPF19;PRPF8;RPL7A;PSMB4;UBC;PSMB1;GEMIN4;RPS3;RPL38;RPL27;RPS20;HNRNPA1,High
Dual Incision in GG-NER,3/41,0.004749747319218418,0.046532372881785786,0,0,9.587988375847594,51.29251488811611,POLD2;UBC;POLE3,High
Major Pathway of rRNA Processing in the Nucleolus and Cytosol,6/189,0.005016550369573998,0.046532372881785786,0,0,4.026844262295082,21.32219174683004,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
AUF1 (hnRNP D0) Binds and Destabilizes mRNA,3/42,0.005084297274494409,0.046532372881785786,0,0,9.341670599339311,49.3389530027632,PSMB4;PSMB1;UBC,High
Degradation of AXIN,3/42,0.005084297274494409,0.046532372881785786,0,0,9.341670599339311,49.3389530027632,PSMB4;PSMB1;UBC,High
FBXL7 Down-Regulates AURKA During Mitotic Entry and in Early Mitosis,3/42,0.005084297274494409,0.046532372881785786,0,0,9.341670599339311,49.3389530027632,PSMB4;PSMB1;UBC,High
GSK3B and BTRC CUL1-mediated-degradation of NFE2L2,3/42,0.005084297274494409,0.046532372881785786,0,0,9.341670599339311,49.3389530027632,PSMB4;PSMB1;UBC,High
SCF-beta-TrCP Mediated Degradation of Emi1,3/42,0.005084297274494409,0.046532372881785786,0,0,9.341670599339311,49.3389530027632,PSMB4;PSMB1;UBC,High
Vif-mediated Degradation of APOBEC3G,3/42,0.005084297274494409,0.046532372881785786,0,0,9.341670599339311,49.3389530027632,PSMB4;PSMB1;UBC,High
Viral Infection Pathways,17/1029,0.005341044285788724,0.047708551590477516,0,0,2.1220123617263975,11.103077611159037,STAT2;RPS27L;RUNX1;HERC5;RPL7A;TUBA1C;PSMB4;UBC;PSMB1;GEMIN4;RPS3;NPIPB3;RPL38;RPL27;RPS20;HNRNPA1;BCL2L1,High
Activation of Gene Expression by SREBF (SREBP),3/43,0.00543270588228766,0.047708551590477516,0,0,9.107668711656443,47.499388099014006,HELZ2;SC5D;ACACA,High
Hh Mutants Are Degraded by ERAD,3/43,0.00543270588228766,0.047708551590477516,0,0,9.107668711656443,47.499388099014006,PSMB4;PSMB1;UBC,High
RUNX1 Regulates Transcription of Genes Involved in Differentiation of HSCs,4/85,0.005501561360820639,0.047708551590477516,0,0,6.021338210638622,31.327356866065763,PSMB4;PSMB1;UBC;RUNX1,High
Bile Acid and Bile Salt Metabolism,3/44,0.005795125663155014,0.047708551590477516,0,0,8.885081550202004,45.76472821923697,AKR1C1;AKR1C3;AKR1C4,High
Degradation of DVL,3/44,0.005795125663155014,0.047708551590477516,0,0,8.885081550202004,45.76472821923697,PSMB4;PSMB1;UBC,High
Negative Regulation of NOTCH4 Signaling,3/44,0.005795125663155014,0.047708551590477516,0,0,8.885081550202004,45.76472821923697,PSMB4;PSMB1;UBC,High
Smooth Muscle Contraction,3/44,0.005795125663155014,0.047708551590477516,0,0,8.885081550202004,45.76472821923697,LMOD1;MYH11;ACTG2,High
Stabilization of P53,3/44,0.005795125663155014,0.047708551590477516,0,0,8.885081550202004,45.76472821923697,PSMB4;PSMB1;UBC,High
Immune System,29/2150,0.00581215725144382,0.047708551590477516,0,0,1.7677827219635416,9.100198043236281,FPR1;IFIT3;IFIT2;HERC5;TUBA1C;MT2A;PSMB4;RNF213;C7;CAPZB;FTH1;UBC;PSMB1;CCT8;STX3;GBP1;HSPA9;PRKCE;ZBTB16;MMP2;STAT2;GLMN;SOD2;MUC3A;CXCL10;S100A9;S100A8;BCL2L1;VPS35L,High
Carnitine Shuttle,2/14,0.005836081726626109,0.047708551590477516,0,0,20.14430894308943,103.6161941728909,MID1IP1;ACACA,High
Nuclear Events Mediated by NFE2L2,4/87,0.005971433198590733,0.048345641857821135,0,0,5.875650751152759,30.08784618842072,PSMB4;PSMB1;UBC;BCL2L1,High
Aerobic Respiration and Respiratory Electron Transport,7/260,0.006108551581125082,0.04898476601245066,0,0,3.407338354836304,17.370834423685896,HSPA9;LDHA;FH;ATP5PD;UQCC2;UBC;NDUFA1,High
Regulation of RUNX3 Expression and Activity,3/45,0.006171702422164881,0.04902427773078141,0,0,8.673093777388257,44.12679791400487,PSMB4;PSMB1;UBC,High
rRNA Processing in the Nucleus and Cytosol,6/199,0.006416717007279626,0.05014489462983156,0,0,3.8162564766839377,19.26770140484516,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Hh Mutants Abrogate Ligand Secretion,3/46,0.006562575377164179,0.05014489462983156,0,0,8.47096590098445,42.57822721610337,PSMB4;PSMB1;UBC,High
NIK-->noncanonical NF-kB Signaling,3/46,0.006562575377164179,0.05014489462983156,0,0,8.47096590098445,42.57822721610337,PSMB4;PSMB1;UBC,High
Diseases of Metabolism,7/264,0.006622755541982677,0.05014489462983156,0,0,3.3536206348041016,16.825932171943474,UGT1A1;LUM;UBC;PRELP;ALDOB;MUC3A;ACACA,High
Keratan Sulfate Degradation,2/15,0.006697417955168179,0.05014489462983156,0,0,18.593808630393998,93.08122344256823,LUM;PRELP,High
ABC-family Proteins Mediated Transport,4/90,0.006725166781398653,0.05014489462983156,0,0,5.6698248636233135,28.35988878448748,PSMB4;ABCC6;PSMB1;UBC,High
DNA Replication,5/143,0.006871636080392181,0.05014489462983156,0,0,4.432442164011162,22.075126861881994,PSMB4;UBC;POLD2;PSMB1;POLE3,High
Cellular Response to Chemical Stress,6/202,0.00688723368008062,0.05014489462983156,0,0,3.7572704081632655,18.704014361898118,HELZ2;PSMB4;UBC;PSMB1;SOD2;BCL2L1,High
Degradation of GLI1 by the Proteasome,3/47,0.006967877282292509,0.05014489462983156,0,0,8.27802565532627,41.11235623837757,PSMB4;PSMB1;UBC,High
Degradation of GLI2 by the Proteasome,3/47,0.006967877282292509,0.05014489462983156,0,0,8.27802565532627,41.11235623837757,PSMB4;PSMB1;UBC,High
GLI3 Is Processed to GLI3R by the Proteasome,3/47,0.006967877282292509,0.05014489462983156,0,0,8.27802565532627,41.11235623837757,PSMB4;PSMB1;UBC,High
DNA Damage Bypass,3/48,0.007387734548772809,0.05227287806778744,0,0,8.093660531697342,39.723152900520105,POLD2;UBC;POLE3,High
Defective CFTR Causes Cystic Fibrosis,3/48,0.007387734548772809,0.05227287806778744,0,0,8.093660531697342,39.723152900520105,PSMB4;PSMB1;UBC,High
Signaling by Nuclear Receptors,7/270,0.007453623692715619,0.05229959291055459,0,0,3.276107803046608,16.049832192293366,KDM4B;MMP2;APOC1;AKR1C3;UGT1A3;TNRC6A;RUNX1,High
Dectin-1 Mediated Noncanonical NF-kB Signaling,3/49,0.007822267367336884,0.054432637382625264,0,0,7.917311283008802,38.405141731669744,PSMB4;PSMB1;UBC,High
SCF(Skp2)-mediated Degradation of P27 P21,3/50,0.008271589822049126,0.05708752975545381,0,0,7.748466257668712,37.153342067959336,PSMB4;PSMB1;UBC,High
S Phase,5/150,0.008362104602038995,0.057243024999323856,0,0,4.21696294709788,20.174141079605995,PSMB4;UBC;POLD2;PSMB1;POLE3,High
Formation of Senescence-Associated Heterochromatin Foci (SAHF),2/17,0.008581000495283724,0.05826776142765238,0,0,16.1130081300813,76.66899205398923,H1-5;CABIN1,High
Asymmetric Localization of PCP Proteins,3/51,0.008735810014014328,0.05884441625440051,0,0,7.586656441717792,35.963214220811075,PSMB4;PSMB1;UBC,High
SARS-CoV Infections,10/498,0.00882838973180261,0.058996064715696815,0,0,2.541246321984027,12.019542748676685,STAT2;UBC;GEMIN4;RPS3;RPS27L;NPIPB3;RPS20;HNRNPA1;RUNX1;BCL2L1,High
Hedgehog Ligand Biogenesis,3/52,0.009215030171132827,0.06055755537584207,0,0,7.431451108050582,34.83061247052997,PSMB4;PSMB1;UBC,High
Proteasome Assembly,3/52,0.009215030171132827,0.06055755537584207,0,0,7.431451108050582,34.83061247052997,PSMB4;PSMB1;PSMB9,High
Hedgehog 'Off' State,4/99,0.009356897736974998,0.06055755537584207,0,0,5.130344379467187,23.967129618976003,TUBA1C;PSMB4;UBC;PSMB1,High
Visual Phototransduction,4/99,0.009356897736974998,0.06055755537584207,0,0,5.130344379467187,23.967129618976003,RBP4;AKR1C1;AKR1C3;AKR1C4,High
Mitochondrial Unfolded Protein Response (UPRmt),2/18,0.009601370877517652,0.06055755537584207,0,0,15.105182926829269,70.1764049009769,HSPA9;SOD2,High
p53-Dependent G1 DNA Damage Response,3/53,0.009709346764535248,0.06055755537584207,0,0,7.282453987730062,33.75174388487755,PSMB4;PSMB1;UBC,High
p53-Dependent G1 S DNA Damage Checkpoint,3/53,0.009709346764535248,0.06055755537584207,0,0,7.282453987730062,33.75174388487755,PSMB4;PSMB1;UBC,High
"Formation of the Ternary Complex, and Subsequently, the 43S Complex",3/53,0.009709346764535248,0.06055755537584207,0,0,7.282453987730062,33.75174388487755,RPS3;RPS27L;RPS20,High
Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha,3/53,0.009709346764535248,0.06055755537584207,0,0,7.282453987730062,33.75174388487755,PSMB4;PSMB1;UBC,High
SARS-CoV-2-host Interactions,6/218,0.009828099653707865,0.06084749932663252,0,0,3.470872641509434,16.044142399389486,STAT2;UBC;GEMIN4;RPS3;RPS27L;RPS20,High
Activation of NF-kappaB in B Cells,3/54,0.010218850616735439,0.06112252669046532,0,0,7.139299891735836,32.72313215453358,PSMB4;PSMB1;UBC,High
Autodegradation of Cdh1 by Cdh1 APC C,3/54,0.010218850616735439,0.06112252669046532,0,0,7.139299891735836,32.72313215453358,PSMB4;PSMB1;UBC,High
NR1H2 and NR1H3-mediated Signaling,3/54,0.010218850616735439,0.06112252669046532,0,0,7.139299891735836,32.72313215453358,APOC1;UGT1A3;TNRC6A,High
SARS-CoV-1 Activates Modulates Innate Immune Responses,3/54,0.010218850616735439,0.06112252669046532,0,0,7.139299891735836,32.72313215453358,UBC;NPIPB3;RUNX1,High
Aflatoxin Activation and Detoxification,2/19,0.01067289622724377,0.06112252669046532,0,0,14.215925394548064,64.54098101179628,GGT7;CYP3A5,High
MyD88 Deficiency (TLR2 4),2/19,0.01067289622724377,0.06112252669046532,0,0,14.215925394548064,64.54098101179628,S100A9;S100A8,High
RHO GTPases Activate ROCKs,2/19,0.01067289622724377,0.06112252669046532,0,0,14.215925394548064,64.54098101179628,MYH11;PPP1R12B,High
RHO GTPases Activate CIT,2/19,0.01067289622724377,0.06112252669046532,0,0,14.215925394548064,64.54098101179628,MYH11;PPP1R12B,High
Scavenging by Class A Receptors,2/19,0.01067289622724377,0.06112252669046532,0,0,14.215925394548064,64.54098101179628,COL4A1;FTH1,High
APC C Cdc20 Mediated Degradation of Securin,3/55,0.010743627019226683,0.06112252669046532,0,0,7.001651722510618,31.74158573846616,PSMB4;PSMB1;UBC,High
G1 S DNA Damage Checkpoints,3/55,0.010743627019226683,0.06112252669046532,0,0,7.001651722510618,31.74158573846616,PSMB4;PSMB1;UBC,High
Regulation of RAS by GAPs,3/55,0.010743627019226683,0.06112252669046532,0,0,7.001651722510618,31.74158573846616,PSMB4;PSMB1;UBC,High
Regulation of PTEN Stability and Activity,3/56,0.011283755829497527,0.06292001594991337,0,0,6.869197823822201,30.804169755124224,PSMB4;PSMB1;UBC,High
Regulation of Cholesterol Biosynthesis by SREBP (SREBF),3/56,0.011283755829497527,0.06292001594991337,0,0,6.869197823822201,30.804169755124224,HELZ2;SC5D;ACACA,High
Transcriptional Activation of Mitochondrial Biogenesis,3/56,0.011283755829497527,0.06292001594991337,0,0,6.869197823822201,30.804169755124224,HELZ2;SSBP1;SOD2,High
IRAK4 Deficiency (TLR2 4),2/20,0.011794667655805476,0.06473182051615796,0,0,13.425474254742548,59.61055219489654,S100A9;S100A8,High
Transcriptional Regulation by RUNX2,4/106,0.01181179195233002,0.06473182051615796,0,0,4.776567417090293,21.201544060326032,PSMB4;UBC;PSMB1;RUNX1,High
Chemokine Receptors Bind Chemokines,3/57,0.011839311590841242,0.06473182051615796,0,0,6.741649625085208,29.90818109167935,CXCL10;CXCL9;CXCL11,High
Antigen Processing Ubiquitination & Proteasome Degradation,7/296,0.01196795765751673,0.06501303450083282,0,0,2.977410720114905,13.176597823158511,HERC5;PSMB4;RNF213;ZBTB16;UBC;GLMN;PSMB1,High
Organelle Biogenesis and Maintenance,7/297,0.012173835331185994,0.06570749582601672,0,0,2.966991975710258,13.07988406392171,HELZ2;HSPA9;TUBA1C;ATP5PD;CCT8;SSBP1;SOD2,High
Orc1 Removal From Chromatin,3/58,0.012410363628502539,0.06655749156177795,0,0,6.6187395426659235,29.051126339821625,PSMB4;PSMB1;UBC,High
Nucleotide Excision Repair,4/108,0.012582063975717485,0.06686592405343582,0,0,4.684235517568851,20.49579274932577,UBC;POLD2;POLE3;PRPF19,High
Infectious Disease,19/1311,0.012626700622917215,0.06686592405343582,0,0,1.8549419767907163,8.109698012628362,STAT2;RPS27L;ENO1;RUNX1;HERC5;RPL7A;TUBA1C;PSMB4;RNF213;UBC;PSMB1;GEMIN4;RPS3;NPIPB3;RPL38;RPL27;RPS20;HNRNPA1;BCL2L1,High
PCNA-Dependent Long Patch Base Excision Repair,2/21,0.012965787679204827,0.0671377541231915,0,0,12.718228498074454,55.26631293087005,POLD2;POLE3,High
RHO GTPases Activate PAKs,2/21,0.012965787679204827,0.0671377541231915,0,0,12.718228498074454,55.26631293087005,MYH11;PPP1R12B,High
Iron Uptake and Transport,3/59,0.012996976154489567,0.0671377541231915,0,0,6.500219106047327,28.23070217451619,STEAP4;FTH1;UBC,High
Regulation of RUNX2 Expression and Activity,3/59,0.012996976154489567,0.0671377541231915,0,0,6.500219106047327,28.23070217451619,PSMB4;PSMB1;UBC,High
Apoptosis,5/168,0.013193301519315224,0.06773634072721596,0,0,3.74785657127615,16.220895787487756,H1-5;PSMB4;UBC;PSMB1;BCL2L1,High
Neddylation,6/234,0.013570771558081758,0.0677546358211673,0,0,3.224671052631579,13.865559740858272,PSMB4;UBD;ZBTB16;UBC;PSMB1;COMMD6,High
CDK-mediated Phosphorylation and Removal of Cdc6,3/60,0.013599208377407686,0.0677546358211673,0,0,6.385857281239909,27.444777870669878,PSMB4;PSMB1;UBC,High
Cdc20 Phospho-APC C Mediated Degradation of Cyclin A,3/60,0.013599208377407686,0.0677546358211673,0,0,6.385857281239909,27.444777870669878,PSMB4;PSMB1;UBC,High
Ribosomal Scanning and Start Codon Recognition,3/60,0.013599208377407686,0.0677546358211673,0,0,6.385857281239909,27.444777870669878,RPS3;RPS27L;RPS20,High
Translation Initiation Complex Formation,3/60,0.013599208377407686,0.0677546358211673,0,0,6.385857281239909,27.444777870669878,RPS3;RPS27L;RPS20,High
Chaperone Mediated Autophagy,2/22,0.014185370094036713,0.06879776141836741,0,0,12.081707317073171,51.4142385392671,UBC;RNASE1,High
Regulation of TLR by Endogenous Ligand,2/22,0.014185370094036713,0.06879776141836741,0,0,12.081707317073171,51.4142385392671,S100A9;S100A8,High
APC C Cdh1 Mediated Degradation of Cdc20 and Other APC C Cdh1 Targets in Late Mitosis Early G1,3/61,0.014217114592394215,0.06879776141836741,0,0,6.2754389676327484,26.691379704090995,PSMB4;PSMB1;UBC,High
APC Cdc20 Mediated Degradation of Cell Cycle Proteins Prior to Satisfation of the Checkpoint,3/61,0.014217114592394215,0.06879776141836741,0,0,6.2754389676327484,26.691379704090995,PSMB4;PSMB1;UBC,High
"mRNA Activation Upon Binding of the Cap-Binding Complex and eIFs, and Subsequent Binding to 43S",3/61,0.014217114592394215,0.06879776141836741,0,0,6.2754389676327484,26.691379704090995,RPS3;RPS27L;RPS20,High
rRNA Processing,6/237,0.014369853125095177,0.06913952189331508,0,0,3.182305194805195,13.501320575667366,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Cellular Response to Hypoxia,3/62,0.01485074429194618,0.07104731076033342,0,0,6.168763647707185,25.96867698715954,PSMB4;PSMB1;UBC,High
APC C Cdc20 Mediated Degradation of Mitotic Proteins,3/63,0.01550014225173487,0.07373513997717944,0,0,6.065644171779141,25.27496956375001,PSMB4;PSMB1;UBC,High
MAPK Family Signaling Cascades,7/314,0.016077395114827645,0.07561790860762349,0,0,2.8002581279577163,11.566021022854574,DLG1;PSMB4;MMP2;UBC;PSMB1;TNRC6A;BCL2L1,High
Activation of APC C and APC C Cdc20 Mediated Degradation of Mitotic Proteins,3/64,0.0161653486334587,0.07561790860762349,0,0,5.9659056622749675,24.608676572621615,PSMB4;PSMB1;UBC,High
Collagen Degradation,3/64,0.0161653486334587,0.07561790860762349,0,0,5.9659056622749675,24.608676572621615,COL4A1;MMP2;COL6A3,High
Xenobiotics,2/24,0.01676643292366346,0.07714391541926029,0,0,10.982261640798226,44.89961965764408,CYP2C19;CYP3A5,High
RAS Processing,2/24,0.01676643292366346,0.07714391541926029,0,0,10.982261640798226,44.89961965764408,UBC;BCL2L1,High
RHO GTPases Activate NADPH Oxidases,2/24,0.01676643292366346,0.07714391541926029,0,0,10.982261640798226,44.89961965764408,S100A9;S100A8,High
DNA Replication Pre-Initiation,4/118,0.0169128117985803,0.07739449746959028,0,0,4.271171756551873,17.4250304343761,PSMB4;UBC;PSMB1;POLE3,High
KEAP1-NFE2L2 Pathway,4/119,0.017390961581510628,0.07915237649530782,0,0,4.233816425120773,17.154597108444303,PSMB4;UBC;PSMB1;BCL2L1,High
Complex III Assembly,2/25,0.018126196217959568,0.08118221923149978,0,0,10.50424178154825,42.12618059130718,HSPA9;UQCC2,High
Formation of Tubulin Folding Intermediates by CCT TriC,2/25,0.018126196217959568,0.08118221923149978,0,0,10.50424178154825,42.12618059130718,TUBA1C;CCT8,High
Resolution of AP Sites via the Multiple-Nucleotide Patch Replacement Pathway,2/25,0.018126196217959568,0.08118221923149978,0,0,10.50424178154825,42.12618059130718,POLD2;POLE3,High
G1 S Transition,4/121,0.018372407827433847,0.08184956291375291,0,0,4.1610214202806795,16.63120862826212,PSMB4;UBC;PSMB1;POLE3,High
G2 M Transition,5/184,0.018828766133097745,0.08325672088473654,0,0,3.4100766855199693,13.54608449925817,TUBA1C;PSMB4;UBC;PSMB1;PPP1R12B,High
Downstream Signaling Events of B Cell Receptor (BCR),3/68,0.018984905474904293,0.08325672088473654,0,0,5.597640396413403,22.18966822909577,PSMB4;PSMB1;UBC,High
Regulation of APC C Activators Between G1 S and Early Anaphase,3/68,0.018984905474904293,0.08325672088473654,0,0,5.597640396413403,22.18966822909577,PSMB4;PSMB1;UBC,High
Gluconeogenesis,2/26,0.019530987419333175,0.08475664270034261,0,0,10.066056910569106,39.617513445035065,ENO1;ALDOB,High
HDMs Demethylate Histones,2/26,0.019530987419333175,0.08475664270034261,0,0,10.066056910569106,39.617513445035065,KDM4B;KDM5D,High
Mitotic G2-G2 M Phases,5/186,0.019628913689509274,0.08475664270034261,0,0,3.3720531210322227,13.25470323965091,TUBA1C;PSMB4;UBC;PSMB1;PPP1R12B,High
HDR Through Homologous Recombination (HRR),3/69,0.019729601508615368,0.08475675750129663,0,0,5.512548800892359,21.64025537406243,POLD2;UBC;POLE3,High
Prefoldin Mediated Transfer of Substrate to CCT TriC,2/27,0.02097997488736471,0.08921787300586408,0,0,9.662926829268292,37.3393550083645,TUBA1C;CCT8,High
Regulation of RUNX1 Expression and Activity,2/27,0.02097997488736471,0.08921787300586408,0,0,9.662926829268292,37.3393550083645,TNRC6A;RUNX1,High
Translocation of SLC2A4 (GLUT4) to the Plasma Membrane,3/71,0.021266877200530457,0.08998347036606355,0,0,5.349873691808011,20.600247592468534,TUBA1C;RAB4A;TBC1D4,High
Degradation of Beta-Catenin by the Destruction Complex,3/72,0.022059473856344488,0.09240834321911472,0,0,5.272072552680715,20.107753864506382,PSMB4;PSMB1;UBC,High
Signaling by NOTCH4,3/72,0.022059473856344488,0.09240834321911472,0,0,5.272072552680715,20.107753864506382,PSMB4;PSMB1;UBC,High
Keratan Sulfate Biosynthesis,2/28,0.02247233753494775,0.09367182279418816,0,0,9.29080675422139,35.262979882036056,LUM;PRELP,High
Cyclin E Associated Events During G1 S Transition,3/73,0.022868047977986455,0.09438674704639509,0,0,5.196494303242769,19.632431489591283,PSMB4;PSMB1;UBC,High
Hedgehog 'On' State,3/73,0.022868047977986455,0.09438674704639509,0,0,5.196494303242769,19.632431489591283,PSMB4;PSMB1;UBC,High
C-type Lectin Receptors (CLRs),4/131,0.023792043379696523,0.09772146597904621,0,0,3.831437736949548,14.323462414349157,PSMB4;UBC;PSMB1;MUC3A,High
APC C-mediated Degradation of Cell Cycle Proteins,3/75,0.024533121031748647,0.09931196109967481,0,0,5.051635991820041,18.730108355434638,PSMB4;PSMB1;UBC,High
Cyclin A Cdk2-associated Events at S Phase Entry,3/75,0.024533121031748647,0.09931196109967481,0,0,5.051635991820041,18.730108355434638,PSMB4;PSMB1;UBC,High
Regulation of Mitotic Cell Cycle,3/75,0.024533121031748647,0.09931196109967481,0,0,5.051635991820041,18.730108355434638,PSMB4;PSMB1;UBC,High
Metabolism of Vitamins and Cofactors,5/198,0.024899587844699565,0.10031317208247384,0,0,3.1604608502558493,11.671278604467908,RBP4;AKR1C1;AKR1C3;AKR1C4;ACACA,High
ECM Proteoglycans,3/76,0.02538960714812374,0.10114897629896778,0,0,4.9821833767543495,18.301628923006675,COL4A1;LUM;COL6A3,High
Regulation of mRNA Stability by Proteins That Bind AU-rich Elements,3/76,0.02538960714812374,0.10114897629896778,0,0,4.9821833767543495,18.301628923006675,PSMB4;PSMB1;UBC,High
Paracetamol ADME,2/30,0.025583956145223512,0.10114897629896778,0,0,8.626306620209059,31.622227139558046,GGT7;UGT1A1,High
Beta-catenin Independent WNT Signaling,4/134,0.025587567638574983,0.10114897629896778,0,0,3.7424501424501426,13.718507441762334,PSMB4;UBC;PSMB1;TNRC6A,High
Signaling by Hedgehog,4/136,0.026828753752675818,0.10462644161374286,0,0,3.6853722409277965,13.334712598274919,TUBA1C;PSMB4;UBC;PSMB1,High
Programmed Cell Death,5/202,0.026840037278584868,0.10462644161374286,0,0,3.095658479679667,11.199660776462702,H1-5;PSMB4;UBC;PSMB1;BCL2L1,High
Transcriptional Regulation by RUNX1,5/202,0.026840037278584868,0.10462644161374286,0,0,3.095658479679667,11.199660776462702,PSMB4;UBC;PSMB1;TNRC6A;RUNX1,High
PCP CE Pathway,3/79,0.02805471369761198,0.10835811437334536,0,0,4.784791733936067,17.098925112839883,PSMB4;PSMB1;UBC,High
Switching of Origins to a Post-Replicative State,3/79,0.02805471369761198,0.10835811437334536,0,0,4.784791733936067,17.098925112839883,PSMB4;PSMB1;UBC,High
Mitotic G1 Phase and G1 S Transition,4/139,0.02875722579879784,0.11045310583702772,0,0,3.6029263831732967,12.786303702631804,PSMB4;UBC;PSMB1;POLE3,High
Cooperation of Prefoldin and TriC CCT in Actin and Tubulin Folding,2/32,0.02885948133509038,0.11045310583702772,0,0,8.050406504065041,28.541240600967136,TUBA1C;CCT8,High
Signaling by NOTCH,5/209,0.030462909445716047,0.11537576771325189,0,0,2.988369260747777,10.433130492301336,PSMB4;UBC;PSMB1;TNRC6A;RUNX1,High
Cristae Formation,2/33,0.030556765083200918,0.11537576771325189,0,0,7.790322580645161,27.173963088287994,HSPA9;ATP5PD,High
Regulation of Pyruvate Metabolism,2/33,0.030556765083200918,0.11537576771325189,0,0,7.790322580645161,27.173963088287994,LDHA;UBC,High
Infection With Mycobacterium Tuberculosis,3/82,0.03086287243558978,0.11549572707007376,0,0,4.602391861458414,16.00804561708135,RNF213;UBC;ENO1,High
UCH Proteinases,3/82,0.03086287243558978,0.11549572707007376,0,0,4.602391861458414,16.00804561708135,PSMB4;PSMB1;UBC,High
Diseases of Carbohydrate Metabolism,2/34,0.03229271278042159,0.11978178044544044,0,0,7.546493902439025,25.906462189344023,UBC;ALDOB,High
Late Endosomal Microautophagy,2/34,0.03229271278042159,0.11978178044544044,0,0,7.546493902439025,25.906462189344023,UBC;RNASE1,High
Global Genome Nucleotide Excision Repair (GG-NER),3/84,0.032814089937518116,0.12080696039490477,0,0,4.488298114064985,15.336053638269393,POLD2;UBC;POLE3,High
PTEN Regulation,4/145,0.03285604979861424,0.12080696039490477,0,0,3.448559670781893,11.778967267598224,PSMB4;UBC;PSMB1;TNRC6A,High
Integrin Cell Surface Interactions,3/85,0.03381333040195454,0.1225814331548662,0,0,4.433338321113273,15.015274285313511,COL4A1;LUM;COL6A3,High
Diseases Associated With the TLR Signaling Cascade,2/35,0.034066574059665906,0.1225814331548662,0,0,7.317442719881744,24.728848441514916,S100A9;S100A8,High
Diseases of Immune System,2/35,0.034066574059665906,0.1225814331548662,0,0,7.317442719881744,24.728848441514916,S100A9;S100A8,High
Negative Regulators of DDX58 IFIH1 Signaling,2/35,0.034066574059665906,0.1225814331548662,0,0,7.317442719881744,24.728848441514916,HERC5;UBC,High
Oncogene Induced Senescence,2/35,0.034066574059665906,0.1225814331548662,0,0,7.317442719881744,24.728848441514916,UBC;TNRC6A,High
RHO GTPase Effectors,6/291,0.03479784154582112,0.12467992587906972,0,0,2.572236842105263,8.638085553959622,TUBA1C;MRTFA;MYH11;PPP1R12B;S100A9;S100A8,High
CLEC7A (Dectin-1) Signaling,3/87,0.03585887640795202,0.12746390761084264,0,0,4.327344434706398,14.402112586482684,PSMB4;PSMB1;UBC,High
Keratan Sulfate Keratin Metabolism,2/36,0.03587760819925143,0.12746390761084264,0,0,7.1018651362984215,23.63246403210629,LUM;PRELP,High
TNFR2 Non-Canonical NF-kB Pathway,3/88,0.03690509439351646,0.1305634011737011,0,0,4.276217971851318,14.108977856777804,PSMB4;PSMB1;UBC,High
Cross-presentation of Soluble Exogenous Antigens (Endosomes),2/37,0.03772508404145059,0.13125835025992313,0,0,6.898606271777004,22.609699474728522,PSMB4;PSMB1,High
Evasion by RSV of Host Interferon Responses,2/37,0.03772508404145059,0.13125835025992313,0,0,6.898606271777004,22.609699474728522,STAT2;UBC,High
Gene and Protein Expression by JAK-STAT Signaling After Interleukin-12 Stimulation,2/37,0.03772508404145059,0.13125835025992313,0,0,6.898606271777004,22.609699474728522,HSPA9;SOD2,High
Plasma Lipoprotein Clearance,2/37,0.03772508404145059,0.13125835025992313,0,0,6.898606271777004,22.609699474728522,UBC;APOC1,High
DNA Double-Strand Break Repair,4/152,0.038048821462333904,0.13183994926454792,0,0,3.284284284284284,10.735948186194705,KDM4B;UBC;POLD2;POLE3,High
Regulation of Ornithine Decarboxylase (ODC),2/38,0.03960827986169273,0.1347879985461072,0,0,6.706639566395664,21.65384181910448,PSMB4;PSMB1,High
Resolution of Abasic Sites (AP Sites),2/38,0.03960827986169273,0.1347879985461072,0,0,6.706639566395664,21.65384181910448,POLD2;POLE3,High
Signal Transduction,30/2613,0.03975568447237298,0.1347879985461072,0,0,1.4732356357177017,4.75118852358506,CXCL9;FPR1;TUBA1C;PSMB4;CAPZB;UBC;PSMB1;OXER1;MYH11;UGT1A3;HNRNPA1;FARP1;RAB4A;KDM4B;PRKCE;MMP2;AKR1C3;MRTFA;RUNX1;CXCL10;DLG1;CXCL11;COL4A1;APOC1;COL6A3;PPP1R12B;S100A9;S100A8;TNRC6A;BCL2L1,High
Downstream TCR Signaling,3/91,0.040136947686985065,0.1347879985461072,0,0,4.129810373675404,13.279231722684365,PSMB4;PSMB1;UBC,High
Fructose Catabolism,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,ALDOB,High
Maturation of Protein E 9683683,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,UBC,High
Maturation of Protein E 9694493,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,UBC,High
RUNX1 Regulates Expression of Components of Tight Junctions,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,RUNX1,High
RUNX1 Regulates Transcription of Genes Involved in Interleukin Signaling,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,RUNX1,High
Signaling by Membrane-Tethered Fusions of PDGFRA or PDGFRB,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,GOLGA4,High
Tyrosine Catabolism,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,FAH,High
VLDL Assembly,1/5,0.04082059338391608,0.1347879985461072,0,0,30.045454545454547,96.1024470343946,APOC1,High
Diseases Associated With Glycosaminoglycan Metabolism,2/41,0.04546510959358319,0.14953758702264472,0,0,6.1898061288305195,19.131515110021255,LUM;PRELP,High
DNA Repair,6/312,0.04617490879966601,0.15128121871330263,0,0,2.3931372549019607,7.359659818676341,KDM4B;MGMT;UBC;POLD2;POLE3;PRPF19,High
SARS-CoV-2 Infection,6/313,0.04676804914810215,0.1526306100104729,0,0,2.3852198697068405,7.304867085111621,STAT2;UBC;GEMIN4;RPS3;RPS27L;RPS20,High
NCAM1 Interactions,2/42,0.04748415348842961,0.1537756047586836,0,0,6.034756097560976,18.390069721084554,COL4A1;COL6A3,High
RHOF GTPase Cycle,2/42,0.04748415348842961,0.1537756047586836,0,0,6.034756097560976,18.390069721084554,FARP1;CAPZB,High
Disorders of Transmembrane Transporters,4/164,0.04798560097735492,0.15442075111346706,0,0,3.036111111111111,9.220227060939237,PSMB4;UBC;ABCC6;PSMB1,High
RUNX1 Regulates Estrogen Receptor Mediated Transcription,1/6,0.048783752727057296,0.15442075111346706,0,0,24.035151515151515,72.5947611380124,RUNX1,High
RUNX1 Regulates Transcription of Genes Involved in BCR Signaling,1/6,0.048783752727057296,0.15442075111346706,0,0,24.035151515151515,72.5947611380124,RUNX1,High
RUNX1 Regulates Transcription of Genes Involved in WNT Signaling,1/6,0.048783752727057296,0.15442075111346706,0,0,24.035151515151515,72.5947611380124,RUNX1,High
SARS-CoV-1-mediated Effects on Programmed Cell Death,1/6,0.048783752727057296,0.15442075111346706,0,0,24.035151515151515,72.5947611380124,BCL2L1,High
VLDL Clearance,1/6,0.048783752727057296,0.15442075111346706,0,0,24.035151515151515,72.5947611380124,APOC1,High
Aggrephagy,2/43,0.04953544685119325,0.15563002331606238,0,0,5.887269482450922,17.691637874086517,TUBA1C;UBC,High
Assembly and Cell Surface Presentation of NMDA Receptors,2/43,0.04953544685119325,0.15563002331606238,0,0,5.887269482450922,17.691637874086517,TUBA1C;DLG1,High
Cellular Senescence,4/167,0.05067387312943712,0.15861487425645374,0,0,2.9797773233356057,8.886723477221272,H1-5;UBC;TNRC6A;CABIN1,High
Metabolism of Lipids,11/758,0.05157846083347833,0.15978907181181856,0,0,1.8133350606727987,5.375905817377977,HELZ2;RAB4A;AKR1C1;MID1IP1;GPD1;AKR1C3;SC5D;AKR1C4;CYP2C19;ACACA;CERS2,High
Collagen Chain Trimerization,2/44,0.051618322485528084,0.15978907181181856,0,0,5.746806039488966,17.032835338764485,COL4A1;COL6A3,High
NR1H3 & NR1H2 Regulate Gene Expression Linked to Cholesterol Transport and Efflux,2/44,0.051618322485528084,0.15978907181181856,0,0,5.746806039488966,17.032835338764485,APOC1;TNRC6A,High
Assembly of the Pre-Replicative Complex,3/101,0.05190184836993018,0.160078228305792,0,0,3.706523100037561,10.965381183768404,PSMB4;UBC;PSMB1,High
Interleukin-1 Signaling,3/102,0.05316057944244062,0.16336207259319344,0,0,3.668897564603086,10.766152964497447,PSMB4;UBC;PSMB1,High
Somitogenesis,2/45,0.053732121920829885,0.16451798784486824,0,0,5.61287577992059,16.410613471214077,PSMB4;PSMB1,High
Interleukin-10 Signaling,2/46,0.05587619533061399,0.16804777813418129,0,0,5.485033259423504,15.82221927153863,CXCL10;FPR1,High
Interleukin-12 Signaling,2/46,0.05587619533061399,0.16804777813418129,0,0,5.485033259423504,15.82221927153863,HSPA9;SOD2,High
Metabolism of Polyamines,2/46,0.05587619533061399,0.16804777813418129,0,0,5.485033259423504,15.82221927153863,PSMB4;PSMB1,High
Defective HLCS Causes Multiple Carboxylase Deficiency,1/7,0.05668119832554333,0.16804777813418129,0,0,20.02828282828283,57.487435010574046,ACACA,High
FLT3 Signaling by CBL Mutants,1/7,0.05668119832554333,0.16804777813418129,0,0,20.02828282828283,57.487435010574046,UBC,High
Fructose Metabolism,1/7,0.05668119832554333,0.16804777813418129,0,0,20.02828282828283,57.487435010574046,ALDOB,High
NrCAM Interactions,1/7,0.05668119832554333,0.16804777813418129,0,0,20.02828282828283,57.487435010574046,DLG1,High
Post-transcriptional Silencing by Small RNAs,1/7,0.05668119832554333,0.16804777813418129,0,0,20.02828282828283,57.487435010574046,TNRC6A,High
RUNX1 Regulates Transcription of Genes Involved in Differentiation of Myeloid Cells,1/7,0.05668119832554333,0.16804777813418129,0,0,20.02828282828283,57.487435010574046,RUNX1,High
Fatty Acid Metabolism,4/176,0.05922487807031168,0.17497314854456994,0,0,2.822566752799311,7.977741022282806,MID1IP1;AKR1C3;CYP2C19;ACACA,High
Separation of Sister Chromatids,4/177,0.06021970728198384,0.17729018717283357,0,0,2.806108613430386,7.884479437799369,TUBA1C;PSMB4;UBC;PSMB1,High
RSV-host Interactions,3/109,0.06237750460963072,0.182678006373912,0,0,3.425396457923371,9.503935700474214,HERC5;STAT2;UBC,High
Pyruvate Metabolism,2/49,0.06248368864095802,0.182678006373912,0,0,5.134146341463414,14.236216338017247,LDHA;UBC,High
ChREBP Activates Metabolic Gene Expression,1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,ACACA,High
DNA Damage Reversal,1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,MGMT,High
DNA Replication Initiation,1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,POLE3,High
Defects in Biotin (Btn) Metabolism,1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,ACACA,High
RUNX1 Regulates Transcription of Genes Involved in Differentiation of Keratinocytes,1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,RUNX1,High
RUNX3 Regulates YAP1-mediated Transcription,1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,TEAD1,High
Synthesis of Epoxy (EET) and Dihydroxyeicosatrienoic Acids (DHET),1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,CYP2C19,High
Terminal Pathway of Complement,1/8,0.06451346874924052,0.1835146644826369,0,0,17.166233766233766,47.050608420266336,C7,High
Signaling by ERBB2,2/50,0.06474252903659296,0.18354615976030733,0,0,5.0269308943089435,13.760403766207606,PRKCE;UBC,High
Formation of TC-NER Pre-Incision Complex,2/51,0.06702852046500261,0.18938930950178592,0,0,4.924091587854654,13.30803246921321,UBC;PRPF19,High
TCR Signaling,3/113,0.06795560022549446,0.19136660665507135,0,0,3.3001673173452315,8.873822291977328,PSMB4;UBC;PSMB1,High
COPI-independent Golgi-to-ER Retrograde Traffic,2/52,0.06934106291795228,0.1944488856411952,0,0,4.825365853658536,12.877540757384395,TUBA1C;CAPZB,High
RAF MAP Kinase Cascade,5/265,0.07033101268638899,0.1944488856411952,0,0,2.3380315336837074,6.206403908137109,DLG1;PSMB4;UBC;PSMB1;BCL2L1,High
MyD88 MAL(TIRAP) Cascade Initiated on Plasma Membrane,3/115,0.07082717318176658,0.1944488856411952,0,0,3.240907099035933,8.580342217800606,UBC;S100A9;S100A8,High
Toll Like Receptor TLR6 TLR2 Cascade,3/115,0.07082717318176658,0.1944488856411952,0,0,3.240907099035933,8.580342217800606,UBC;S100A9;S100A8,High
Atorvastatin ADME,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,UGT1A3,High
BH3-only Proteins Associate With and Inactivate Anti-Apoptotic BCL-2 Members,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,BCL2L1,High
Downregulation of ERBB4 Signaling,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,UBC,High
Formyl Peptide Receptors Bind Formyl Peptides and Many Other Ligands,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,FPR1,High
Myoclonic Epilepsy of Lafora,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,UBC,High
NR1H2 & NR1H3 Regulate Gene Expression to Control Bile Acid Homeostasis,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,UGT1A3,High
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,UBC,High
Regulation of PTEN Localization,1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,UBC,High
Synthesis of (16-20)-Hydroxyeicosatetraenoic Acids (HETE),1/9,0.07228109831100976,0.1944488856411952,0,0,15.01969696969697,39.45963700558561,CYP2C19,High
HDR Through Homologous Recombination (HRR) or Single Strand Annealing (SSA),3/116,0.07228325558871032,0.1944488856411952,0,0,3.212063629947337,8.438613992858773,UBC;POLD2;POLE3,High
Toll Like Receptor 2 (TLR2) Cascade,3/118,0.07523551968327036,0.2011057383279798,0,0,3.155881568418245,8.164681636309997,UBC;S100A9;S100A8,High
Toll Like Receptor TLR1 TLR2 Cascade,3/118,0.07523551968327036,0.2011057383279798,0,0,3.155881568418245,8.164681636309997,UBC;S100A9;S100A8,High
MAPK1 MAPK3 Signaling,5/271,0.07576754992731681,0.20188695265443277,0,0,2.2845934712557794,5.894445755725318,DLG1;PSMB4;UBC;PSMB1;BCL2L1,High
ESR-mediated Signaling,4/192,0.07619584359599008,0.20224338610773196,0,0,2.580246913580247,6.642712444767598,KDM4B;MMP2;TNRC6A;RUNX1,High
L1CAM Interactions,3/120,0.07824057979497659,0.20224338610773196,0,0,3.1016202611294634,7.90282558436275,TUBA1C;DLG1;SCN9A,High
HSP90 Chaperone Cycle for Steroid Hormone Receptors (SHR) in the Presence of Ligand,2/56,0.07884502059081663,0.20224338610773196,0,0,4.467028003613369,11.347462220737667,TUBA1C;CAPZB,High
Interleukin-12 Family Signaling,2/56,0.07884502059081663,0.20224338610773196,0,0,4.467028003613369,11.347462220737667,HSPA9;SOD2,High
Estrogen-dependent Gene Expression,3/121,0.07976265329961559,0.20224338610773196,0,0,3.0751793698658627,7.776205727663175,KDM4B;TNRC6A;RUNX1,High
Transport of Small Molecules,10/724,0.07989005972309524,0.20224338610773196,0,0,1.716584069525246,4.337986198795714,PSMB4;STEAP4;FTH1;UBC;ABCC6;PSMB1;APOC1;AQP7;CUTC;RUNX1,High
Activation of Ca-permeable Kainate Receptor,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,DLG1,High
Folding of Actin by CCT TriC,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,CCT8,High
IRAK2 Mediated Activation of TAK1 Complex,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,UBC,High
InlA-mediated Entry of Listeria Monocytogenes Into Host Cells,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,UBC,High
Ionotropic Activity of Kainate Receptors,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,DLG1,High
MET Receptor Recycling,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,RAB4A,High
Organic Cation Transport,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,RUNX1,High
RUNX1 and FOXP3 Control the Development of Regulatory T Lymphocytes (Tregs),1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,RUNX1,High
RUNX3 Regulates p14-ARF,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,RUNX1,High
Regulation of NPAS4 mRNA Translation,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,TNRC6A,High
STAT5 Activation Downstream of FLT3 ITD Mutants,1/10,0.07998461707111014,0.20224338610773196,0,0,13.35016835016835,33.721469913824805,BCL2L1,High
Homology Directed Repair,3/122,0.08129761776116129,0.2049478866913108,0,0,3.049182863329381,7.6523469045984545,UBC;POLD2;POLE3,High
Diseases of Signal Transduction by Growth Factor Receptors and Second Messengers,7/451,0.08249255995925119,0.20733950891250597,0,0,1.9226301773471586,4.797052986830873,GOLGA4;PSMB4;RNF213;ZMYM2;UBC;PSMB1;BCL2L1,High
Peptide Ligand-Binding Receptors,4/198,0.08312778486806312,0.20831427041342007,0,0,2.499681812396589,6.217649243690986,CXCL10;CXCL11;CXCL9;FPR1,High
Signaling by PDGF,2/58,0.08374128384621701,0.20922896438728403,0,0,4.30705574912892,10.681598126277828,COL4A1;COL6A3,High
Arachidonate Metabolism,2/59,0.08622354278874728,0.21019906489009185,0,0,4.231279418057339,10.370070459461067,AKR1C3;CYP2C19,High
Formation of Paraxial Mesoderm,2/59,0.08622354278874728,0.21019906489009185,0,0,4.231279418057339,10.370070459461067,PSMB4;PSMB1,High
Host Interactions of HIV Factors,3/126,0.08756427818551792,0.21019906489009185,0,0,2.9494239114170284,7.182974339204876,PSMB4;UBC;PSMB1,High
Alpha-protein Kinase 1 Signaling Pathway,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,UBC,High
Biotin Transport and Metabolism,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,ACACA,High
CYP2E1 Reactions,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,CYP2C19,High
Metallothioneins Bind Metals,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,MT2A,High
Modulation by Mtb of Host Immune System,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,UBC,High
NFE2L2 Regulating Tumorigenic Genes,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,BCL2L1,High
Pexophagy,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,UBC,High
Phenylalanine and Tyrosine Metabolism,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,FAH,High
Regulation of CDH11 mRNA Translation by microRNAs,1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,TNRC6A,High
"Regulation of TBK1, IKK?-mediated Activation of IRF3, IRF7 Upon TLR3 Ligation",1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,UBC,High
"TICAM1,TRAF6-dependent Induction of TAK1 Complex",1/11,0.087624550803351825,0.21019906489009185,0,0,12.014545454545454,29.25174245169941,UBC,High
DNA Damage Telomere Stress Induced Senescence,2/60,0.0887278326738941,0.21163975952243297,0,0,4.15811606391926,10.071712447363208,H1-5;CABIN1,High
Recruitment and ATM-med Phosphorylation of Repair and Signaling Proteins at DNA Double Strand Breaks,2/60,0.0887278326738941,0.21163975952243297,0,0,4.15811606391926,10.071712447363208,KDM4B;UBC,High
Muscle Contraction,4/204,0.0903593914920991,0.21492262044165944,0,0,2.4239506172839507,5.827081105630513,SCN9A;LMOD1;MYH11;ACTG2,High
Assembly of Collagen Fibrils and Other Multimeric Structures,2/61,0.0912536221631014,0.21522562986367333,0,0,4.0874328234807775,9.785774393158777,COL4A1;COL6A3,High
DNA Double Strand Break Response,2/61,0.0912536221631014,0.21522562986367333,0,0,4.0874328234807775,9.785774393158777,KDM4B;UBC,High
"Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways",2/61,0.0912536221631014,0.21522562986367333,0,0,4.0874328234807775,9.785774393158777,UBC;BCL2L1,High
RHO GTPases Activate PKNs,2/62,0.09380038715602552,0.22061431839489803,0,0,4.019105691056911,9.511560448683708,MYH11;PPP1R12B,High
Metabolism of Carbohydrates,5/290,0.09443674165446374,0.2214923021533662,0,0,2.130216846463986,5.026939116932218,LUM;UBC;PRELP;ENO1;ALDOB,High
Josephin Domain DUBs,1/12,0.09520142108649829,0.22204874391920099,0,0,10.92176308539945,25.685370030735868,UBC,High
Suppression of Apoptosis,1/12,0.09520142108649829,0.22204874391920099,0,0,10.92176308539945,25.685370030735868,RNF213,High
NCAM Signaling for Neurite Out-Growth,2/63,0.09636761065942155,0.22414786788738383,0,0,3.953018792483007,9.24842395717149,COL4A1;COL6A3,High
Innate Immune System,14/1149,0.09682775593560244,0.22459771486990981,0,0,1.5174240667748666,3.5429144737001343,PRKCE;FPR1;MUC3A;HERC5;PSMB4;C7;FTH1;UBC;PSMB1;CCT8;S100A9;S100A8;BCL2L1;VPS35L,High
Respiratory Syncytial Virus Infection Pathway,3/133,0.09900249420005228,0.22819698541634517,0,0,2.789617744218971,6.451298547646033,HERC5;STAT2;UBC,High
Adaptive Immune System,11/854,0.09931256325781827,0.22819698541634517,0,0,1.5987525351088663,3.6922921171591967,HERC5;TUBA1C;PSMB4;RNF213;CAPZB;ZBTB16;UBC;GLMN;PSMB1;S100A9;S100A8,High
Cytochrome P450 - Arranged by Substrate Type,2/65,0.10156140032117918,0.22819698541634517,0,0,3.827138985675571,8.75301793948059,CYP2C19;CYP3A5,High
Mitochondrial Protein Import,2/65,0.10156140032117918,0.22819698541634517,0,0,3.827138985675571,8.75301793948059,HSPA9;TIMM10,High
RUNX1 Regulates Genes Involved in Megakaryocyte Differentiation and Platelet Function,2/65,0.10156140032117918,0.22819698541634517,0,0,3.827138985675571,8.75301793948059,TNRC6A;RUNX1,High
p75NTR Recruits Signalling Complexes,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,UBC,High
Apoptosis Induced DNA Fragmentation,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,H1-5,High
Diseases Associated With Visual Transduction,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,RBP4,High
Diseases of the Neuronal System,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,RBP4,High
Downregulation of ERBB2 ERBB3 Signaling,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,UBC,High
Glutathione Synthesis and Recycling,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,GGT7,High
NF-kB Is Activated and Signals Survival,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,UBC,High
Passive Transport by Aquaporins,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,AQP7,High
Retinoid Cycle Disease Events,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,RBP4,High
TICAM1-dependent Activation of IRF3 IRF7,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,UBC,High
TRAF6 Mediated IRF7 Activation in TLR7 8 or 9 Signaling,1/13,0.10271574521709599,0.22819698541634517,0,0,10.011111111111111,22.783185164726877,UBC,High
Neutrophil Degranulation,7/478,0.10390213690985547,0.23022526125815346,0,0,1.8098919734540453,4.098148918389182,FTH1;PSMB1;FPR1;CCT8;S100A9;S100A8;VPS35L,High
Extracellular Matrix Organization,5/300,0.10512627746731285,0.23232631398288037,0,0,2.0569533635119486,4.633478766226942,MFAP5;COL4A1;LUM;MMP2;COL6A3,High
G2 M Checkpoints,3/137,0.10579589477212362,0.23319409266525679,0,0,2.7057961725116746,6.077877232822685,PSMB4;UBC;PSMB1,High
Collagen Biosynthesis and Modifying Enzymes,2/67,0.10683099463534293,0.23424617824072838,0,0,3.7090056285178234,8.295217728550588,COL4A1;COL6A3,High
Complex I Biogenesis,2/68,0.10949299946313869,0.23424617824072838,0,0,3.6526237989652626,8.079219089116346,HSPA9;NDUFA1,High
Glycogen Synthesis,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,UBC,High
IRAK1 Recruits IKK Complex,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,UBC,High
IRAK1 Recruits IKK Complex Upon TLR7 8 or 9 Stimulation,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,UBC,High
Leading Strand Synthesis,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,POLD2,High
Mismatch Repair (MMR) Directed by MSH2 MSH3 (MutSbeta),1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,POLD2,High
Mismatch Repair (MMR) Directed by MSH2 MSH6 (MutSalpha),1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,POLD2,High
Polymerase Switching,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,POLD2,High
Regulation of NPAS4 Gene Expression,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,TNRC6A,High
"Regulation of TBK1, IKK? (IKBKE)-mediated Activation of IRF3, IRF7",1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,UBC,High
Removal of the Flap Intermediate,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,POLD2,High
Response to Metal Ions,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,MT2A,High
Tryptophan Catabolism,1/14,0.1101680363222428,0.23424617824072838,0,0,9.24055944055944,20.3823499020957,TDO2,High
Degradation of the Extracellular Matrix,3/140,0.11100818051749936,0.23484645225058912,0,0,2.646142134252832,5.816620989454468,COL4A1;MMP2;COL6A3,High
Interleukin-1 Family Signaling,3/140,0.11100818051749936,0.23484645225058912,0,0,2.646142134252832,5.816620989454468,PSMB4;UBC;PSMB1,High
Mitotic Anaphase,4/221,0.11240691484936044,0.23720957970717169,0,0,2.232121522444103,4.878591368912918,TUBA1C;PSMB4;UBC;PSMB1,High
Mitotic Metaphase and Anaphase,4/222,0.11377262680267035,0.23742007884697594,0,0,2.2217691697814024,4.82913376410771,TUBA1C;PSMB4;UBC;PSMB1,High
Circadian Clock,2/70,0.11486904476454028,0.23742007884697594,0,0,3.5448350071736012,7.670890168326765,HELZ2;UBC,High
Bacterial Infection Pathways,3/143,0.11631749379822612,0.23742007884697594,0,0,2.5890446976336547,5.570153123056446,RNF213;UBC;ENO1,High
YAP1- and WWTR1 (TAZ)-stimulated Gene Expression,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,TEAD1,High
Anchoring Fibril Formation,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,COL4A1,High
Constitutive Signaling by NOTCH1 HD Domain Mutants,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,UBC,High
Eicosanoid Ligand-Binding Receptors,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,OXER1,High
IRAK2 Mediated Activation of TAK1 Complex Upon TLR7 8 or 9 Stimulation,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,UBC,High
Membrane Binding and Targetting of GAG Proteins,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,UBC,High
Mismatch Repair,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,POLD2,High
Negative Regulation of FLT3,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,UBC,High
Organic Cation Anion Zwitterion Transport,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,RUNX1,High
Processive Synthesis on the Lagging Strand,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,POLD2,High
Regulation of Innate Immune Responses to Cytosolic DNA,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,UBC,High
Signaling by NOTCH1 HD Domain Mutants in Cancer,1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,UBC,High
"Synthesis And Processing Of GAG, GAGPOL Polyproteins",1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,UBC,High
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),1/15,0.11755880336673992,0.23742007884697594,0,0,8.58008658008658,18.3683919207857,AKR1C3,High
Base Excision Repair,2/71,0.1175821530631698,0.23742007884697594,0,0,3.4932838458819373,7.477786330959557,POLD2;POLE3,High
Diseases of Glycosylation,3/146,0.1217206901893467,0.24229529973372774,0,0,2.534342957655841,5.337392880646788,LUM;PRELP;MUC3A,High
Pre-NOTCH Transcription and Translation,2/73,0.12305625875071795,0.24229529973372774,0,0,3.3945379594641016,7.111942780244071,TNRC6A;RUNX1,High
G Alpha (I) Signalling Events,5/316,0.1234115803713294,0.24229529973372774,0,0,1.9495316650356493,4.0788692744728525,CXCL10;CXCL11;CXCL9;FPR1;OXER1,High
FCERI Mediated NF-kB Activation,3/147,0.12354207183794891,0.24229529973372774,0,0,2.5166155419222904,5.262679776937106,PSMB4;UBC;PSMB1,High
p75NTR Signals via NF-kB,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
Glycogen Storage Diseases,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
Heme Degradation,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UGT1A1,High
InlB-mediated Entry of Listeria Monocytogenes Into Host Cell,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
MAP3K8 (TPL2)-dependent MAPK1 3 Activation,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
NRIF Signals Cell Death From the Nucleus,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
Regulation of BACH1 Activity,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
Signaling by FLT3 ITD and TKD Mutants,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,BCL2L1,High
Spry Regulation of FGF Signaling,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
TGF-beta Receptor Signaling in EMT (Epithelial to Mesenchymal Transition),1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
TRAF6-mediated Induction of TAK1 Complex Within TLR4 Complex,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
Translesion Synthesis by REV1,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
VLDLR Internalisation and Degradation,1/16,0.12488855116916608,0.24229529973372774,0,0,8.007676767676768,16.658638477439094,UBC,High
Toll Like Receptor 4 (TLR4) Cascade,3/148,0.12537341559297588,0.24267681822824297,0,0,2.4991326422678233,5.189345642827047,UBC;S100A9;S100A8,High
Glycolysis,2/74,0.12581636227641732,0.24297563540537476,0,0,3.3472222222222223,6.938563645130339,ENO1;ALDOB,High
"Plasma Lipoprotein Assembly, Remodeling, and Clearance",2/75,0.12859124741393105,0.247200525850525,0,0,3.3012028065486136,6.771151645525317,UBC;APOC1,High
Signaling by FGFR2,2/75,0.12859124741393105,0.247200525850525,0,0,3.3012028065486136,6.771151645525317,UBC;HNRNPA1,High
Intracellular Signaling by Second Messengers,5/321,0.12941221086534377,0.2482120308624589,0,0,1.91819325418665,3.922230521231998,PSMB4;PRKCE;UBC;PSMB1;TNRC6A,High
ISG15 Antiviral Mechanism,2/76,0.1313804827220259,0.2511892802186704,0,0,3.2564271588661833,6.609432513758495,HERC5;UBC,High
Removal of the Flap Intermediate From the C-strand,1/17,0.13215778044759025,0.2511892802186704,0,0,7.506818181818182,15.191989083592048,POLD2,High
Translesion Synthesis by POLI,1/17,0.13215778044759025,0.2511892802186704,0,0,7.506818181818182,15.191989083592048,UBC,High
Translesion Synthesis by POLK,1/17,0.13215778044759025,0.2511892802186704,0,0,7.506818181818182,15.191989083592048,UBC,High
"Cell Cycle, Mitotic",7/516,0.1386351577455121,0.26077111942759645,0,0,1.6714855864872546,3.3027043514237517,TUBA1C;PSMB4;UBC;PSMB1;POLD2;POLE3;PPP1R12B,High
"Activation of IRF3, IRF7 Mediated by TBK1, IKK? (IKBKE)",1/18,0.13936698781759904,0.26077111942759645,0,0,7.06488413547237,13.922375947326568,UBC,High
Crosslinking of Collagen Fibrils,1/18,0.13936698781759904,0.26077111942759645,0,0,7.06488413547237,13.922375947326568,COL4A1,High
Prevention of Phagosomal-Lysosomal Fusion,1/18,0.13936698781759904,0.26077111942759645,0,0,7.06488413547237,13.922375947326568,UBC,High
RORA Activates Gene Expression,1/18,0.13936698781759904,0.26077111942759645,0,0,7.06488413547237,13.922375947326568,HELZ2,High
Regulation of NF-kappa B Signaling,1/18,0.13936698781759904,0.26077111942759645,0,0,7.06488413547237,13.922375947326568,UBC,High
Signaling by Cytosolic FGFR1 Fusion Mutants,1/18,0.13936698781759904,0.26077111942759645,0,0,7.06488413547237,13.922375947326568,ZMYM2,High
Signaling by MET,2/79,0.13983006557036842,0.26105746166352595,0,0,3.1290782388343366,6.155921390423331,RAB4A;UBC,High
PKR-mediated Signaling,2/80,0.1426725072251806,0.2624830482399379,0,0,3.0888055034396498,6.014532684528838,HERC5;TUBA1C,High
Post NMDA Receptor Activation Events,2/80,0.1426725072251806,0.2624830482399379,0,0,3.0888055034396498,6.014532684528838,TUBA1C;DLG1,High
Antiviral Mechanism by IFN-stimulated Genes,3/158,0.14420877905256096,0.2624830482399379,0,0,2.3367108648327726,4.525024641460409,HERC5;TUBA1C;UBC,High
Autophagy,3/158,0.14420877905256096,0.2624830482399379,0,0,2.3367108648327726,4.525024641460409,TUBA1C;UBC;RNASE1,High
Respiratory Electron Transport,3/158,0.14420877905256096,0.2624830482399379,0,0,2.3367108648327726,4.525024641460409,HSPA9;UQCC2;NDUFA1,High
Class A 1 (Rhodopsin-like Receptors),5/333,0.14434264030747518,0.2624830482399379,0,0,1.846879260718073,3.57475551972037,CXCL10;CXCL11;CXCL9;FPR1;OXER1,High
Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,TNRC6A,High
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,UBC,High
Defective GALNT12 Causes CRCS1,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,MUC3A,High
Defective GALNT3 Causes HFTC,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,MUC3A,High
Microtubule-dependent Trafficking of Connexons From Golgi to the Plasma Membrane,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,TUBA1C,High
Plasma Lipoprotein Assembly,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,APOC1,High
Processive Synthesis on the C-strand of the Telomere,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,POLD2,High
Regulation of MITF-M-dependent Genes Involved in Apoptosis,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,TNRC6A,High
Regulation of TP53 Activity Through Methylation,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,UBC,High
Signaling by FLT3 Fusion Proteins,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,ZMYM2,High
Signaling by Ligand-Responsive EGFR Variants in Cancer,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,UBC,High
"TICAM1, RIP1-mediated IKK Complex Recruitment",1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,UBC,High
Translesion Synthesis by POLH,1/19,0.14651666588215062,0.2624830482399379,0,0,6.672053872053872,12.814454064766325,UBC,High
Signaling by the B Cell Receptor (BCR),3/162,0.1519920579758676,0.2705802286752066,0,0,2.277462669290427,4.290573436167944,PSMB4;UBC;PSMB1,High
Defective C1GALT1C1 Causes TNPS,1/20,0.15360730321466595,0.2705802286752066,0,0,6.320574162679426,11.84068497759772,MUC3A,High
Formation of ATP by Chemiosmotic Coupling,1/20,0.15360730321466595,0.2705802286752066,0,0,6.320574162679426,11.84068497759772,ATP5PD,High
Lagging Strand Synthesis,1/20,0.15360730321466595,0.2705802286752066,0,0,6.320574162679426,11.84068497759772,POLD2,High
Ras Activation Upon Ca2+ Influx Through NMDA Receptor,1/20,0.15360730321466595,0.2705802286752066,0,0,6.320574162679426,11.84068497759772,DLG1,High
Sema4D Induced Cell Migration and Growth-Cone Collapse,1/20,0.15360730321466595,0.2705802286752066,0,0,6.320574162679426,11.84068497759772,MYH11,High
Signaling by PDGFR in Disease,1/20,0.15360730321466595,0.2705802286752066,0,0,6.320574162679426,11.84068497759772,GOLGA4,High
Transport of Connexons to the Plasma Membrane,1/20,0.15360730321466595,0.2705802286752066,0,0,6.320574162679426,11.84068497759772,TUBA1C,High
Protein Localization,3/164,0.15593329582348284,0.2741040398400262,0,0,2.2489425751629004,4.179270605537536,HSPA9;UBC;TIMM10,High
Glucose Metabolism,2/85,0.1570611149927494,0.27551137254978125,0,0,2.9019982368498383,5.371947794296931,ENO1;ALDOB,High
DDX58 IFIH1-mediated Induction of Interferon-Alpha Beta,2/86,0.15997142210853302,0.2777379089568245,0,0,2.8673054587688735,5.255083015037552,HERC5;UBC,High
ER Quality Control Compartment (ERQC),1/21,0.16063938439664313,0.2777379089568245,0,0,6.004242424242424,10.979317316507991,UBC,High
Negative Regulation of MET Activity,1/21,0.16063938439664313,0.2777379089568245,0,0,6.004242424242424,10.979317316507991,UBC,High
Negative Regulation of NMDA Receptor-Mediated Neuronal Transmission,1/21,0.16063938439664313,0.2777379089568245,0,0,6.004242424242424,10.979317316507991,DLG1,High
Regulation of FZD by Ubiquitination,1/21,0.16063938439664313,0.2777379089568245,0,0,6.004242424242424,10.979317316507991,UBC,High
Synaptic Adhesion-Like Molecules,1/21,0.16063938439664313,0.2777379089568245,0,0,6.004242424242424,10.979317316507991,DLG1,High
"Unblocking of NMDA Receptors, Glutamate Binding and Activation",1/21,0.16063938439664313,0.2777379089568245,0,0,6.004242424242424,10.979317316507991,DLG1,High
Regulation of PLK1 Activity at G2 M Transition,2/87,0.16289171860984275,0.28105497350304837,0,0,2.833428981348637,5.141737441679395,UBC;PPP1R12B,High
Defects in Vitamin and Cofactor Metabolism,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,ACACA,High
Deregulated CDK5 Triggers Multiple Neurodegenerative Pathways in Alzheimer's Disease Models,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,SOD2,High
JNK (c-Jun Kinases) Phosphorylation and Activation Mediated by Activated Human TAK1,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,UBC,High
Listeria Monocytogenes Entry Into Host Cells,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,UBC,High
Neurodegenerative Diseases,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,SOD2,High
Post-chaperonin Tubulin Folding Pathway,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,TUBA1C,High
RA Biosynthesis Pathway,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,AKR1C3,High
Regulation of Signaling by CBL,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,UBC,High
SHC1 Events in ERBB2 Signaling,1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,PRKCE,High
The Canonical Retinoid Cycle in Rods (Twilight Vision),1/22,0.16761339007915518,0.2833945270013025,0,0,5.7180375180375185,10.212959370400487,RBP4,High
Pre-NOTCH Expression and Processing,2/89,0.16876083256325206,0.28419324203651647,0,0,2.768012335295767,4.925048942892013,TNRC6A;RUNX1,High
Selective Autophagy,2/89,0.16876083256325206,0.28419324203651647,0,0,2.768012335295767,4.925048942892013,TUBA1C;UBC,High
Collagen Formation,2/90,0.17170893948508598,0.28858069270746983,0,0,2.736419068736142,4.821445749404792,COL4A1;COL6A3,High
Activated TAK1 Mediates P38 MAPK Activation,1/23,0.17452979701770077,0.289504817915785,0,0,5.457851239669422,9.527551478192855,UBC,High
BBSome-mediated Cargo-Targeting to Cilium,1/23,0.17452979701770077,0.289504817915785,0,0,5.457851239669422,9.527551478192855,CCT8,High
IKK Complex Recruitment Mediated by RIP1,1/23,0.17452979701770077,0.289504817915785,0,0,5.457851239669422,9.527551478192855,UBC,High
Long-term Potentiation,1/23,0.17452979701770077,0.289504817915785,0,0,5.457851239669422,9.527551478192855,DLG1,High
Suppression of Phagosomal Maturation,1/23,0.17452979701770077,0.289504817915785,0,0,5.457851239669422,9.527551478192855,UBC,High
Chaperonin-mediated Protein Folding,2/91,0.17466561460952348,0.289504817915785,0,0,2.7055357632228008,4.72084040083976,TUBA1C;CCT8,High
Signaling by FGFR,2/91,0.17466561460952348,0.289504817915785,0,0,2.7055357632228008,4.72084040083976,UBC;HNRNPA1,High
Toll-like Receptor Cascades,3/174,0.176097808026349,0.2913052148490881,0,0,2.1163491550963296,3.675496827365201,UBC;S100A9;S100A8,High
EPH-Ephrin Signaling,2/92,0.17763051556232484,0.29326449824211276,0,0,2.6753387533875337,4.623118173211031,MMP2;MYH11,High
Activation of NMDA Receptors and Postsynaptic Events,2/93,0.18060330493553856,0.2948447947497921,0,0,2.645805414098097,4.528169862943641,TUBA1C;DLG1,High
Signaling by ALK Fusions and Activated Point Mutants,2/93,0.18060330493553856,0.2948447947497921,0,0,2.645805414098097,4.528169862943641,RNF213;UBC,High
Signaling by ALK in Cancer,2/93,0.18060330493553856,0.2948447947497921,0,0,2.645805414098097,4.528169862943641,RNF213;UBC,High
APC C Cdc20 Mediated Degradation of Cyclin B,1/24,0.1813890780052165,0.2948447947497921,0,0,5.220289855072464,8.911613987167629,UBC,High
Assembly Of The HIV Virion,1/24,0.1813890780052165,0.2948447947497921,0,0,5.220289855072464,8.911613987167629,UBC,High
Cytosolic tRNA Aminoacylation,1/24,0.1813890780052165,0.2948447947497921,0,0,5.220289855072464,8.911613987167629,PPA1,High
Other Interleukin Signaling,1/24,0.1813890780052165,0.2948447947497921,0,0,5.220289855072464,8.911613987167629,STX3,High
Sema4D in Semaphorin Signaling,1/24,0.1813890780052165,0.2948447947497921,0,0,5.220289855072464,8.911613987167629,MYH11,High
MITF-M-dependent Gene Expression,2/94,0.18358365031126736,0.297264295311706,0,0,2.616914103923648,4.435891465321197,SS18L1;TNRC6A,High
Oxidative Stress Induced Senescence,2/94,0.18358365031126736,0.297264295311706,0,0,2.616914103923648,4.435891465321197,UBC;TNRC6A,High
Antimicrobial Peptides,2/95,0.18657122421462904,0.29954142365846864,0,0,2.5886441122475743,4.346183875855971,S100A9;S100A8,High
Defective Intrinsic Pathway for Apoptosis,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,SOD2,High
Glycogen Metabolism,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,UBC,High
Inactivation of CSF3 (G-CSF) Signaling,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,UBC,High
Inflammasomes,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,BCL2L1,High
NOTCH2 Activation and Transmission of Signal to the Nucleus,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,UBC,High
NOTCH3 Activation and Transmission of Signal to the Nucleus,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,UBC,High
Regulation of IFNA IFNB Signaling,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,STAT2,High
Signaling by EGFR in Cancer,1/25,0.18819170203720892,0.29954142365846864,0,0,5.002525252525253,8.355688634491692,UBC,High
Protein Folding,2/97,0.19256677165144387,0.3059268334538033,0,0,2.5338896020539154,4.174107558163646,TUBA1C;CCT8,High
APC-Cdc20 Mediated Degradation of Nek2A,1/26,0.19493813427133033,0.30622744226951515,0,0,4.802181818181818,7.8519179804021215,UBC,High
Calnexin Calreticulin Cycle,1/26,0.19493813427133033,0.30622744226951515,0,0,4.802181818181818,7.8519179804021215,UBC,High
Downregulation of TGF-beta Receptor Signaling,1/26,0.19493813427133033,0.30622744226951515,0,0,4.802181818181818,7.8519179804021215,UBC,High
Interleukin-20 Family Signaling,1/26,0.19493813427133033,0.30622744226951515,0,0,4.802181818181818,7.8519179804021215,STAT2,High
Polymerase Switching on the C-strand of the Telomere,1/26,0.19493813427133033,0.30622744226951515,0,0,4.802181818181818,7.8519179804021215,POLD2,High
Termination of O-glycan Biosynthesis,1/26,0.19493813427133033,0.30622744226951515,0,0,4.802181818181818,7.8519179804021215,MUC3A,High
Signaling by Rho GTPases,8/672,0.1963249680716971,0.30783170040292174,0,0,1.461796553301815,2.3797813888492927,TUBA1C;FARP1;CAPZB;MRTFA;MYH11;PPP1R12B;S100A9;S100A8,High
Interferon Gamma Signaling,2/99,0.19858742327619167,0.31080039107537805,0,0,2.4813930098063866,4.011235959953636,MT2A;GBP1,High
Cholesterol Biosynthesis,1/27,0.2016288360937524,0.314391629612851,0,0,4.617249417249417,7.393724850129072,SC5D,High
Effects of PIP2 Hydrolysis,1/27,0.2016288360937524,0.314391629612851,0,0,4.617249417249417,7.393724850129072,PRKCE,High
COPI-mediated Anterograde Transport,2/101,0.2046307300154978,0.31848257795388013,0,0,2.4310174919931016,3.8569265261597705,TUBA1C;CAPZB,High
PIP3 Activates AKT Signaling,4/281,0.20568580519096322,0.3188336566919348,0,0,1.7432811873245087,2.756834443805768,PSMB4;UBC;PSMB1;TNRC6A,High
TCF Dependent Signaling in Response to WNT,3/189,0.207581204902502,0.3188336566919348,0,0,1.9441915693647338,3.0567214961459057,PSMB4;UBC;PSMB1,High
Activation of AMPK Downstream of NMDARs,1/28,0.2082642650600524,0.3188336566919348,0,0,4.446015712682379,6.975565240010467,TUBA1C,High
"BMAL1 CLOCK,NPAS2 Activates Circadian Gene Expression",1/28,0.2082642650600524,0.3188336566919348,0,0,4.446015712682379,6.975565240010467,HELZ2,High
CREB1 Phosphorylation Through NMDA Receptor-Mediated Activation of RAS Signaling,1/28,0.2082642650600524,0.3188336566919348,0,0,4.446015712682379,6.975565240010467,DLG1,High
FGFR2 Alternative Splicing,1/28,0.2082642650600524,0.3188336566919348,0,0,4.446015712682379,6.975565240010467,HNRNPA1,High
Metabolism of Porphyrins,1/28,0.2082642650600524,0.3188336566919348,0,0,4.446015712682379,6.975565240010467,UGT1A1,High
Regulation of PTEN mRNA Translation,1/28,0.2082642650600524,0.3188336566919348,0,0,4.446015712682379,6.975565240010467,TNRC6A,High
TGFBR3 Expression,1/28,0.2082642650600524,0.3188336566919348,0,0,4.446015712682379,6.975565240010467,TNRC6A,High
Ub-specific Processing Proteases,3/190,0.20972497339658006,0.3204871644281677,0,0,1.9336964010367115,3.0203530603216224,PSMB4;UBC;PSMB1,High
Processing of Capped Intron-Containing Pre-mRNA,4/285,0.21258137405365138,0.3242636176687943,0,0,1.7181143183515664,2.6603804879369455,THOC2;PRPF19;HNRNPA1;PRPF8,High
"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",8/688,0.2135033178035996,0.32477447897777545,0,0,1.4262099776619508,2.202214971602431,TUBA1C;FARP1;CAPZB;MRTFA;MYH11;PPP1R12B;S100A9;S100A8,High
Downregulation of ERBB2 Signaling,1/29,0.21484487504824337,0.32477447897777545,0,0,4.287012987012987,6.59273586213286,UBC,High
EGR2 and SOX10-mediated Initiation of Schwann Cell Myelination,1/29,0.21484487504824337,0.32477447897777545,0,0,4.287012987012987,6.59273586213286,TEAD1,High
EPHA-mediated Growth Cone Collapse,1/29,0.21484487504824337,0.32477447897777545,0,0,4.287012987012987,6.59273586213286,MYH11,High
Negative Regulation of FGFR3 Signaling,1/29,0.21484487504824337,0.32477447897777545,0,0,4.287012987012987,6.59273586213286,UBC,High
Signaling by WNT,4/287,0.21605360849123156,0.32601637697063973,0,0,1.7057976704619815,2.6136721720341867,PSMB4;UBC;PSMB1;TNRC6A,High
Phase I - Functionalization of Compounds,2/105,0.21677587696770784,0.3265210883842755,0,0,2.336135448733128,3.5716971262941293,CYP2C19;CYP3A5,High
Activation of Kainate Receptors Upon Glutamate Binding,1/30,0.22137111624035788,0.32990173429094044,0,0,4.138975966562174,6.24122281400424,DLG1,High
Dectin-2 Family,1/30,0.22137111624035788,0.32990173429094044,0,0,4.138975966562174,6.24122281400424,MUC3A,High
Laminin Interactions,1/30,0.22137111624035788,0.32990173429094044,0,0,4.138975966562174,6.24122281400424,COL4A1,High
Regulation of CDH11 Expression and Function,1/30,0.22137111624035788,0.32990173429094044,0,0,4.138975966562174,6.24122281400424,TNRC6A,High
Signaling by CSF3 (G-CSF),1/30,0.22137111624035788,0.32990173429094044,0,0,4.138975966562174,6.24122281400424,UBC,High
Synthesis of Active Ubiquitin Roles of E1 and E2 Enzymes,1/30,0.22137111624035788,0.32990173429094044,0,0,4.138975966562174,6.24122281400424,UBC,High
Fc Epsilon Receptor (FCERI) Signaling,3/197,0.22486468106548171,0.33019651008536927,0,0,1.8632597558661692,2.7804614356494453,PSMB4;UBC;PSMB1,High
Activated NOTCH1 Transmits Signal to the Nucleus,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,UBC,High
Downregulation of SMAD2 3 SMAD4 Transcriptional Activity,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,UBC,High
EGFR Downregulation,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,UBC,High
Endosomal Sorting Complex Required For Transport (ESCRT),1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,UBC,High
FGFR1 Mutant Receptor Activation,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,ZMYM2,High
"FOXO-mediated Transcription of Oxidative Stress, Metabolic and Neuronal Genes",1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,SOD2,High
"Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity",1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,DLG1,High
Interaction Between L1 and Ankyrins,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,SCN9A,High
Metalloprotease DUBs,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,UBC,High
Negative Regulation of FGFR4 Signaling,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,UBC,High
RHO GTPases Activate IQGAPs,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,TUBA1C,High
Sealing of the Nuclear Envelope (NE) by ESCRT-III,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,TUBA1C,High
Signaling by CSF1 (M-CSF) in Myeloid Cells,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,UBC,High
Trafficking of AMPA Receptors,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,DLG1,High
Transferrin Endocytosis and Recycling,1/31,0.22784343510641275,0.33019651008536927,0,0,4.00080808080808,5.917581525697768,STEAP4,High
Post-translational Protein Modification,15/1457,0.2289186231303045,0.33118467470054364,0,0,1.2670040690358313,1.8680564772889046,RAB4A;CMAS;IGFBP5;ZBTB16;MRTFA;COMMD6;MUC3A;PSMB9;TUBA1C;PSMB4;EID3;CAPZB;UBD;UBC;PSMB1,High
DNA Strand Elongation,1/32,0.2342622744888858,0.3360286799312468,0,0,3.8715542521994135,5.6188407336471915,POLD2,High
PINK1-PRKN Mediated Mitophagy,1/32,0.2342622744888858,0.3360286799312468,0,0,3.8715542521994135,5.6188407336471915,UBC,High
Phase 0 - Rapid Depolarisation,1/32,0.2342622744888858,0.3360286799312468,0,0,3.8715542521994135,5.6188407336471915,SCN9A,High
Regulation of MECP2 Expression and Activity,1/32,0.2342622744888858,0.3360286799312468,0,0,3.8715542521994135,5.6188407336471915,TNRC6A,High
Regulation of Necroptotic Cell Death,1/32,0.2342622744888858,0.3360286799312468,0,0,3.8715542521994135,5.6188407336471915,UBC,High
Interleukin-4 and Interleukin-13 Signaling,2/112,0.2381712405425084,0.33937828809768933,0,0,2.1866962305986695,3.1373960175110254,MMP2;BCL2L1,High
mRNA Splicing - Major Pathway,3/204,0.24021146952689523,0.33937828809768933,0,0,1.7977291456826299,2.563985343713817,PRPF19;HNRNPA1;PRPF8,High
Intra-Golgi and Retrograde Golgi-to-ER Traffic,3/204,0.24021146952689523,0.33937828809768933,0,0,1.7977291456826299,2.563985343713817,TUBA1C;GOLGA4;CAPZB,High
Activation of Matrix Metalloproteinases,1/33,0.24062807362745908,0.33937828809768933,0,0,3.750378787878788,5.342425086287716,MMP2,High
Activation of the Pre-Replicative Complex,1/33,0.24062807362745908,0.33937828809768933,0,0,3.750378787878788,5.342425086287716,POLE3,High
Negative Regulation of FGFR1 Signaling,1/33,0.24062807362745908,0.33937828809768933,0,0,3.750378787878788,5.342425086287716,UBC,High
Regulation of Expression and Function of Type II Classical Cadherins,1/33,0.24062807362745908,0.33937828809768933,0,0,3.750378787878788,5.342425086287716,TNRC6A,High
Regulation of Homotypic Cell-Cell Adhesion,1/33,0.24062807362745908,0.33937828809768933,0,0,3.750378787878788,5.342425086287716,TNRC6A,High
Sialic Acid Metabolism,1/33,0.24062807362745908,0.33937828809768933,0,0,3.750378787878788,5.342425086287716,CMAS,High
TNFR1-induced NF-kappa-B Signaling Pathway,1/33,0.24062807362745908,0.33937828809768933,0,0,3.750378787878788,5.342425086287716,UBC,High
Citric Acid Cycle (TCA Cycle),1/34,0.2469412681410595,0.34538961424380743,0,0,3.6365472910927457,5.0860923201364825,FH,High
Metabolic Disorders of Biological Oxidation Enzymes,1/34,0.2469412681410595,0.34538961424380743,0,0,3.6365472910927457,5.0860923201364825,UGT1A1,High
Negative Regulation of FGFR2 Signaling,1/34,0.2469412681410595,0.34538961424380743,0,0,3.6365472910927457,5.0860923201364825,UBC,High
RIPK1-mediated Regulated Necrosis,1/34,0.2469412681410595,0.34538961424380743,0,0,3.6365472910927457,5.0860923201364825,UBC,High
Telomere C-strand (Lagging Strand) Synthesis,1/34,0.2469412681410595,0.34538961424380743,0,0,3.6365472910927457,5.0860923201364825,POLD2,High
Asparagine N-linked Glycosylation,4/306,0.24976006599965897,0.3487528616446316,0,0,1.5969258441664622,2.215342656048408,TUBA1C;CMAS;CAPZB;UBC,High
N-glycan Trimming in the ER and Calnexin Calreticulin Cycle,1/35,0.25320229017902113,0.35180912265797987,0,0,3.5294117647058822,4.847881919337103,UBC,High
Transcriptional Regulation by NPAS4,1/35,0.25320229017902113,0.35180912265797987,0,0,3.5294117647058822,4.847881919337103,TNRC6A,High
Translation of Structural Proteins 9683701,1/35,0.25320229017902113,0.35180912265797987,0,0,3.5294117647058822,4.847881919337103,UBC,High
Budding and Maturation of HIV Virion,1/36,0.25941156821878103,0.35748697289724,0,0,3.4283982683982686,4.626072903688683,UBC,High
Detoxification of Reactive Oxygen Species,1/36,0.25941156821878103,0.35748697289724,0,0,3.4283982683982686,4.626072903688683,SOD2,High
Regulation of TP53 Degradation,1/36,0.25941156821878103,0.35748697289724,0,0,3.4283982683982686,4.626072903688683,UBC,High
SMAD2 SMAD3 SMAD4 Heterotrimer Regulates Transcription,1/36,0.25941156821878103,0.35748697289724,0,0,3.4283982683982686,4.626072903688683,UBC,High
Signaling by NOTCH2,1/36,0.25941156821878103,0.35748697289724,0,0,3.4283982683982686,4.626072903688683,UBC,High
Gastrulation,2/120,0.26274586339738165,0.36007977783420353,0,0,2.0376188507647788,2.723416178294795,PSMB4;PSMB1,High
mRNA Splicing,3/215,0.26466065409822476,0.36007977783420353,0,0,1.7034957749739552,2.2644685586247317,PRPF19;HNRNPA1;PRPF8,High
Fatty acyl-CoA Biosynthesis,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,ACACA,High
Gap Junction Assembly,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,TUBA1C,High
Glutathione Conjugation,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,GGT7,High
Molecules Associated With Elastic Fibres,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,MFAP5,High
NOD1 2 Signaling Pathway,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,UBC,High
RUNX1 Interacts With Co-Factors Whose Precise Effect on RUNX1 Targets Is Not Known,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,RUNX1,High
Regulation of TP53 Expression and Degradation,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,UBC,High
Sphingolipid De Novo Biosynthesis,1/37,0.26556952735753014,0.36007977783420353,0,0,3.332996632996633,4.419148907217865,CERS2,High
Binding and Uptake of Ligands by Scavenger Receptors,2/122,0.26889660506775415,0.36400472904670256,0,0,2.0034552845528455,2.631394950750871,COL4A1;FTH1,High
Cooperation of PDCL (PhLP1) and TRiC CCT in G-protein Beta Folding,1/38,0.27167658917265325,0.3648352282031484,0,0,3.2427518427518427,4.225769139294853,CCT8,High
DNA Damage Recognition in GG-NER,1/38,0.27167658917265325,0.3648352282031484,0,0,3.2427518427518427,4.225769139294853,UBC,High
FLT3 Signaling,1/38,0.27167658917265325,0.3648352282031484,0,0,3.2427518427518427,4.225769139294853,UBC,High
Fanconi Anemia Pathway,1/38,0.27167658917265325,0.3648352282031484,0,0,3.2427518427518427,4.225769139294853,UBC,High
Signaling by FGFR1 in Disease,1/38,0.27167658917265325,0.3648352282031484,0,0,3.2427518427518427,4.225769139294853,ZMYM2,High
Membrane Trafficking,7/633,0.2734396853377248,0.36661817683815967,0,0,1.3508549842264954,1.7516188199961202,TUBA1C;GOLGA4;RAB4A;CAPZB;TBC1D4;FTH1;UBC,High
Regulation of IGF Transport and Uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),2/124,0.2750466853546344,0.368186500903978,0,0,1.9704118352658937,2.5434360315764994,IGFBP5;MMP2,High
Association of TriC CCT With Target Proteins During Biosynthesis,1/39,0.2777331718645593,0.3694333818482764,0,0,3.15725677830941,4.0447441032211655,CCT8,High
Mitophagy,1/39,0.2777331718645593,0.3694333818482764,0,0,3.15725677830941,4.0447441032211655,UBC,High
Ovarian Tumor Domain Proteases,1/39,0.2777331718645593,0.3694333818482764,0,0,3.15725677830941,4.0447441032211655,UBC,High
Synthesis of PA,1/39,0.2777331718645593,0.3694333818482764,0,0,3.15725677830941,4.0447441032211655,GPD1,High
MHC Class II Antigen Presentation,2/126,0.28119445483832534,0.37344752519537844,0,0,1.9384343036978757,2.459308734682276,TUBA1C;CAPZB,High
Signaling by FGFR3,1/40,0.283739690105335,0.37623436073809774,0,0,3.076146076146076,3.8750151991082595,UBC,High
Glycosaminoglycan Metabolism,2/127,0.2842669724222111,0.3763408660055059,0,0,1.9228292682926829,2.418614333098294,LUM;PRELP,High
Signaling by Receptor Tyrosine Kinases,6/536,0.28664111197298514,0.37888825161892226,0,0,1.3658490566037735,1.706661622767335,RAB4A;COL4A1;PRKCE;UBC;COL6A3;HNRNPA1,High
Vesicle-mediated Transport,8/752,0.2873052952340061,0.37917093822418985,0,0,1.2991697291411461,1.6203373247618806,TUBA1C;GOLGA4;RAB4A;CAPZB;TBC1D4;COL4A1;FTH1;UBC,High
DAG and IP3 Signaling,1/41,0.2896965552786852,0.3793538095562254,0,0,2.999090909090909,3.7156375027236566,PRKCE,High
"Sensory Perception of Sweet, Bitter, and Umami (Glutamate) Taste",1/41,0.2896965552786852,0.3793538095562254,0,0,2.999090909090909,3.7156375027236566,SCN9A,High
Signaling by FGFR4,1/41,0.2896965552786852,0.3793538095562254,0,0,2.999090909090909,3.7156375027236566,UBC,High
Signaling by Retinoic Acid,1/41,0.2896965552786852,0.3793538095562254,0,0,2.999090909090909,3.7156375027236566,AKR1C3,High
Transcriptional Regulation by VENTX,1/41,0.2896965552786852,0.3793538095562254,0,0,2.999090909090909,3.7156375027236566,TNRC6A,High
HIV Infection,3/227,0.29166039823064,0.38133238402204794,0,0,1.6112510955302366,1.9853274853606717,PSMB4;UBC;PSMB1,High
Cell Cycle,7/649,0.29423572208261495,0.38410295628980895,0,0,1.3160916162150513,1.6100723400479298,TUBA1C;PSMB4;UBC;PSMB1;POLD2;POLE3;PPP1R12B,High
tRNA Aminoacylation,1/42,0.29560417538693134,0.38410295628980895,0,0,2.9257945306725794,3.5657651687993317,PPA1,High
Deactivation of the Beta-Catenin Transactivating Complex,1/42,0.29560417538693134,0.38410295628980895,0,0,2.9257945306725794,3.5657651687993317,UBC,High
Regulation of MITF-M-dependent Genes Involved in Pigmentation,1/42,0.29560417538693134,0.38410295628980895,0,0,2.9257945306725794,3.5657651687993317,SS18L1,High
Formation of Incision Complex in GG-NER,1/43,0.3014629550579916,0.39051047409050604,0,0,2.855988455988456,3.4246390029225693,UBC,High
Negative Regulation of MAPK Pathway,1/43,0.3014629550579916,0.39051047409050604,0,0,2.855988455988456,3.4246390029225693,UBC,High
Elastic Fibre Formation,1/44,0.3072732956921061,0.39681612725882415,0,0,2.789429175475687,3.291575837390745,MFAP5,High
SUMOylation of Transcription Cofactors,1/44,0.3072732956921061,0.39681612725882415,0,0,2.789429175475687,3.291575837390745,MRTFA,High
Golgi-to-ER Retrograde Transport,2/135,0.3087892677311914,0.39816319055078586,0,0,1.8064368237667339,2.122737076398149,TUBA1C;CAPZB,High
MITF-M-regulated Melanocyte Development,2/136,0.3118446212481897,0.4011810825022047,0,0,1.792864943574809,2.089136277174256,SS18L1;TNRC6A,High
Carboxyterminal Post-Translational Modifications of Tubulin,1/45,0.3130355952540956,0.4011810825022047,0,0,2.7258953168044076,3.1659594191318527,TUBA1C,High
TAK1-dependent IKK and NF-kappa-B Activation,1/45,0.3130355952540956,0.4011810825022047,0,0,2.7258953168044076,3.1659594191318527,UBC,High
TBC RABGAPs,1/45,0.3130355952540956,0.4011810825022047,0,0,2.7258953168044076,3.1659594191318527,RAB4A,High
SARS-CoV-2 Activates Modulates Innate and Adaptive Immune Responses,2/138,0.3179468246403999,0.4068559670930345,0,0,1.7663199426111909,2.0239750255723483,STAT2;UBC,High
M-decay Degradation of Maternal mRNAs by Maternally Stored Factors,1/46,0.31875024868156443,0.40726511288297,0,0,2.665185185185185,3.0472325582161406,KDM4B,High
RHO GTPases Activate Formins,2/139,0.32099335007375895,0.40950969812440163,0,0,1.7533380808260637,1.9923792042580761,TUBA1C;MRTFA,High
Cyclin D Associated Events in G1,1/47,0.3244176475329849,0.4107664048462756,0,0,2.607114624505929,2.9348903503973744,UBC,High
G1 Phase,1/47,0.3244176475329849,0.4107664048462756,0,0,2.607114624505929,2.9348903503973744,UBC,High
Heme Signaling,1/47,0.3244176475329849,0.4107664048462756,0,0,2.607114624505929,2.9348903503973744,HELZ2,High
Sensory Perception of Taste,1/47,0.3244176475329849,0.4107664048462756,0,0,2.607114624505929,2.9348903503973744,SCN9A,High
TGF-beta Receptor Signaling Activates SMADs,1/47,0.3244176475329849,0.4107664048462756,0,0,2.607114624505929,2.9348903503973744,UBC,High
G Alpha (Z) Signalling Events,1/48,0.3300381801688704,0.41476439955550576,0,0,2.5515151515151517,2.8284742975844512,PRKCE,High
Gap Junction Trafficking,1/48,0.3300381801688704,0.41476439955550576,0,0,2.5515151515151517,2.8284742975844512,TUBA1C,High
"Interleukin-3, Interleukin-5 and GM-CSF Signaling",1/48,0.3300381801688704,0.41476439955550576,0,0,2.5515151515151517,2.8284742975844512,UBC,High
NOTCH1 Intracellular Domain Regulates Transcription,1/48,0.3300381801688704,0.41476439955550576,0,0,2.5515151515151517,2.8284742975844512,UBC,High
Recycling Pathway of L1,1/48,0.3300381801688704,0.41476439955550576,0,0,2.5515151515151517,2.8284742975844512,TUBA1C,High
Macroautophagy,2/143,0.33314529068831744,0.4180452082854893,0,0,1.7032520325203253,1.872174736801448,TUBA1C;UBC,High
Retrograde Transport at the Trans-Golgi-Network,1/49,0.3356122319023523,0.41926631937949643,0,0,2.4982323232323234,2.727567195504404,GOLGA4,High
Signaling by NOTCH3,1/49,0.3356122319023523,0.41926631937949643,0,0,2.4982323232323234,2.727567195504404,UBC,High
Signaling by TGFBR3,1/49,0.3356122319023523,0.41926631937949643,0,0,2.4982323232323234,2.727567195504404,TNRC6A,High
Regulation of TNFR1 Signaling,1/50,0.34114018472714763,0.42554079339297524,0,0,2.4471243042671613,2.6317886779390967,UBC,High
GPCR Ligand Binding,5/467,0.34655288027247866,0.4285698614525857,0,0,1.3021967680352773,1.379963775903937,CXCL10;CXCL11;CXCL9;FPR1;OXER1,High
Cargo Trafficking to the Periciliary Membrane,1/51,0.34662241763564233,0.4285698614525857,0,0,2.3980606060606062,2.5407913150697836,CCT8,High
EPH-ephrin Mediated Repulsion of Cells,1/51,0.34662241763564233,0.4285698614525857,0,0,2.3980606060606062,2.5407913150697836,MMP2,High
Extension of Telomeres,1/51,0.34662241763564233,0.4285698614525857,0,0,2.3980606060606062,2.5407913150697836,POLD2,High
Gap Junction Trafficking and Regulation,1/51,0.34662241763564233,0.4285698614525857,0,0,2.3980606060606062,2.5407913150697836,TUBA1C,High
Transcriptional Activity of SMAD2 SMAD3 SMAD4 Heterotrimer,1/51,0.34662241763564233,0.4285698614525857,0,0,2.3980606060606062,2.5407913150697836,UBC,High
Apoptotic Execution Phase,1/52,0.3520593064661331,0.4333829474334562,0,0,2.350920974450386,2.4542571947138705,H1-5,High
Aquaporin-mediated Transport,1/52,0.3520593064661331,0.4333829474334562,0,0,2.350920974450386,2.4542571947138705,AQP7,High
Signaling by FGFR1,1/52,0.3520593064661331,0.4333829474334562,0,0,2.350920974450386,2.4542571947138705,UBC,High
mRNA Splicing - Minor Pathway,1/53,0.35745122403485163,0.43682718525013803,0,0,2.3055944055944058,2.371894913920962,PRPF8,High
Intraflagellar Transport,1/53,0.35745122403485163,0.43682718525013803,0,0,2.3055944055944058,2.371894913920962,TUBA1C,High
RHOD GTPase Cycle,1/53,0.35745122403485163,0.43682718525013803,0,0,2.3055944055944058,2.371894913920962,CAPZB,High
Signaling by EGFR,1/53,0.35745122403485163,0.43682718525013803,0,0,2.3055944055944058,2.371894913920962,UBC,High
Synthesis of PIPs at the Plasma Membrane,1/53,0.35745122403485163,0.43682718525013803,0,0,2.3055944055944058,2.371894913920962,RAB4A,High
snRNP Assembly,1/54,0.36279854007800766,0.4420786841471526,0,0,2.261978273299028,2.293436927928128,GEMIN4,High
Metabolism of Non-Coding RNA,1/54,0.36279854007800766,0.4420786841471526,0,0,2.261978273299028,2.293436927928128,GEMIN4,High
Intrinsic Pathway for Apoptosis,1/55,0.36810162135550845,0.4459590865918534,0,0,2.2199775533108865,2.2186372062244897,BCL2L1,High
Ion Transport by P-type ATPases,1/55,0.36810162135550845,0.4459590865918534,0,0,2.2199775533108865,2.2186372062244897,CUTC,High
Signaling by Non-Receptor Tyrosine Kinases,1/55,0.36810162135550845,0.4459590865918534,0,0,2.2199775533108865,2.2186372062244897,UBC,High
Signaling by PTK6,1/55,0.36810162135550845,0.4459590865918534,0,0,2.2199775533108865,2.2186372062244897,UBC,High
Cell Cycle Checkpoints,3/261,0.3686986687522035,0.4460002341444665,0,0,1.3964902268511914,1.393383852207644,PSMB4;UBC;PSMB1,High
ER to Golgi Anterograde Transport,2/155,0.3691949681694693,0.4460002341444665,0,0,1.568707157659812,1.5631075091493556,TUBA1C;CAPZB,High
M Phase,4/372,0.37262722830232115,0.44950161351082296,0,0,1.3060923242082663,1.289343971879014,TUBA1C;PSMB4;UBC;PSMB1,High
Golgi Associated Vesicle Biogenesis,1/56,0.3733608314752076,0.44974223190575796,0,0,2.179504132231405,2.147269157873668,FTH1,High
Factors Involved in Megakaryocyte Development and Platelet Production,2/158,0.3780935282498392,0.45472387931016167,0,0,1.5383051907442151,1.4961766798178382,TUBA1C;CAPZB,High
E3 Ubiquitin Ligases Ubiquitinate Target Proteins,1/57,0.37857653134967145,0.45472387931016167,0,0,2.1404761904761904,2.0791237858807836,UBC,High
mRNA 3'-End Processing,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,THOC2,High
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,UBC,High
Constitutive Signaling by NOTCH1 PEST Domain Mutants,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,UBC,High
Signaling by ERBB4,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,UBC,High
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,UBC,High
Signaling by NOTCH1 PEST Domain Mutants in Cancer,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,UBC,High
Signaling by NOTCH1 in Cancer,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,UBC,High
Transcriptional Regulation of Granulopoiesis,1/58,0.3837490786466901,0.45573585926729626,0,0,2.102817650186071,2.0140080507306575,RUNX1,High
Deubiquitination,3/268,0.384459090151879,0.45593599141955227,0,0,1.3591156383840721,1.299202957688399,PSMB4;UBC;PSMB1,High
Signaling by TGFB Family Members,2/161,0.38694018311430445,0.4579524104178937,0,0,1.509050467863169,1.4328210302012079,UBC;TNRC6A,High
Adherens Junctions Interactions,1/59,0.3888788283239834,0.4579524104178937,0,0,2.066457680250784,1.951743405292569,TNRC6A,High
Cytoprotection by HMOX1,1/59,0.3888788283239834,0.4579524104178937,0,0,2.066457680250784,1.951743405292569,HELZ2,High
Non-integrin membrane-ECM Interactions,1/59,0.3888788283239834,0.4579524104178937,0,0,2.066457680250784,1.951743405292569,COL4A1,High
TNF Signaling,1/59,0.3888788283239834,0.4579524104178937,0,0,2.066457680250784,1.951743405292569,UBC,High
Regulated Necrosis,1/61,0.3990113397472151,0.46922841908820545,0,0,1.9973737373737375,1.8351179648112526,UBC,High
Kinesins,1/62,0.4040147968820767,0.47444973357699943,0,0,1.9645305514157974,1.780461456316442,TUBA1C,High
Ca2+ Pathway,1/63,0.4089768470915394,0.4762911552573668,0,0,1.9327468230694038,1.7280626204540348,TNRC6A,High
MAP Kinase Activation,1/63,0.4089768470915394,0.4762911552573668,0,0,1.9327468230694038,1.7280626204540348,UBC,High
Peroxisomal Protein Import,1/63,0.4089768470915394,0.4762911552573668,0,0,1.9327468230694038,1.7280626204540348,UBC,High
Signaling by FGFR in Disease,1/63,0.4089768470915394,0.4762911552573668,0,0,1.9327468230694038,1.7280626204540348,ZMYM2,High
Transcriptional Regulation by MECP2,1/63,0.4089768470915394,0.4762911552573668,0,0,1.9327468230694038,1.7280626204540348,TNRC6A,High
Translation of Structural Proteins 9694635,1/63,0.4089768470915394,0.4762911552573668,0,0,1.9327468230694038,1.7280626204540348,UBC,High
SUMO E3 Ligases SUMOylate Target Proteins,2/170,0.4131409486465741,0.4793699776078206,0,0,1.427555168408827,1.2619108947087072,EID3;MRTFA,High
Cytosolic Sensors of Pathogen-Associated DNA,1/64,0.4138978310224294,0.4793699776078206,0,0,1.9019721019721019,1.6777982914911853,UBC,High
Semaphorin Interactions,1/64,0.4138978310224294,0.4793699776078206,0,0,1.9019721019721019,1.6777982914911853,MYH11,High
Synthesis of Substrates in N-glycan Biosythesis,1/64,0.4138978310224294,0.4793699776078206,0,0,1.9019721019721019,1.6777982914911853,CMAS,High
O-linked Glycosylation of Mucins,1/65,0.4187780864775593,0.48369156215926606,0,0,1.8721590909090908,1.629553718672261,MUC3A,High
RAB Geranylgeranylation,1/65,0.4187780864775593,0.48369156215926606,0,0,1.8721590909090908,1.629553718672261,RAB4A,High
Regulation of Endogenous Retroelements by Piwi-interacting RNAs (piRNAs),1/66,0.42361794850255324,0.4886113871769176,0,0,1.8432634032634032,1.5832218755256053,SS18L1,High
FOXO-mediated Transcription,1/67,0.4284177495076014,0.49279746596366175,0,0,1.81524334251607,1.5387028350226102,SOD2,High
RNA Polymerase II Transcription Termination,1/67,0.4284177495076014,0.49279746596366175,0,0,1.81524334251607,1.5387028350226102,THOC2,High
GPCR Downstream Signalling,6/633,0.429362880091007,0.49321083906770513,0,0,1.148744019138756,0.9712088971658943,CXCL10;CXCL11;CXCL9;PRKCE;FPR1;OXER1,High
SUMOylation,2/176,0.43030057220506795,0.4936145528564948,0,0,1.3779086066722737,1.1619507949224792,EID3;MRTFA,High
Sensory Processing of Sound by Inner Hair Cells of the Cochlea,1/69,0.43789848385299784,0.501646970617992,0,0,1.7616755793226382,1.454735614856356,CAPZB,High
Sensory Perception,6/640,0.439692310547574,0.5030175617949149,0,0,1.135646687697161,0.9331382735774382,RBP4;CAPZB;AKR1C1;SCN9A;AKR1C3;AKR1C4,High
Diseases Associated With O-glycosylation of Proteins,1/71,0.4472228942659399,0.5109385033540317,0,0,1.7111688311688311,1.3769744163255409,MUC3A,High
trans-Golgi Network Vesicle Budding,1/72,0.4518272802787947,0.5148018538494522,0,0,1.686982501067008,1.340232181311951,FTH1,High
Interleukin-17 Signaling,1/72,0.4518272802787947,0.5148018538494522,0,0,1.686982501067008,1.340232181311951,UBC,High
Ion Channel Transport,2/184,0.452763016569457,0.515170891826328,0,0,1.3168051460734387,1.0434185321482101,UBC;CUTC,High
Transport to the Golgi and Subsequent Modification,2/186,0.45830047245338473,0.5207678782803643,0,0,1.3023594909862142,1.0161402798183858,TUBA1C;CAPZB,High
Signaling by NOTCH1,1/74,0.4609219957197416,0.5223369049744581,0,0,1.6405977584059777,1.2706863691544725,UBC,High
Transport of Mature mRNA Derived From an Intron-Containing Transcript,1/74,0.4609219957197416,0.5223369049744581,0,0,1.6405977584059777,1.2706863691544725,THOC2,High
Extra-nuclear Estrogen Signaling,1/75,0.4654129501307578,0.5253052332575041,0,0,1.6183456183456184,1.2377596073077237,MMP2,High
Nuclear Envelope (NE) Reassembly,1/75,0.4654129501307578,0.5253052332575041,0,0,1.6183456183456184,1.2377596073077237,TUBA1C,High
Transcriptional Regulation by Small RNAs,1/75,0.4654129501307578,0.5253052332575041,0,0,1.6183456183456184,1.2377596073077237,TNRC6A,High
"Cell Death Signalling via NRAGE, NRIF and NADE",1/76,0.4698667146306185,0.529622187040135,0,0,1.5966868686868687,1.2059875079648261,UBC,High
Protein Ubiquitination,1/77,0.4742835954373444,0.5324623831443253,0,0,1.5755980861244019,1.1753171301465062,UBC,High
SUMOylation of DNA Damage Response and Repair Proteins,1/77,0.4742835954373444,0.5324623831443253,0,0,1.5755980861244019,1.1753171301465062,EID3,High
Sensory Processing of Sound,1/77,0.4742835954373444,0.5324623831443253,0,0,1.5755980861244019,1.1753171301465062,CAPZB,High
Diseases of Programmed Cell Death,1/78,0.47866389608016313,0.5366644480685717,0,0,1.5550570641479733,1.1456985650168554,SOD2,High
Biosynthesis of the N-glycan Precursor (Dolichol LLO) and Transfer to a Nascent Protein,1/79,0.48300791773489654,0.5408147163999772,0,0,1.5350427350427351,1.1170847263401216,CMAS,High
Amyloid Fiber Formation,1/80,0.487315959090938,0.5434702484166487,0,0,1.5155350978135789,1.089431159241575,UBC,High
Late SARS-CoV-2 Infection Events,1/80,0.487315959090938,0.5434702484166487,0,0,1.5155350978135789,1.089431159241575,UBC,High
Processing of DNA Double-Strand Break Ends,1/80,0.487315959090938,0.5434702484166487,0,0,1.5155350978135789,1.089431159241575,UBC,High
Senescence-Associated Secretory Phenotype (SASP),1/81,0.4915883163019557,0.5475097385267813,0,0,1.4965151515151516,1.0626958638325408,UBC,High
Cilium Assembly,2/200,0.4961360332084165,0.5518448348236283,0,0,1.209411185020941,0.8476825030852104,TUBA1C;CCT8,High
Regulation of HSF1-mediated Heat Shock Response,1/83,0.5000271512495771,0.5547073272096757,0,0,1.4598669623059868,1.0118233966428425,HSPA9,High
Transport of Mature Transcript to Cytoplasm,1/83,0.5000271512495771,0.5547073272096757,0,0,1.4598669623059868,1.0118233966428425,THOC2,High
PI Metabolism,1/84,0.504194209352044,0.5571279846121011,0,0,1.442205184373859,0.9876130952043071,RAB4A,High
Transcriptional Regulation of White Adipocyte Differentiation,1/84,0.504194209352044,0.5571279846121011,0,0,1.442205184373859,0.9876130952043071,HELZ2,High
"Transport of Bile Salts and Organic Acids, Metal Ions and Amine Compounds",1/84,0.504194209352044,0.5571279846121011,0,0,1.442205184373859,0.9876130952043071,RUNX1,High
Neurotransmitter Receptors and Postsynaptic Signal Transmission,2/204,0.5066370111863919,0.5590935300379319,0,0,1.1852209611205022,0.8059034208310533,TUBA1C;DLG1,High
TP53 Regulates Metabolic Genes,1/86,0.5124250401417375,0.5647406856012342,0,0,1.4081283422459894,0.9414757949953488,TNRC6A,High
Protein-protein Interactions at Synapses,1/88,0.52052004066895885,0.5729122539127626,0,0,1.3756182514803204,0.8981781453111252,DLG1,High
Phospholipid Metabolism,2/211,0.524670720168132,0.5767268229524375,0,0,1.1451161162329326,0.7385820458647098,RAB4A;GPD1,High
Mitochondrial Translation Elongation,1/91,0.5324127239411499,0.5829538537821174,0,0,1.3295622895622896,0.838071365624585,MRPL45,High
Mitochondrial Translation Initiation,1/91,0.5324127239411499,0.5829538537821174,0,0,1.3295622895622896,0.838071365624585,MRPL45,High
Mitochondrial Translation Termination,1/91,0.5324127239411499,0.5829538537821174,0,0,1.3295622895622896,0.838071365624585,MRPL45,High
Signaling by GPCR,6/706,0.5346602351352693,0.584183986916249,0,0,1.0250357142857143,0.6417992651180906,CXCL10;CXCL11;CXCL9;PRKCE;FPR1;OXER1,High
Cell-cell Junction Organization,1/92,0.5363114274183616,0.584183986916249,0,0,1.3148851148851148,0.8192263708643077,TNRC6A,High
Regulation of TP53 Activity Through Phosphorylation,1/92,0.5363114274183616,0.584183986916249,0,0,1.3148851148851148,0.8192263708643077,UBC,High
Telomere Maintenance,1/92,0.5363114274183616,0.584183986916249,0,0,1.3148851148851148,0.8192263708643077,POLD2,High
Recruitment of NuMA to Mitotic Centrosomes,1/94,0.5440121615938746,0.5910428904026354,0,0,1.286477680026067,0.7831866117878795,TUBA1C,High
Signaling by TGF-beta Receptor Complex,1/94,0.5440121615938746,0.5910428904026354,0,0,1.286477680026067,0.7831866117878795,UBC,High
Mitochondrial Translation,1/97,0.5553255416347704,0.6025568377016451,0,0,1.2460858585858585,0.7329486685984987,MRPL45,High
P75 NTR Receptor-Mediated Signalling,1/98,0.5590343169918047,0.6034703780860251,0,0,1.2331771321462044,0.7171472772890255,UBC,High
MyD88 Cascade Initiated on Plasma Membrane,1/98,0.5590343169918047,0.6034703780860251,0,0,1.2331771321462044,0.7171472772890255,UBC,High
Toll Like Receptor 10 (TLR10) Cascade,1/98,0.5590343169918047,0.6034703780860251,0,0,1.2331771321462044,0.7171472772890255,UBC,High
Toll Like Receptor 5 (TLR5) Cascade,1/98,0.5590343169918047,0.6034703780860251,0,0,1.2331771321462044,0.7171472772890255,UBC,High
COPI-dependent Golgi-to-ER Retrograde Traffic,1/101,0.5699771660218432,0.6137094293994783,0,0,1.196,0.6723421383658332,TUBA1C,High
Cellular Response to Heat Stress,1/101,0.5699771660218432,0.6137094293994783,0,0,1.196,0.6723421383658332,HSPA9,High
TRAF6 Mediated Induction of NFkB and MAP Kinases Upon TLR7 8 or 9 Activation,1/102,0.5735644610362591,0.6167832390709198,0,0,1.1840984098409841,0.65822248459561294,UBC,High
MyD88 Dependent Cascade Initiated on Endosome,1/103,0.5771220091594975,0.6198172598371134,0,0,1.17243018419489,0.6444867252522097,UBC,High
Cargo Recognition for Clathrin-Mediated Endocytosis,1/105,0.5841488433543327,0.6265647466297428,0,0,1.1497668997668997,0.6181140642911073,UBC,High
Toll Like Receptor 3 (TLR3) Cascade,1/106,0.5876186138372826,0.6275815742318258,0,0,1.1387590187590189,0.6054521581129901,UBC,High
Chromatin Modifying Enzymes,2/238,0.5900002629608749,0.6275815742318258,0,0,1.0127118644067796,0.5343394865943706,KDM4B;KDM5D,High
Chromatin Organization,2/238,0.5900002629608749,0.6275815742318258,0,0,1.0127118644067796,0.5343394865943706,KDM4B;KDM5D,High
Post-translational Protein Phosphorylation,1/107,0.5910596061351994,0.6275815742318258,0,0,1.127958833619211,0.5931240799056291,IGFBP5,High
Role of Phospholipids in Phagocytosis,1/107,0.5910596061351994,0.6275815742318258,0,0,1.127958833619211,0.5931240799056291,PRKCE,High
Sphingolipid Metabolism,1/107,0.5910596061351994,0.6275815742318258,0,0,1.127958833619211,0.5931240799056291,CERS2,High
Stimuli-sensing Channels,1/107,0.5910596061351994,0.6275815742318258,0,0,1.127958833619211,0.5931240799056291,UBC,High
Toll Like Receptor 7 8 (TLR7 8) Cascade,1/107,0.5910596061351994,0.6275815742318258,0,0,1.127958833619211,0.5931240799056291,UBC,High
Integration of Energy Metabolism,1/108,0.5944720574801863,0.6304099148593411,0,0,1.1173605210988389,0.5811186092324172,ACACA,High
Maternal to Zygotic Transition (MZT),1/109,0.5978562032888148,0.633201161219097,0,0,1.1069584736251403,0.5694249920837137,KDM4B,High
Adipogenesis,1/110,0.6012122768382878,0.6335678812238278,0,0,1.0967472894078398,0.5580329182600923,HELZ2,High
MyD88-independent TLR4 Cascade,1/110,0.6012122768382878,0.6335678812238278,0,0,1.0967472894078398,0.5580329182600923,UBC,High
TRIF (TICAM1)-mediated TLR4 Signaling,1/110,0.6012122768382878,0.6335678812238278,0,0,1.0967472894078398,0.5580329182600923,UBC,High
Toll Like Receptor 9 (TLR9) Cascade,1/110,0.6012122768382878,0.6335678812238278,0,0,1.0967472894078398,0.5580329182600923,UBC,High
Regulation of Endogenous Retroelements,1/111,0.6045405096637111,0.6362788864210559,0,0,1.0867217630853994,0.5469324987546905,SS18L1,High
O-linked Glycosylation,1/114,0.6143604497508266,0.6458071144696579,0,0,1.0577098417806383,0.5152881753235423,MUC3A,High
EML4 and NUDC in Mitotic Spindle Formation,1/116,0.6207720315678814,0.6517332301498207,0,0,1.039209486166008,0.4954861077366164,TUBA1C,High
PPARA Activates Gene Expression,1/117,0.6239379754709523,0.6542413142547221,0,0,1.0301985370950888,0.4859490940560897,HELZ2,High
Cell Junction Organization,1/119,0.630191261510353,0.6583387620244631,0,0,1.0126348228043143,0.46756581691301136,TNRC6A,High
Chromosome Maintenance,1/119,0.630191261510353,0.6583387620244631,0,0,1.0126348228043143,0.46756581691301136,POLD2,High
Regulation of Lipid Metabolism by PPARalpha,1/119,0.630191261510353,0.6583387620244631,0,0,1.0126348228043143,0.46756581691301136,HELZ2,High
"Platelet Activation, Signaling and Aggregation",2/262,0.6423109402672109,0.6694206721353863,0,0,0.9181050656660413,0.406429286190875,PRKCE;PLEK,High
Rab Regulation of Trafficking,1/123,0.6423894335931022,0.6694206721353863,0,0,0.9792349726775956,0.43337078259421263,RAB4A,High
Resolution of Sister Chromatid Cohesion,1/126,0.6512748319607857,0.6778410488392851,0,0,0.9555878787878788,0.40977859316128235,TUBA1C,High
Metabolism of Water-Soluble Vitamins and Cofactors,1/127,0.6541875901917914,0.6796782930586167,0,0,0.947955747955748,0.40227557570904526,ACACA,High
Transmission Across Chemical Synapses,2/269,0.6565500076872985,0.6796782930586167,0,0,0.8937151731067873,0.3760363922393614,TUBA1C;DLG1,High
Glycerophospholipid Biosynthesis,1/128,0.6570761645483539,0.6796782930586167,0,0,0.9404438081603436,0.3949443986815018,GPD1,High
Platelet Degranulation,1/128,0.6570761645483539,0.6796782930586167,0,0,0.9404438081603436,0.3949443986815018,PLEK,High
Regulation of Complement Cascade,1/128,0.6570761645483539,0.6796782930586167,0,0,0.9404438081603436,0.3949443986815018,C7,High
Cardiac Conduction,1/130,0.6627815583518013,0.6847387388125359,0,0,0.9257693211181584,0.38077801067123,SCN9A,High
Response to Elevated Platelet Cytosolic Ca2+,1/133,0.6711632068547831,0.6925483090339798,0,0,0.9045913682277319,0.3606994237409947,PLEK,High
Gene Silencing by RNA,1/134,0.6739108125358193,0.6945323184273682,0,0,0.8977443609022556,0.354301547303411,TNRC6A,High
Complement Cascade,1/139,0.6873102755569503,0.7074758582138779,0,0,0.8649978041282389,0.32434775117000936,C7,High
Clathrin-mediated Endocytosis,1/145,0.7026690029584441,0.7215210981597683,0,0,0.8287037037037037,0.29242412326433737,UBC,High
Late Phase of HIV Life Cycle,1/145,0.7026690029584441,0.7215210981597683,0,0,0.8287037037037037,0.29242412326433737,UBC,High
RHOA GTPase Cycle,1/149,0.7124891613972104,0.7307136101052998,0,0,0.8061425061425062,0.27327471493723965,FARP1,High
CDC42 GTPase Cycle,1/155,0.7266181085188693,0.7442973812322238,0,0,0.7744982290436836,0.2473392911792392,FARP1,High
Cell-Cell Communication,1/157,0.7311726547423888,0.7471448729285091,0,0,0.7644910644910645,0.23936647726481164,TNRC6A,High
Death Receptor Signaling,1/157,0.7311726547423888,0.7471448729285091,0,0,0.7644910644910645,0.23936647726481164,UBC,High
HIV Life Cycle,1/158,0.7334215635834758,0.7485344927724685,0,0,0.7595830920671685,0.23549705649509195,UBC,High
Regulation of TP53 Activity,1/160,0.737863431988127,0.7521561861186475,0,0,0.7499523537259386,0.2279829079576585,UBC,High
Potential Therapeutics for SARS,1/164,0.746527655876261,0.7600680607591436,0,0,0.7313998884551032,0.21380472822305382,STAT2,High
Fcgamma Receptor (FCGR) Dependent Phagocytosis,1/168,0.7549071732338313,0.7676713041822294,0,0,0.7137361640355653,0.2006744072207776,PRKCE,High
RAC1 GTPase Cycle,1/184,0.7857597163937382,0.7980816419825424,0,0,0.650803113098195,0.1569113884266658,FARP1,High
Transcriptional Regulation by TP53,2/362,0.8054885590353729,0.8171341767563662,0,0,0.6596883468834689,0.14269473228843274,UBC;TNRC6A,High
Mitotic Prometaphase,1/203,0.8174193801113562,0.8282396125797374,0,0,0.589018901890189,0.11874797689705355,TUBA1C,High
HCMV Early Events,1/205,0.8204685089832768,0.8303299093316335,0,0,0.583184789067142,0.11540045995232112,TUBA1C,High
G Alpha (Q) Signalling Events,1/219,0.8404408862277692,0.8495212799565207,0,0,0.5453433416736169,0.094796302476361,PRKCE,High
Hemostasis,4/707,0.8426397669170633,0.8507226423790974,0,0,0.6719350929877246,0.11504586086134402,TUBA1C;CAPZB;PRKCE;PLEK,High
Neuronal System,2/411,0.8583551377467405,0.8655509293206654,0,0,0.5791937503727116,0.08846451953862741,TUBA1C;DLG1,High
SLC-mediated Transmembrane Transport,1/249,0.8761077426033667,0.8823955972153525,0,0,0.4786412512218964,0.0633080603092773,RUNX1,High
RNA Polymerase II Transcription,8/1360,0.8840836186535321,0.8893648828031948,0,0,0.692157890794697,0.0852763643889913,PSMB4;UBC;PSMB1;THOC2;SOD2;TEAD1;TNRC6A;RUNX1,High
HCMV Infection,1/259,0.8861373708552437,0.8903671435084908,0,0,0.4598543575287761,0.05558870962867746,TUBA1C,High
RHO GTPase Cycle,2/450,0.8907148122687016,0.8932194959437,0,0,0.527711236933798,0.06107253795498241,FARP1;CAPZB,High
Generic Transcription Pathway,7/1230,0.8910978344331448,0.8932194959437,0,0,0.6699527401944902,0.0772462574658397,PSMB4;UBC;PSMB1;SOD2;TEAD1;TNRC6A;RUNX1,High
Epigenetic Regulation of Gene Expression,1/291,0.9131170157937665,0.9142027672988721,0,0,0.4084430512016719,0.03712389553259861,SS18L1,High
Gene Expression (Transcription),9/1615,0.9267907911329065,0.9267907911329065,0,0,0.6506333732579261,0.0494659784718697,PSMB4;SS18L1;UBC;PSMB1;THOC2;SOD2;TEAD1;TNRC6A;RUNX1,High
Steroid hormone biosynthesis,9/61,1.8012880014488402e-9,3.2963570426513774e-7,0,0,21.807692307692307,439.09273519928644,UGT2B10;UGT1A1;AKR1C1;AKR1C3;UGT1A3;AKR1C4;CYP3A5;UGT2B7;UGT1A7,High
Metabolism of xenobiotics by cytochrome P450,7/76,3.2302120659087787e-6,2.725034956108629e-4,0,0,12.610974387020326,159.44007964083784,UGT2B10;UGT1A1;AKR1C1;UGT1A3;CYP3A5;UGT2B7;UGT1A7,High
Ascorbate and aldarate metabolism,5/30,4.467270419850212e-6,2.725034956108629e-4,0,0,24.607453416149067,303.1326479559256,UGT2B10;UGT1A1;UGT1A3;UGT1A7;UGT2B7,High
Pentose and glucuronate interconversions,5/34,8.491979001352598e-6,3.8850803931188136e-4,0,0,21.20903833797387,247.64497106737247,UGT2B10;UGT1A1;UGT1A3;UGT1A7;UGT2B7,High
Retinol metabolism,6/68,2.135885066409096e-5,7.817339343057292e-4,0,0,11.958870967741936,128.606228801064,UGT2B10;UGT1A1;UGT1A3;CYP3A5;UGT2B7;UGT1A7,High
Porphyrin and chlorophyll metabolism,5/43,2.7658862290168747e-5,8.435952998501468e-4,0,0,16.17848970251716,169.80237999360634,UGT2B10;UGT1A1;UGT1A3;UGT1A7;UGT2B7,High
Drug metabolism,7/108,3.299572333388919e-5,8.626024814431031e-4,0,0,8.601469580920357,88.75970516759872,UGT2B10;UGT1A1;UGT1A3;CYP2C19;CYP3A5;UGT2B7;UGT1A7,High
Coronavirus disease,9/232,1.4244206749232217e-4,0.0032583622938868696,0,0,5.0412441804004455,44.64815810880565,CXCL10;RPL7A;C7;STAT2;RPS3;RPS27L;RPL38;RPL27;RPS20,High
Bile secretion,5/90,9.231522977418176e-4,0.01877076338741696,0,0,7.215564486664231,50.420317823232594,UGT2B10;UGT1A1;UGT1A3;UGT2B7;UGT1A7,High
Parkinson disease,8/249,0.0011494154602891351,0.021034302923291174,0,0,4.116392667682126,27.86181102113567,TUBA1C;PSMB4;ATP5PD;UBC;PSMB1;NDUFA1;CALM2;BCL2L1,High
Ribosome,6/158,0.00207718214534783,0.034556757508968444,0,0,4.855756578947369,29.992760660567793,RPL7A;RPS3;RPS27L;RPL38;RPL27;RPS20,High
DNA replication,3/36,0.0032790529897592773,0.05000555809382898,0,0,11.043502509760179,63.17104991333868,POLD2;POLE3;SSBP1,High
Chemical carcinogenesis,7/239,0.003882370113048986,0.054651825437535724,0,0,3.7197462589459986,20.64946258851178,UGT2B10;UGT1A1;UGT1A3;CYP2C19;CYP3A5;UGT2B7;UGT1A7,High
Vascular smooth muscle contraction,5/133,0.0050801607502428325,0.06640495837817417,0,0,4.781152950310559,25.25602150739468,PRKCE;MYH11;PPP1R12B;CALM2;ACTG2,High
Proteasome,3/46,0.006562575377164179,0.07969509641622056,0,0,8.47096590098445,42.57822721610337,PSMB4;PSMB1;PSMB9,High
Pyruvate metabolism,3/47,0.006967877282292509,0.07969509641622056,0,0,8.27802565532627,41.11235623837757,FH;LDHA;ACACA,High
Viral protein interaction with cytokine and cytokine receptor,4/100,0.009685106101044453,0.10425731861712559,0,0,5.07664609053498,23.54125078208122,CXCL10;CXCL11;CXCL9;CCL15,High
Tight junction,5/169,0.01350693245730817,0.13732047998263305,0,0,3.724814422057264,16.033658152252393,TUBA1C;DLG1;PRKCE;MYH11;RUNX1,High
Mismatch repair,2/23,0.01545253984792937,0.14883235748268814,0,0,11.505807200929151,47.97900774627138,POLD2;SSBP1,High
Glycolysis / Gluconeogenesis,3/67,0.018256152744620315,0.1670437976132759,0,0,5.685391104294479,22.760059671456084,LDHA;ENO1;ALDOB,High
Chemokine signaling pathway,5/192,0.022162381663751146,0.19312932592697427,0,0,3.2628624572358587,12.429414294553453,CXCL10;CXCL11;CXCL9;STAT2;CCL15,High
PPAR signaling pathway,3/74,0.023692598578629136,0.19707934272223326,0,0,5.123045018577724,19.173470252407807,UBC;AQP7;PLIN5,High
Prion disease,6/273,0.026637492812655178,0.21194179063982163,0,0,2.748174157303371,9.963328291265876,TUBA1C;PSMB4;ATP5PD;C7;PSMB1;NDUFA1,High
Base excision repair,2/33,0.030556765083200918,0.2291982217524845,0,0,7.790322580645161,27.173963088287994,POLD2;POLE3,High
Propanoate metabolism,2/34,0.03229271278042159,0.2291982217524845,0,0,7.546493902439025,25.906462189344023,LDHA;ACACA,High
Amyotrophic lateral sclerosis,7/364,0.032563681779041516,0.2291982217524845,0,0,2.401899124429646,8.225442063099704,TUBA1C;PSMB4;ATP5PD;PSMB1;NDUFA1;HNRNPA1;BCL2L1,High
Spliceosome,4/150,0.036519854810939965,0.24752346038525977,0,0,3.3296127177405714,11.020682466987976,THOC2;PRPF19;HNRNPA1;PRPF8,High
Small cell lung cancer,3/92,0.041245122582799824,0.2600035954883039,0,0,4.083201213207417,13.01815362722486,COL4A1;FHIT;BCL2L1,High
Huntington disease,6/306,0.04271501433655318,0.2600035954883039,0,0,2.44175,7.699337812454192,TUBA1C;PSMB4;ATP5PD;PSMB1;NDUFA1;SOD2,High
IL-17 signaling pathway,3/94,0.04350746596649147,0.2600035954883039,0,0,3.9930560237308703,12.517522762198771,CXCL10;S100A9;S100A8,High
Pathways of neurodegeneration,8/475,0.04498741920995372,0.2600035954883039,0,0,2.099802130485458,6.512268375913308,TUBA1C;PSMB4;ATP5PD;UBC;PSMB1;NDUFA1;CALM2;BCL2L1,High
Homologous recombination,2/41,0.04546510959358319,0.2600035954883039,0,0,6.1898061288305195,19.131515110021255,POLD2;SSBP1,High
AGE-RAGE signaling pathway in diabetic complications,3/100,0.05065785270183577,0.280920819528362,0,0,3.7449244197077984,11.169840096133063,COL4A1;PRKCE;MMP2,High
Toll-like receptor signaling pathway,3/104,0.05572193326382273,0.2999151113905753,0,0,3.5958816740569763,10.382681986776497,CXCL10;CXCL11;CXCL9,High
Nucleotide excision repair,2/47,0.058049901426630884,0.30333504849589954,0,0,5.362872628726287,15.265160961949023,POLD2;POLE3,High
Glucagon signaling pathway,3/107,0.0596724685565704,0.30333504849589954,0,0,3.491623407267579,9.842483200902858,LDHA;CALM2;ACACA,High
HIF-1 signaling pathway,3/109,0.06237750460963072,0.3085157660422276,0,0,3.425396457923371,9.503935700474214,LDHA;ENO1;ALDOB,High
Riboflavin metabolism,1/8,0.06451346874924052,0.3106832837134478,0,0,17.166233766233766,47.050608420266336,ACP1,High
Pathways in cancer,8/531,0.07558260866121096,0.3546568560256822,0,0,1.8695452235157441,4.828154880724953,FH;COL4A1;ZBTB16;MMP2;STAT2;CALM2;RUNX1;BCL2L1,High
Glutathione metabolism,2/57,0.08128159444930544,0.3707148591277622,0,0,4.385587583148559,11.007104187793972,GGT7;TXNDC12,High
Alzheimer disease,6/369,0.0876217965285927,0.3707148591277622,0,0,2.0114669421487603,4.897369842719315,TUBA1C;PSMB4;ATP5PD;PSMB1;NDUFA1;CALM2,High
Taurine and hypotaurine metabolism,1/11,0.087624550803351825,0.3707148591277622,0,0,12.014545454545454,29.25174245169941,GGT7,High
Mineral absorption,2/60,0.0887278326738941,0.3707148591277622,0,0,4.15811606391926,10.071712447363208,MT2A;FTH1,High
Diabetic cardiomyopathy,4/203,0.08913362733126523,0.3707148591277622,0,0,2.436255350828215,5.889936261674074,ATP5PD;TBC1D4;MMP2;NDUFA1,High
Arachidonic acid metabolism,2/61,0.0912536221631014,0.371098063463279,0,0,4.0874328234807775,9.785774393158777,AKR1C3;CYP2C19,High
Oxidative phosphorylation,3/133,0.09900249420005228,0.39385774866542533,0,0,2.789617744218971,6.451298547646033,ATP5PD;PPA1;NDUFA1,High
Acute myeloid leukemia,2/67,0.10683099463534293,0.4145815721367833,0,0,3.7090056285178234,8.295217728550588,ZBTB16;RUNX1,High
Mitophagy,2/68,0.10949299946313869,0.4145815721367833,0,0,3.6526237989652626,8.079219089116346,UBC;BCL2L1,High
Ubiquitin mediated proteolysis,3/140,0.11100818051749936,0.4145815721367833,0,0,2.646142134252832,5.816620989454468,UBC;UBR5;PRPF19,High
Thiamine metabolism,1/15,0.11755880336673992,0.4302652203222681,0,0,8.58008658008658,18.3683919207857,ACP1,High
Chronic myeloid leukemia,2/76,0.1313804827220259,0.46509372734440413,0,0,3.2564271588661833,6.609432513758495,RUNX1;BCL2L1,High
Primary bile acid biosynthesis,1/17,0.13215778044759025,0.46509372734440413,0,0,7.506818181818182,15.191989083592048,AKR1C4,High
Fatty acid biosynthesis,1/18,0.13936698781759904,0.4738685555440263,0,0,7.06488413547237,13.922375947326568,ACACA,High
RNA degradation,2/79,0.13983006557036842,0.4738685555440263,0,0,3.1290782388343366,6.155921390423331,HSPA9;ENO1,High
Shigellosis,4/246,0.148650972174334,0.4946023255982386,0,0,1.9989796959493928,3.8103635222333088,PRKCE;UBC;GLMN;BCL2L1,High
Steroid biosynthesis,1/20,0.15360730321466595,0.5019667230050691,0,0,6.320574162679426,11.84068497759772,SC5D,High
Endocytosis,4/252,0.15795464271767068,0.5071175371462059,0,0,1.9500199123855038,3.5986590964808745,AGAP9;RAB4A;CAPZB;AGAP5,High
ECM-receptor interaction,2/88,0.16582164139750205,0.5231958685472909,0,0,2.800340328984685,5.031770567073515,COL4A1;COL6A3,High
GnRH signaling pathway,2/93,0.18060330493553856,0.5601763525966704,0,0,2.645805414098097,4.528169862943641,MMP2;CALM2,High
NOD-like receptor signaling pathway,3/181,0.1906235666970406,0.5663650748712924,0,0,2.0323981526159787,3.3686077699548367,STAT2;GBP1;BCL2L1,High
Folate biosynthesis,1/26,0.19493813427133033,0.5663650748712924,0,0,4.802181818181818,7.8519179804021215,AKR1C3,High
Aldosterone synthesis and secretion,2/98,0.19557411423985127,0.5663650748712924,0,0,2.5073678861788617,4.091562709663729,PRKCE;CALM2,High
Inflammatory mediator regulation of TRP channels,2/98,0.19557411423985127,0.5663650748712924,0,0,2.5073678861788617,4.091562709663729,PRKCE;CALM2,High
Phototransduction,1/28,0.2082642650600524,0.5663650748712924,0,0,4.446015712682379,6.975565240010467,CALM2,High
Protein digestion and absorption,2/103,0.2106943160472285,0.5663650748712924,0,0,2.382637044192224,3.710592498123414,COL4A1;COL6A3,High
C-type lectin receptor signaling pathway,2/104,0.2137329909232959,0.5663650748712924,0,0,2.359158297465328,3.640246717176701,STAT2;CALM2,High
Transcriptional misregulation in cancer,3/192,0.21402733847202307,0.5663650748712924,0,0,1.9130392443275879,2.9492398631422634,ZBTB16;RUNX1;BCL2L1,High
Linoleic acid metabolism,1/29,0.21484487504824337,0.5663650748712924,0,0,4.287012987012987,6.59273586213286,CYP2C19,High
Kaposi sarcoma-associated herpesvirus infection,3/193,0.21618571693048289,0.5663650748712924,0,0,1.9028737487891507,2.91447461997427,STAT2;UBC;CALM2,High
Citrate cycle (TCA cycle),1/30,0.22137111624035788,0.5663650748712924,0,0,4.138975966562174,6.24122281400424,FH,High
Pentose phosphate pathway,1/30,0.22137111624035788,0.5663650748712924,0,0,4.138975966562174,6.24122281400424,ALDOB,High
Pathogenic Escherichia coli infection,3/197,0.22486468106548171,0.5663650748712924,0,0,1.8632597558661692,2.7804614356494453,TUBA1C;RPS3;MYH11,High
Insulin resistance,2/108,0.22592705172461391,0.5663650748712924,0,0,2.2696732627703637,3.376236828057308,TBC1D4;PRKCE,High
Cytokine-cytokine receptor interaction,4/295,0.23009511017073445,0.5687514966185412,0,0,1.6582240889228288,2.4363665252624895,CXCL10;CXCL11;CXCL9;CCL15,High
Focal adhesion,3/201,0.23361124105542816,0.5687514966185412,0,0,1.825246328313813,2.6540850427581524,COL4A1;COL6A3;PPP1R12B,High
SNARE interactions in vesicular transport,1/33,0.24062807362745908,0.5687514966185412,0,0,3.750378787878788,5.342425086287716,STX3,High
Fructose and mannose metabolism,1/33,0.24062807362745908,0.5687514966185412,0,0,3.750378787878788,5.342425086287716,ALDOB,High
Proteoglycans in cancer,3/205,0.24241867068987,0.5687514966185412,0,0,1.7887383830407582,2.534801492665031,LUM;MMP2;PPP1R12B,High
Tyrosine metabolism,1/36,0.25941156821878103,0.5939968980943093,0,0,3.4283982683982686,4.626072903688683,FAH,High
Sphingolipid signaling pathway,2/119,0.2596707751231953,0.5939968980943093,0,0,2.05513862830936,2.7710270564124277,PRKCE;CERS2,High
Lipid and atherosclerosis,3/215,0.26466065409822476,0.5979370333330263,0,0,1.7034957749739552,2.2644685586247317,SOD2;CALM2;BCL2L1,High
Bladder cancer,1/41,0.2896965552786852,0.629081417448043,0,0,2.999090909090909,3.7156375027236566,MMP2,High
Ferroptosis,1/41,0.2896965552786852,0.629081417448043,0,0,2.999090909090909,3.7156375027236566,FTH1,High
Relaxin signaling pathway,2/129,0.2904083008967168,0.629081417448043,0,0,1.892356443249472,2.339837074126928,COL4A1;MMP2,High
Tryptophan metabolism,1/42,0.29560417538693134,0.629081417448043,0,0,2.9257945306725794,3.5657651687993317,TDO2,High
Human papillomavirus infection,4/331,0.29563389016683994,0.629081417448043,0,0,1.4729489938460376,1.7949849107189075,DLG1;COL4A1;STAT2;COL6A3,High
ABC transporters,1/45,0.3130355952540956,0.6305924626774547,0,0,2.7258953168044076,3.1659594191318527,ABCC6,High
Apelin signaling pathway,2/137,0.31489719478256767,0.6305924626774547,0,0,1.7794941282746162,2.0562215860056794,PRKCE;CALM2,High
Estrogen signaling pathway,2/137,0.31489719478256767,0.6305924626774547,0,0,1.7794941282746162,2.0562215860056794,MMP2;CALM2,High
Insulin signaling pathway,2/137,0.31489719478256767,0.6305924626774547,0,0,1.7794941282746162,2.0562215860056794,CALM2;ACACA,High
Type II diabetes mellitus,1/46,0.31875024868156443,0.6305924626774547,0,0,2.665185185185185,3.0472325582161406,PRKCE,High
Fluid shear stress and atherosclerosis,2/139,0.32099335007375895,0.6305924626774547,0,0,1.7533380808260637,1.9923792042580761,MMP2;CALM2,High
Measles,2/139,0.32099335007375895,0.6305924626774547,0,0,1.7533380808260637,1.9923792042580761,STAT2;BCL2L1,High
Amino sugar and nucleotide sugar metabolism,1/48,0.3300381801688704,0.6305924626774547,0,0,2.5515151515151517,2.8284742975844512,CMAS,High
Apoptosis,2/142,0.3301127344222513,0.6305924626774547,0,0,1.7155052264808361,1.9013305768795863,TUBA1C;BCL2L1,High
Spinocerebellar ataxia,2/143,0.33314529068831744,0.6305924626774547,0,0,1.7032520325203253,1.872174736801448,PSMB4;PSMB1,High
Sphingolipid metabolism,1/49,0.3356122319023523,0.6305924626774547,0,0,2.4982323232323234,2.727567195504404,CERS2,High
Cholesterol metabolism,1/50,0.34114018472714763,0.6305924626774547,0,0,2.4471243042671613,2.6317886779390967,APOC1,High
Cysteine and methionine metabolism,1/50,0.34114018472714763,0.6305924626774547,0,0,2.4471243042671613,2.6317886779390967,LDHA,High
Ovarian steroidogenesis,1/51,0.34662241763564233,0.6343190242732255,0,0,2.3980606060606062,2.5407913150697836,AKR1C3,High
Oxytocin signaling pathway,2/154,0.36621776710360765,0.660089731921116,0,0,1.5791078305519897,1.586256657667125,PPP1R12B;CALM2,High
Regulation of lipolysis in adipocytes,1/55,0.36810162135550845,0.660089731921116,0,0,2.2199775533108865,2.2186372062244897,AQP7,High
Pyrimidine metabolism,1/56,0.3733608314752076,0.660089731921116,0,0,2.179504132231405,2.147269157873668,CMPK2,High
Hepatitis C,2/157,0.37513296240325716,0.660089731921116,0,0,1.5483084185680567,1.5180773087619719,CXCL10;STAT2,High
Necroptosis,2/159,0.38104832536447864,0.6641127956352342,0,0,1.5284293925741805,1.4746731150100159,FTH1;STAT2,High
JAK-STAT signaling pathway,2/162,0.38987703397666346,0.6718112940137977,0,0,1.4995426829268292,1.4124550727311436,STAT2;BCL2L1,High
Hippo signaling pathway,2/163,0.39280769649987074,0.6718112940137977,0,0,1.4901530071201332,1.3924512872671757,DLG1;TEAD1,High
cGMP-PKG signaling pathway,2/167,0.40446650167714154,0.685346016730712,0,0,1.4537324464153731,1.3158987816730905,PRKCE;CALM2,High
Cytosolic DNA-sensing pathway,1/63,0.4089768470915394,0.6866308533738689,0,0,1.9327468230694038,1.7280626204540348,CXCL10,High
Influenza A,2/172,0.4188894134318822,0.6878848702192255,0,0,1.4106169296987088,1.2274459566930713,CXCL10;STAT2,High
Long-term potentiation,1/67,0.4284177495076014,0.6878848702192255,0,0,1.81524334251607,1.5387028350226102,CALM2,High
Amphetamine addiction,1/69,0.43789848385299784,0.6878848702192255,0,0,1.7616755793226382,1.454735614856356,CALM2,High
Renal cell carcinoma,1/69,0.43789848385299784,0.6878848702192255,0,0,1.7616755793226382,1.454735614856356,FH,High
Renin secretion,1/69,0.43789848385299784,0.6878848702192255,0,0,1.7616755793226382,1.454735614856356,CALM2,High
Tuberculosis,2/180,0.4415932804903484,0.6878848702192255,0,0,1.3466703206357906,1.10072253385692,HSPA9;CALM2,High
Central carbon metabolism in cancer,1/70,0.4425800684201329,0.6878848702192255,0,0,1.736056214317084,1.4151182471112724,LDHA,High
RIG-I-like receptor signaling pathway,1/70,0.4425800684201329,0.6878848702192255,0,0,1.736056214317084,1.4151182471112724,CXCL10,High
Adherens junction,1/71,0.4472228942659399,0.6878848702192255,0,0,1.7111688311688311,1.3769744163255409,ACP1,High
Non-small cell lung cancer,1/72,0.4518272802787947,0.6878848702192255,0,0,1.686982501067008,1.340232181311951,FHIT,High
p53 signaling pathway,1/73,0.45639354285208683,0.6878848702192255,0,0,1.6634680134680135,1.3048239922013845,BCL2L1,High
RNA transport,2/186,0.45830047245338473,0.6878848702192255,0,0,1.3023594909862142,1.0161402798183858,GEMIN4;THOC2,High
Glioma,1/75,0.4654129501307578,0.6878848702192255,0,0,1.6183456183456184,1.2377596073077237,CALM2,High
Gastric acid secretion,1/76,0.4698667146306185,0.6878848702192255,0,0,1.5966868686868687,1.2059875079648261,CALM2,High
Pancreatic cancer,1/76,0.4698667146306185,0.6878848702192255,0,0,1.5966868686868687,1.2059875079648261,BCL2L1,High
Pertussis,1/76,0.4698667146306185,0.6878848702192255,0,0,1.5966868686868687,1.2059875079648261,CALM2,High
Synaptic vesicle cycle,1/78,0.47866389608016313,0.6952023252592845,0,0,1.5550570641479733,1.1456985650168554,STX3,High
Peroxisome,1/82,0.4958252832404141,0.713147383669941,0,0,1.477964833520389,1.0368391317180785,SOD2,High
Epstein-Barr virus infection,2/202,0.50140413907606185,0.713147383669941,0,0,1.1971951219512196,0.8264750784316479,CXCL10;STAT2,High
Complement and coagulation cascades,1/85,0.5083267442555275,0.713147383669941,0,0,1.424963924963925,0.9641745386765581,C7,High
Taste transduction,1/86,0.5124250401417375,0.713147383669941,0,0,1.4081283422459894,0.9414757949953488,SCN9A,High
Gap junction,1/88,0.52052004066895885,0.713147383669941,0,0,1.3756182514803204,0.8981781453111252,TUBA1C,High
Rap1 signaling pathway,2/210,0.5221215162454121,0.713147383669941,0,0,1.1506801125703565,0.7477751422217018,FPR1;CALM2,High
Human immunodeficiency virus 1 infection,2/212,0.5272108361593648,0.713147383669941,0,0,1.1396051103368177,0.7295236151995624,CALM2;BCL2L1,High
Salivary secretion,1/93,0.5401778178667844,0.713147383669941,0,0,1.3005270092226613,0.8009385339343845,CALM2,High
Regulation of actin cytoskeleton,2/218,0.542259329137233,0.713147383669941,0,0,1.1076106594399278,0.6778698241444764,MYH11;PPP1R12B,High
Human T-cell leukemia virus 1 infection,2/219,0.5447351723863818,0.713147383669941,0,0,1.1024502641339777,0.6696895035936202,DLG1;BCL2L1,High
Staphylococcus aureus infection,1/95,0.5478147226069197,0.713147383669941,0,0,1.2727272727272727,0.7659503684440017,FPR1,High
Circadian entrainment,1/97,0.5553255416347704,0.713147383669941,0,0,1.2460858585858585,0.7329486685984987,CALM2,High
Fc gamma R-mediated phagocytosis,1/97,0.5553255416347704,0.713147383669941,0,0,1.2460858585858585,0.7329486685984987,PRKCE,High
Phosphatidylinositol signaling system,1/97,0.5553255416347704,0.713147383669941,0,0,1.2460858585858585,0.7329486685984987,CALM2,High
Glycerophospholipid metabolism,1/98,0.5590343169918047,0.713147383669941,0,0,1.2331771321462044,0.7171472772890255,GPD1,High
PI3K-Akt signaling pathway,3/354,0.5656225736577433,0.713147383669941,0,0,1.0216034817261812,0.582138528479752,COL4A1;COL6A3;BCL2L1,High
Melanogenesis,1/101,0.5699771660218432,0.713147383669941,0,0,1.196,0.6723421383658332,CALM2,High
Amoebiasis,1/102,0.5735644610362591,0.713147383669941,0,0,1.1840984098409841,0.65822248459561294,COL4A1,High
Longevity regulating pathway,1/102,0.5735644610362591,0.713147383669941,0,0,1.1840984098409841,0.65822248459561294,SOD2,High
Thermogenesis,2/232,0.5760726178290563,0.713147383669941,0,0,1.0394485683987276,0.5732782893439099,ATP5PD;NDUFA1,High
Ras signaling pathway,2/232,0.5760726178290563,0.713147383669941,0,0,1.0394485683987276,0.5732782893439099,CALM2;BCL2L1,High
T cell receptor signaling pathway,1/104,0.5806500555564001,0.713147383669941,0,0,1.1609885260370698,0.6311215101192602,DLG1,High
NF-kappa B signaling pathway,1/104,0.5806500555564001,0.713147383669941,0,0,1.1609885260370698,0.6311215101192602,BCL2L1,High
Th17 cell differentiation,1/107,0.5910596061351994,0.7210927194849432,0,0,1.127958833619211,0.5931240799056291,RUNX1,High
TNF signaling pathway,1/112,0.6078411312551987,0.7256840753401316,0,0,1.0768768768768768,0.5361142456989609,CXCL10,High
Toxoplasmosis,1/112,0.6078411312551987,0.7256840753401316,0,0,1.0768768768768768,0.5361142456989609,BCL2L1,High
Serotonergic synapse,1/113,0.6111143693366455,0.7256840753401316,0,0,1.0672077922077923,0.5255690524209823,CYP2C19,High
Leukocyte transendothelial migration,1/114,0.6143604497508266,0.7256840753401316,0,0,1.0577098417806383,0.5152881753235423,MMP2,High
Salmonella infection,2/249,0.6146504463263409,0.7256840753401316,0,0,0.9670682334353707,0.47067361080102804,TUBA1C;RPS3,High
Neurotrophin signaling pathway,1/119,0.630191261510353,0.7370280772250061,0,0,1.0126348228043143,0.46756581691301136,CALM2,High
AMPK signaling pathway,1/120,0.6332790354250868,0.7370280772250061,0,0,1.0040743570155335,0.4587054858360159,ACACA,High
Thyroid hormone signaling pathway,1/121,0.6363411814292402,0.7370280772250061,0,0,0.9956565656565657,0.4500570897153849,TBC1D4,High
Osteoclast differentiation,1/127,0.6541875901917914,0.7501189943609531,0,0,0.947955747955748,0.40227557570904526,STAT2,High
Oocyte meiosis,1/129,0.6599407546017128,0.7501189943609531,0,0,0.9330492424242425,0.38778012983311483,CALM2,High
Purine metabolism,1/129,0.6599407546017128,0.7501189943609531,0,0,0.9330492424242425,0.38778012983311483,FHIT,High
FoxO signaling pathway,1/131,0.6655987720659962,0.7504039512893402,0,0,0.9186013986013986,0.37393344938138173,SOD2,High
Dopaminergic synapse,1/132,0.6683925904926911,0.7504039512893402,0,0,0.9115429100161925,0.36724201358307795,CALM2,High
Systemic lupus erythematosus,1/135,0.6766355974811878,0.7550263069454719,0,0,0.8909995477159657,0.3480443921711074,C7,High
Autophagy,1/137,0.6820174574215845,0.7564193618675755,0,0,0.877807486631016,0.3359369462659658,BCL2L1,High
Retrograde endocannabinoid signaling,1/148,0.7100647702283709,0.7800561090250685,0,0,0.8116676973819831,0.27791427888310327,NDUFA1,High
Adrenergic signaling in cardiomyocytes,1/150,0.7148934010988786,0.7800561090250685,0,0,0.8006914785438275,0.268729544719172,CALM2,High
Phagosome,1/152,0.7196420910268143,0.7800561090250685,0,0,0.7900060204695967,0.2599129969675919,TUBA1C,High
Cushing syndrome,1/155,0.7266181085188693,0.7800561090250685,0,0,0.7744982290436836,0.2473392911792392,FH,High
Non-alcoholic fatty liver disease,1/155,0.7266181085188693,0.7800561090250685,0,0,0.7744982290436836,0.2473392911792392,NDUFA1,High
Cellular senescence,1/156,0.7289048887611296,0.7800561090250685,0,0,0.7694623655913978,0.2433132516899318,CALM2,High
Hepatitis B,1/162,0.7422317255829081,0.789700033614373,0,0,0.7405608883869753,0.22075659893878302,STAT2,High
Hepatocellular carcinoma,1/168,0.7549071732338313,0.7985434260219141,0,0,0.7137361640355653,0.2006744072207776,BCL2L1,High
Alcoholism,1/186,0.789334157090669,0.8301617859057036,0,0,0.6437018837018837,0.15227767601532136,CALM2,High
Neutrophil extracellular trap formation,1/189,0.7945849663516312,0.8309088505277059,0,0,0.6333333333333333,0.14562572518136305,FPR1,High
Viral carcinogenesis,1/203,0.8174193801113562,0.849930378183967,0,0,0.589018901890189,0.11874797689705355,DLG1,High
cAMP signaling pathway,1/216,0.8363559657411337,0.8647070154272737,0,0,0.5530373502466526,0.09882830550553276,CALM2,High
Human cytomegalovirus infection,1/225,0.8483091149418134,0.872138022664898,0,0,0.5305735930735931,0.08728476115987407,CALM2,High
Calcium signaling pathway,1/240,0.8663327717471085,0.8856921632945299,0,0,0.496893622416635,0.0712973683642623,CALM2,High
Herpes simplex virus 1 infection,2/498,0.9211564042318214,0.9362529009144321,0,0,0.4754622344610543,0.03904754384476738,STAT2;BCL2L1,High
MicroRNAs in cancer,1/310,0.9260206287732908,0.9362529009144321,0,0,0.38295577130528585,0.029433508509545184,PRKCE,High
Neuroactive ligand-receptor interaction,1/341,0.9431091347151274,0.948291053037738,0,0,0.34748663101604277,0.02035342882970746,FPR1,High
Olfactory transduction,1/440,0.975477861027467,0.975477861027467,0,0,0.26775729964796025,0.006647828480071792,CALM2,High
